CONTENTS
MESSAGE FROM THE CHAIRMAN
& THE PRESIDENT AND CEO
FINANCIAL HIGHLIGHTS
ESG
2022 REPORT TO SHAREHOLDERS
1
4
6
9
MESSAGE FROM THE CHAIRMAN &
THE PRESIDENT AND CEO
In 2022, Gildan delivered strong performance, thanks to our focus
on the Gildan Sustainable Growth (GSG) strategy, which allowed us
to end the year with net sales of $3.24 billion, up 11%, diluted EPS
of $2.93, and adjusted diluted EPS1 of $3.11. Further, we continued
to reinvest in our business and delivered on our capital allocation
priorities, returning a record $573 million to our shareholders through
$449 million in share repurchases, and $124 million in dividends.
As we enter the second year of the GSG strategy, we are on a solid
footing to build on this past year’s accomplishments. The combination
of our focused strategy, competitive strengths, and dedicated team
positions us well to deliver long-term value to our shareholders.
PERFORMING IN A CHANGING ENVIRONMENT
In 2022, we witnessed strong demand from our distributors in
the first half of the year as the imprintables industry benefitted
from the return of travel, social, and sporting events. At the same
time, we also saw stable demand related to retail end-markets as
retailers benefitted from the pandemic recovery. Given our increased
yarn-spinning capabilities, and investments in our textile and sewing
capacity, we were well positioned with improved product availability
to capitalize and respond to the positive demand environment. As
we moved through the year, inflationary pressures slowed end
demand and our customers started to manage inventories cautiously.
Nonetheless, we adapted well to the changing market
dynamics, demonstrating once again that exercising
tight control over our supply chain provides us with
the strong ability to deliver solid performance in any
demand environment.
FOCUSED ON OUR STRATEGY
In early 2022, we launched the GSG strategy, to drive organic top-
line and bottom-line growth through capacity expansion, innovation,
and ESG. Central to this plan are capital investments
and initiatives aimed at continuing to leverage our
core strength as a low-cost, low-complexity, large-
scale vertically integrated manufacturer. In this regard,
considerable progress was made in 2022. The construction of our
large-scale manufacturing complex in Bangladesh is well underway,
with production planned to start ramping up through 2023 with a
strong and growing local workforce to support this expansion. Further,
the consolidation and continued modernization of our yarn-spinning
facilities, including the integration of Frontier Yarns, is allowing us
to internalize most of our yarn requirements. Finally, the expansion
and optimization of installed capacity in Central America put us in a
stronger inventory position. This allows us to increase the breadth
and depth of our replenishment-driven products to our customers.
We also made progress on initiatives aimed at driving innovation in
our manufacturing and product-development processes and related
to the launch of new products. These innovations relate to fabric
features, product fit, fabric adaptability to evolving printing and
decorating techniques, and ESG-friendly product attributes. We are
also making ongoing investments to leverage digital tools, predictive
analytics, and artificial intelligence to better inform decision-making,
streamline processes, and enhance supply chain planning and
forecasting activities. We are seeing significant benefits from these
efforts and, as we continue to execute on the GSG strategy, we are
committed to driving leadership in innovation across the organization.
REINFORCING ESG FURTHER INTO THE BUSINESS
Building on our 20 years of experience in the ESG space and enhanc-
ing our commitment to it through our Next Generation ESG strategy,
we worked to further reinforce ESG initiatives into our business in
2022. Progress against our strategic roadmaps included the inclusion
of sustainability-linked terms to our existing $1-billion revolving credit
facility, the linking of executive compensation to the advancements
of ESG targets, and the publication of our first stand-alone Climate
Change Disclosure Report structured in accordance with the Task
Force on Climate-Related Financial Disclosures (TCFD) framework,
which represents a significant step towards fully aligning with the
TCFD framework by 2025. We were also pleased to launch Gildan
Respects™ to enhance our ESG communications and marketing.
In 2022, Gildan continued to be recognized for its sustainability
leadership as one of the world’s 100 most sustainable corporations
and one of Canada’s best 50 corporate citizens by Corporate Knights.
In addition, 2022 marked Gildan’s tenth consecutive inclusion on
the Dow Jones Sustainability Index and its third inclusion on CDP’s
leadership band for its 2022 climate change disclosures.
One year since the launch of the Next Generation ESG strategy, we
are pleased with the progress we’ve made towards
our targets, how our ESG performance is being recog-
nized as a differentiator, and how ESG has been fully
integrated as a core pillar in our GSG strategy.
1) Adjusted diluted earnings per share is a non-GAAP ratio. This ratio is not recognized for financial statement presentation under GAAP, does not have any standardized meanings,
may not be comparable to similar measures or ratios presented by other entities and should not be considered a substitute for, or superior to, GAAP measures. Refer to section 16 of
Gildan’s 2022 MD&A included herein for additional information on Gildan’s non-GAAP financial measures and ratios.
3
2022 Annual Report
POSITIONED FOR FUTURE GROWTH
As we enter 2023, we are confident that our global manufacturing platform,
diversified end markets, and financial strength will help us navigate through
near-term headwinds. Specifically, while the changing environment over the
past few years has made the apparel industry challenging, our manufac-
turing capacity initiatives and vertical integration give us the
confidence that our capital investments are placing us in a
position of strength to capitalize on future growth opportunities.
We are also well positioned to continue benefiting from favourable industry
trends such as the casualization of apparel, the interest in private label, the
growing creator economy, ongoing developments in digital printing, as well as
the appeal of nearshoring and sustainable practices, all of which are creating
long-term growth opportunities for Gildan given our competitive strengths.
In closing, we are pleased with our strong performance and strategic ad-
vancements during 2022. We would like to thank our talented global team,
who continue to show their determination and strength in making Gildan
the leader it is today. We would like to take this opportunity to thank Russell
Goodman, who will be retiring in May 2023. Russell has made invaluable
contributions as a member of the Board for 12 years. He has served as an
important member of the HR Committee, the Governance Committee, and
the Audit and Finance Committee, which he led as Chair from February 2012
until February 2021. On behalf of the entire Board of Directors, we would like
to extend our sincere appreciation for Russell’s many years of service and
contributions to the Company.
We would also like to thank our customers for their loyalty, the Board of
Directors for their expertise and guidance, and our shareholders for their
trust and ongoing support. We head into the second year of the GSG strategy
with the determination and confidence that we are positioned for long-term
success and to continue Making Apparel Better®.
Sincerely,
Donald C. Berg
Chairman of the Board
Glenn J. Chamandy
President and CEO
4
2022 Annual Report
2022 Annual Report
5
FINANCIAL
HIGHLIGHTS
NET SALES
DILUTED EARNINGS
PER SHARE
1,981
In U.S.$ millions
2,909
2,824
2,923
2018
2019
-0.18
2021
2022
-1.14
3,241
2020
1.66
1.86
1.27
1.66
3.07
2.72
2.93
3.11
Diluted earnings (loss) per share
Adjusted diluted earnings (loss) per share(1)
In U.S.$
OPERATING MARGIN(2)
CASH FLOW(1)
13.9%
15.0%
10.2%
13.8%
0.9%
2020
Operating margin(2)
Adjusted operating margin(1)
22.3%
20.2%
18.6%
19.7%
2018
2019
2020
2021
2022
539
429
361
227
415
358
618
594
198
414
Cash flow from operating activities
Free cash flow(1)
In U.S.$ millions
(in U.S. $ millions, except per share data and ratios)
2018
2019
2020
2021
2022
STATEMENT OF EARNINGS
Net sales
Adjusted EBITDA(1)
Gross profit
Adjusted gross profit(1)
Operating income (loss)
Adjusted operating income(1)
Net earnings (loss)
Diluted earnings per share
Adjusted net earnings (loss)(1)
Adjusted diluted earnings per share(1)
CASH FLOW
Cash flow from operating activities
Capital expenditures
Free cash flow(1)
FINANCIAL POSITION
Total assets
Net debt(1)
2,909
2,824
1,981
2,923
3,241
596
806
806
403
437
351
1.66
393
1.86
539
(125)
429
548
705
760
289
391
260
1.27
340
1.66
165
249
306
(181)
18
(225)
(1.14)
(36)
(0.18)
727
940
903
652
591
607
3.07
538
2.72
764
992
966
603
639
542
2.93
575
3.11
361
(140)
227
415
(58)
358
618
414
(130)
(245)
594
198
3,005
3,211
3,021
3,137
3,440
622
862
577
530
874
Shareholders' equity
1,936
1,835
1,559
1,919
1,882
FINANCIAL RATIOS
Gross margin(2)
Adjusted gross margin(1)
Operating margin(3)
Adjusted operating margin(1)
Return on adjusted average net assets
(Adjusted RONA)(1)
27.7%
27.7%
13.9%
15.0%
24.9%
12.6%
32.2%
30.6%
26.7%
15.3%
30.9%
29.8%
10.2%
13.8%
-9.1%
0.9%
22.3%
18.6%
20.2%
19.7%
15.6%
13.3%
1.0%
23.1%
21.0%
Net debt leverage ratio(1)
1.0x
1.6x
3.5x
0.7x
1.1x
(1) This is a non-GAAP financial measure or a non-GAAP ratio. These measures and ratios are not recognized for financial statement presentation under GAAP, do not have any stan-
dardized meanings, may not be comparable to similar measures or ratios presented by other entities and should not be considered a substitute for, or superior to, GAAP measures.
Refer to section 16 of Gildan’s 2022 MD&A included herein for additional information on Gildan’s non-GAAP financial measures and ratios.
(1) This is a non-GAAP financial measure or a non-GAAP ratio. These measures and ratios are not recognized for financial statement presentation under GAAP, do not
have any standardized meanings, may not be comparable to similar measures or ratios presented by other entities and should not be considered a substitute for, or
superior to, GAAP measures. Refer to section 16 of Gildan’s 2022 MD&A included herein for additional information on Gildan’s non-GAAP financial measures and ratios.
(2) Operating margin is defined as operating income (loss) divided by net sales.
Certain minor rounding variances exist between the consolidated financial statements and this summary.
(2) Gross margin is defined as gross profit divided by net sales.
(3) Operating margin is defined as operating income (loss) divided by net sales.
Certain minor rounding variances exist between the consolidated financial statements and this summary.
2018
2019
2020
2021
2022
2018
2019
2021
2022
-9.1%
6
7
2022 Annual Report2022 Annual Report ESG
TM
As a vertically integrated apparel manufacturer with a vision of Making Apparel Better®, we have always
operated with the belief that apparel should be made with respect for the environment, for our people,
and for our communities.
Our ability to exercise tight control over our supply chain allows us to implement the highest standards across
our network of close to 30 facilities worldwide. From sourcing the cotton, to spinning the yarn, knitting,
dyeing, and cutting the fabric, all the way to the final sewing assembly, we do it all. This manufacturing
expertise, combined with our 20-year ESG journey, has established us as a leading sustainable, ethical,
and transparent apparel manufacturer.
Building on our journey, in 2022, ESG was further integrated into our long-term business strategy, the Gildan
Sustainable Growth plan, as one of three pillars, continuing to make it a key factor in our overall success.
2022 also marked the launch of our Next Generation ESG strategy and targets, committing to meaningful
advancements in five areas of focus:
CLIMATE, ENERGY,
AND WATER
CIRCULARITY
HUMAN CAPITAL
MANAGEMENT
LONG-TERM
VALUE CREATION
TRANSPARENCY
AND DISCLOSURE
KEY ACCOMPLISHMENTS
2022 was a testament of the work done in advancing our goals and further
strengthening ESG’s role in our business:
Executive Compensation
Gildan’s Board of Directors tied a portion of the executive short-term incentive
program to the advancements of ESG targets, in order to create greater
alignment between executive compensation and shareholder interest.
Sustainability-linked Loan
Gildan signed its first sustainability-linked loan, incorporating sustainabili-
ty-linked terms into our existing $1-billion revolving credit facility, embedding
ESG into the Company’s financial strategy, and enhancing our commitment
towards our goals.
Climate Change Disclosure Report
Gildan published its first stand-alone Climate Change Disclosure Report
structured in accordance with TCFD, highlighting how we assess, prepare, and
integrate climate-related matters into our business processes. This represented
a significant step towards fully aligning with the TCFD framework by 2025.
Gildan Respects™ Campaign
We launched Gildan Respects™, a new ESG positioning, with accompanying
marketing campaigns, to reinforce the appeal of Gildan’s approach to making
apparel responsibly.
AWARDS & RECOGNITIONS
Our 2022 recognitions are tributes to Gildan’s standards, performance, and
strength in making meaningful sustainability advancements:
Dow Jones
Sustainability Index
Corporate Knights’ –
Global 100 Most Sustainable Corporations
Corporate Knights’ –
Canada’s Best 50 Corporate Citizens
S&P Global –
Sustainability Yearbook Award
CDP’s Leadership Band –
2022 Climate Change Disclosures
8
2022 Annual Report
2022 Annual Report
2022 Annual Report
9
9
1 0
2022 Annual Report 2022
REPORT TO
SHAREHOLDERS
February 23, 2023
TABLE OF CONTENTS
MANAGEMENT’S DISCUSSION AND ANALYSIS
1
PREFACE
2
3
4
5
6
7
8
9
10
11
12
13
14
15
CAUTION REGARDING FORWARD-LOOKING STATEMENTS
OUR BUSINESS
3.1 Overview
3.2 Our operations
3.3 Competitive environment
STRATEGY
OPERATING RESULTS
5.1 Non-GAAP financial measures
5.2 Overview and business environment
5.3 Business dispositions/acquisitions
5.4 Selected annual information
5.5 Consolidated operating review
5.6 Summary of quarterly results
5.7
Fourth quarter operating results
FINANCIAL CONDITION
CASH FLOWS
LIQUIDITY AND CAPITAL RESOURCES
LEGAL PROCEEDINGS
FINANCIAL RISK MANAGEMENT
CRITICAL ACCOUNTING ESTIMATES AND JUDGMENTS
ACCOUNTING POLICIES AND NEW ACCOUNTING STANDARDS NOT YET APPLIED
DISCLOSURE CONTROLS AND PROCEDURES
INTERNAL CONTROL OVER FINANCIAL REPORTING
RISKS AND UNCERTAINTIES
DEFINITION AND RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
16
MANAGEMENT’S RESPONSIBILITY FOR FINANCIAL REPORTING
AUDITED ANNUAL CONSOLIDATED FINANCIAL STATEMENTS
NOTES TO AUDITED ANNUAL CONSOLIDATED FINANCIAL STATEMENTS
P. 3
P. 3
P. 5
P. 9
P. 10
P. 22
P. 24
P. 26
P. 30
P. 30
P. 31
P. 32
P. 33
P. 34
P. 35
P. 48
P. 56
P. 62
P. 66
MANAGEMENT'S DISCUSSION AND ANALYSIS
1.0 PREFACE
In this Management’s Discussion and Analysis (MD&A), “Gildan”, the “Company”, or the words “we”, “us”, and “our” refer,
depending on the context, either to Gildan Activewear Inc. or to Gildan Activewear Inc. together with its subsidiaries.
This MD&A comments on our operations, financial performance and financial condition as at and for the years ended
January 1, 2023 and January 2, 2022. All amounts in this MD&A are in U.S. dollars, unless otherwise noted. For a
complete understanding of our business environment, trends, risks and uncertainties, and the effect of accounting
estimates on our results of operations and financial condition, this MD&A should be read in conjunction with Gildan’s
audited annual consolidated financial statements for the year ended January 1, 2023 and the related notes.
In preparing this MD&A, we have taken into account all information available to us up to February 23, 2023, the date of
this MD&A. The audited annual consolidated financial statements and this MD&A were reviewed by Gildan’s Audit and
Finance Committee and were approved and authorized for issuance by our Board of Directors on February 21, 2023.
All financial information contained in this MD&A and in the audited annual consolidated financial statements has been
prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting
Standards Board (IASB), except for certain information discussed in the section entitled “Definition and reconciliation of
non-GAAP financial measures” in this MD&A.
Additional information about Gildan, including our 2022 Annual Information Form, is available on our website at
www.gildancorp.com, on the SEDAR website at www.sedar.com, and on the EDGAR section of the U.S. Securities and
Exchange Commission website (which includes the Annual Report on Form 40-F) at www.sec.gov.
2.0 CAUTION REGARDING FORWARD-LOOKING STATEMENTS
Certain statements included in this MD&A constitute “forward-looking statements” within the meaning of the U.S. Private
Securities Litigation Reform Act of 1995 and Canadian securities legislation and regulations and are subject to important
risks, uncertainties, and assumptions. This forward-looking information includes, amongst others, information with respect
to our objectives and the strategies to achieve these objectives, as well as information with respect to our beliefs, plans,
expectations, anticipations, estimates, and intentions. In particular, information appearing under the headings “Our
business”, “Strategy”, "Operating results", “Liquidity and capital resources - Long-term debt and net debt”, "Financial risk
management", and "Risks and uncertainties" contain forward looking statements. Forward-looking statements generally
can be identified by the use of conditional or forward-looking terminology such as “may”, “will”, “expect”, “intend”,
“estimate”, “project”, “assume”, “anticipate”, “plan”, “foresee”, “believe”, or “continue”, or the negatives of these terms or
variations of them or similar terminology. We refer you to the Company’s filings with the Canadian securities regulatory
authorities and the U.S. Securities and Exchange Commission, as well as the risks described under the “Financial risk
management”, “Critical accounting estimates and judgments”, and “Risks and uncertainties” sections of this MD&A for a
discussion of the various factors that may affect the Company’s future results. Material factors and assumptions that were
applied in drawing a conclusion or making a forecast or projection are also set out throughout this document.
Forward-looking information is inherently uncertain and the results or events predicted in such forward-looking information
may differ materially from actual results or events. Material factors, which could cause actual results or events to differ
materially from a conclusion, forecast, or projection in such forward-looking information, include, but are not limited to:
•
•
•
•
•
•
•
•
the magnitude and length of economic disruption as a result of the worldwide coronavirus (COVID-19) pandemic and
the appearance of COVID variants, including the reintroduction, scope and duration of government mandated
general, partial, or targeted private sector shutdowns, travel restrictions, and social distancing measures;
changes in general economic and financial conditions globally or in one or more of the markets we serve, including
those resulting from the impact of the COVID-19 pandemic and the appearance of COVID variants;
our ability to implement our growth strategies and plans, including our ability to bring projected capacity expansion
online;
our ability to successfully integrate acquisitions and realize expected benefits and synergies;
the intensity of competitive activity and our ability to compete effectively;
our reliance on a small number of significant customers;
the fact that our customers do not commit to minimum quantity purchases;
our ability to anticipate, identify, or react to changes in consumer preferences and trends;
GILDAN 2022 REPORT TO SHAREHOLDERS 3
MANAGEMENT'S DISCUSSION AND ANALYSIS
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
our ability to manage production and inventory levels effectively in relation to changes in customer demand;
fluctuations and volatility in the price of raw materials used to manufacture our products, such as cotton, polyester
fibres, dyes and other chemicals from current levels;
our reliance on key suppliers and our ability to maintain an uninterrupted supply of raw materials, intermediate
materials and finished goods;
the impact of climate, political, social, and economic risks, natural disasters, epidemics, pandemics and endemics,
such as the COVID-19 pandemic, in the countries in which we operate or sell to, or from which we source production;
disruption to manufacturing and distribution activities due to such factors as operational issues, disruptions in
transportation logistic functions, labour disruptions, political or social instability, weather-related events, natural
disasters, epidemics and pandemics, such as the COVID-19 pandemic, and other unforeseen adverse events;
the impacts of the COVID-19 pandemic on our business and financial performance and consequently on our ability to
comply with the financial covenants under our debt agreements;
compliance with applicable trade, competition, taxation, environmental, health and safety, product liability,
employment, patent and trademark, corporate and securities, licensing and permits, data privacy, bankruptcy, anti-
corruption, and other laws and regulations in the jurisdictions in which we operate;
the imposition of trade remedies, or changes to duties and tariffs, international trade legislation, bilateral and
multilateral trade agreements and trade preference programs that the Company is currently relying on in conducting
its manufacturing operations or the application of safeguards thereunder;
factors or circumstances that could increase our effective income tax rate, including the outcome of any tax audits or
changes to applicable tax laws or treaties, including the implementation of a global minimum tax rate;
changes to and failure to comply with consumer product safety laws and regulations;
changes in our relationship with our employees or changes to domestic and foreign employment laws and
regulations;
negative publicity as a result of actual, alleged, or perceived violations of human rights, labour and environmental
laws or international labour standards, or unethical labour or other business practices by the Company or one of its
third-party contractors;
changes in third-party licensing arrangements and licensed brands;
our ability to protect our intellectual property rights;
operational problems with our information systems as a result of system failures, viruses, security and cyber security
breaches, disasters, and disruptions due to system upgrades or the integration of systems;
an actual or perceived breach of data security;
our reliance on key management and our ability to attract and/or retain key personnel;
changes in accounting policies and estimates; and
exposure to risks arising from financial instruments, including credit risk on trade accounts receivables and other
financial instruments, liquidity risk, foreign currency risk, and interest rate risk, as well as risks arising from commodity
prices.
These factors may cause the Company’s actual performance and financial results in future periods to differ materially from
any estimates or projections of future performance or results expressed or implied by such forward-looking statements.
Forward-looking statements do not take into account the effect that transactions or non-recurring or other special items
announced or occurring after the statements are made may have on the Company’s business. For example, they do not
include the effect of business dispositions, acquisitions, other business transactions, asset write-downs, asset impairment
losses, or other charges announced or occurring after forward-looking statements are made. The financial impact of such
transactions and non-recurring and other special items can be complex and necessarily depends on the facts particular to
each of them.
There can be no assurance that the expectations represented by our forward-looking statements will prove to be correct.
The purpose of the forward-looking statements is to provide the reader with a description of management’s expectations
regarding the Company’s future financial performance and may not be appropriate for other purposes. Furthermore,
unless otherwise stated, the forward-looking statements contained in this report are made as of the date hereof, and we
do not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as
a result of new information, future events, or otherwise unless required by applicable legislation or regulation. The
forward-looking statements contained in this report are expressly qualified by this cautionary statement.
GILDAN 2022 REPORT TO SHAREHOLDERS 4
MANAGEMENT'S DISCUSSION AND ANALYSIS
3.0 OUR BUSINESS
3.1 Overview
Gildan is a leading vertically integrated manufacturer of everyday basic apparel, including activewear, underwear, and
hosiery products. Our products are sold to wholesale distributors, screenprinters and embellishers in North America,
Europe, Asia-Pacific, and Latin America, as well as to retailers in North America, including mass merchants, department
stores, national chains, specialty retailers, craft stores and online retailers. We also manufacture products for global
lifestyle brand companies who market these products under their own brands through their own retail establishments, e-
commerce platforms, and/or to third-party retailers.
Manufacturing and operating as a socially responsible producer is at the heart of what we do. The vast majority of our
sales are derived from products we manufacture ourselves. Since the Company’s formation, we have made significant
capital investments in developing and operating our own large-scale, vertically integrated manufacturing facilities,
including yarn production, textile and sock manufacturing, as well as sewing operations, controlling all aspects of the
production process from start to finish for the garments we produce.
We believe the skill set that we have developed in designing, constructing, and operating our own manufacturing facilities,
the level of vertical integration of our supply chain and the capital investments that we have made over the years
differentiate us from our competition who are not as vertically integrated and may rely more heavily on third-party
suppliers. Owning and operating the vast majority of our manufacturing facilities allows us to exercise tighter control over
our production processes, efficiency levels, costs and product quality, as well as to provide reliable service with short
production/delivery cycle times. In addition, running our own operations allows us to achieve adherence to high standards
for environmental and social responsibility practices employed throughout our supply chain.
3.2 Our Operations
3.2.1 Brands, Products and Customers
The products we manufacture and sell are marketed under Company brands, including Gildan®, American Apparel®,
Comfort Colors®, Gildan® Hammer™, Alstyle® and GoldToe®. Further, we manufacture for and supply products to select
leading global athletic and lifestyle brands, as well as to certain retail customers who market these products under their
own exclusive brands. We also sell sock products under the Under Armour® brand through a sock licensing agreement,
for exclusive distribution in the United States and Canada.
Our primary product categories include activewear tops and bottoms (activewear), socks (hosiery), and underwear tops
and bottoms (underwear).
We sell our activewear products primarily in “blank” or undecorated form, without imprints or embellishment. The majority
of our activewear sales are currently derived from activewear sold to wholesale distributors in the imprintables channels in
North America and internationally. These wholesale distributors then sell the blank garments to screenprinters/
embellishers who decorate the products with designs and logos, and who in turn sell the embellished/imprinted activewear
into a highly diversified range of end-use markets. These include educational institutions, athletic dealers, event
merchandisers, promotional product distributors, charitable organizations, entertainment promoters, travel and tourism
venues, and retailers. The activewear products have diverse applications, such as serving as work or school uniforms or
athletic team wear or simply conveying individual, group, and team identity. We also sell activewear products in blank form
directly to various retailers, or through national accounts servicing retailers, in addition to underwear and socks for men,
ladies, and kids. These retailers include mass merchants, department stores, national chains, sports specialty stores, craft
stores, food and drug retailers, dollar stores, and price clubs, all of which sell to consumers through their brick and mortar
outlets and/or their e-commerce platforms. Additionally, we sell to pure-play online retailers who sell to consumers. We
also manufacture for and sell to select leading global athletic and lifestyle consumer brand companies who distribute
these products within the retail channel through their own retail establishments, e-commerce platforms, and/or through
third-party retailers.
GILDAN 2022 REPORT TO SHAREHOLDERS 5
MANAGEMENT'S DISCUSSION AND ANALYSIS
The following table summarizes our product offering under Company and licensed brands:
Primary product
categories
Product-line details
Brands
Activewear
T-shirts, fleece tops and bottoms, and
sport shirts
Gildan®, Gildan Performance®, Gildan® Hammer™, Comfort Colors®,
American Apparel®, Alstyle®, GoldToe®
Hosiery
athletic, dress, casual and workwear
socks, liner socks, and socks for
therapeutic purposes(1)
Gildan®, Under Armour®(2), GoldToe®, PowerSox®, Signature Gold
by GoldToe®, Peds®, MediPeds®, All Pro®, American Apparel®
Underwear
men's and boys' underwear (tops and
bottoms) and ladies panties
Gildan®, Gildan Platinum®
(1) Applicable only to MediPeds®.
(2) Under license agreement for socks only - with exclusive distribution rights in the U.S. and Canada. License expires on March 31, 2024.
3.2.2 Manufacturing
The vast majority of our products are manufactured in facilities that we own and operate. To a much lesser extent, we also
use third-party contractors to supplement certain product requirements. Our vertically integrated operations range from
start to finish of the garment production process and include capital-intensive yarn-spinning, textile and sock
manufacturing facilities, as well as labour-intensive sewing facilities. Our manufacturing operations are situated in four
main hubs, specifically in the United States, Central America, the Caribbean, and Bangladesh. All of our yarn-spinning
operations are located in the United States, while textile, sewing, and sock manufacturing operations are situated in the
other geographical hubs mentioned above, the largest of which is in Honduras in Central America.
In order to support further sales growth, continue to drive an efficient and competitive cost structure, and enhance
geographic diversification in our supply chain, we are expanding manufacturing capacity across our manufacturing
network, including a significant expansion in Bangladesh, which involves the development of a large multi-plant
manufacturing complex expected to house two large textile facilities and related sewing operations.
GILDAN 2022 REPORT TO SHAREHOLDERS 6
The following table provides a summary of our primary manufacturing operations by geographic area:
United States
Central America Caribbean
Asia
MANAGEMENT'S DISCUSSION AND ANALYSIS
Yarn-spinning facilities(1):
conversion of cotton, polyester and other fibres into
yarn
■ Salisbury, NC
(2 facilities)
■ Mocksville, NC
■ Eden, NC
■ Clarkton, NC
■ Sanford, NC
(2 facilities)
■ Stoneville, NC
■ Cedartown(4), GA
Textile facilities: knitting yarn into fabric, dyeing
and cutting fabric
Sewing facilities(2):
assembly and sewing of cut goods
Garment-dyeing(3):
pigment dyeing or reactive dyeing process
Hosiery manufacturing facilities:
conversion of yarn into finished socks
■ Dominican
Republic
■ Dominican
Republic
(3 facilities)
■ Bangladesh
■ Bangladesh
■ Honduras
(4 facilities)
■ Honduras
(3 facilities)
■ Nicaragua
(4 facilities)
■ Honduras
■ Honduras
(1) While the majority of our yarn requirements are internally produced, we also use third-party yarn-spinning suppliers, primarily in the U.S., to satisfy the
remainder of our yarn needs.
(2) Although the majority of our sewing facilities are Company-operated, we also use the services of third-party sewing contractors, in other regions in Central
America and Haiti, to satisfy the remainder of our sewing requirements.
(3) Garment dyeing is a feature of our Comfort Colors® products only, which involves a different dyeing process than how we typically dye the majority of our
products at our textile facilities. Our garment dyeing operations are located in our Rio Nance 3 facility in Honduras.
(4) Closure effective as of February 2023.
3.2.3 Environmental, Social and Governance (ESG) Program
ESG is core to Gildan’s long-term business strategy and has long-been a key element of success. As one of the most
vertically integrated manufacturers in the apparel industry, producing the vast majority of the products we sell in our
owned and/or Company-operated facilities, we have the advantage of exercising direct control on how we operate and in
driving our ESG practices consistently across our operations.
The Company's ESG program is overseen centrally and the execution of the program is managed by dedicated teams of
skilled professionals located in the regions where we operate. Our Board of Directors’ Corporate Governance and Social
Responsibility Committee, composed of independent directors, has the specific responsibility of overseeing Gildan’s
policies and practices in areas relevant to the environment, labour and human rights, health and safety, and other
sustainability issues, including community engagement and stakeholder relations.
Building on a strong foundation of best-in-class ESG practices, at the beginning of 2022, the Company unveiled its “Next
Generation ESG” strategy, an enhanced framework designed to deliver meaningful advancements by 2030 in key areas
related to Climate, Energy, and Water; Circularity; Human Capital Management; Long-Term Value Creation; and
Transparency and Disclosure. Under this strategy, Gildan seeks to tackle global environmental and social priorities aimed
at improving the lives of people who make Gildan garments, further protecting the environment, empowering neighboring
communities, and increasing the sustainability of products delivered to customers worldwide.
GILDAN 2022 REPORT TO SHAREHOLDERS 7
MANAGEMENT'S DISCUSSION AND ANALYSIS
The Company's targets and objectives in the five key focus areas of its Next Generation ESG strategy are as follows:
•
•
•
•
•
Climate, Energy, and Water
Gildan is committed to continuing its fight against climate change by paving the way towards a low carbon future, with
a goal of reducing its scope 1 and 2 greenhouse gas (GHG) emissions by 30% by 20301 aligned with the Science
Based Targets initiative (SBTi) and the level of decarbonization required to meet the goals of the Paris Agreement. To
that effect, Gildan has signed the SBTi commitment letter, joining companies worldwide in following a science-based
approach in reducing carbon emissions. SBTi is currently in the process of validating our targets. Gildan is also
committed to addressing water related risks linked to climate change. The Company plans to further invest in water
efficiency and implement additional water reducing, reusing, and recycling options in its operations with the goal to
reduce water intensity (usage/withdrawal per kilogram produced) by 20% by 20301.
Circularity
Gildan is committed to fostering a circular economy to reduce its environmental impact and intends to source more
sustainable and transparent raw materials and enhance sustainable waste management initiatives. This will include
sourcing 100% sustainable cotton by 2025 and 30% recycled polyester or alternative fibers and/or yarns by 2027.
The Company also plans to achieve zero manufacturing waste by 2027 and to use 75% recycled or sustainable
packaging and trim materials by 2027.
Human Capital Management
The Company will continue ensuring human rights are respected in its supply chain. Gildan will also push health and
safety performance to new standards by working to improve employee safety and reducing workplace risks across its
operations. To achieve this, Gildan plans to attain the ISO 45001 certification at all its Company-owned and operated
facilities by 2028.
On diversity, equity, and inclusion, the Company set a first-time goal to improve gender parity. While Gildan has
already attained gender parity globally at the manager level and below, by 2027 it is targeting to achieve gender parity
within the employee group encompassing director level and above.
Long-Term Value Creation
Gildan is committed to positively impacting economic development in regions where the Company operates with
meaningful community engagement. Gildan intends to incrementally increase allocation of capital towards purposeful
and value-driven projects in regions where the Company operates and plans to gradually reach a contribution of 1%
of its pre-tax earnings by 2026. In parallel, the Company will also engage one of its most important stakeholders, its
people, and continue to facilitate and encourage employee volunteerism at all levels to further deepen local impact.
Transparency and Disclosure
A key part of Gildan’s accountability in reaching these targets will be to transparently share the journey with
stakeholders. To that effect, Gildan plans to further enhance and strengthen its ESG disclosure across all its areas of
focus, effectively allowing stakeholders to make more informed ESG-focused decisions and maintaining a high
degree of trust and understanding of Gildan.
2022 ESG highlights and recognitions
Progress against our strategic roadmaps included some of the following key milestones: the inclusion of sustainability-
linked terms to our existing $1-billion revolving credit facility and the linking of executive compensation to the
advancements of ESG targets. Gildan also published its first stand-alone Climate Change Disclosure Report structured in
accordance with the Task Force on Climate-Related Financial Disclosures (TCFD) framework, highlighting how we
assess, prepare and integrate climate-related matters into our business processes. This represented a significant step
forward towards fully aligning with the TCFD framework by 2025. In 2022, Gildan also continued to be recognized for its
sustainability leadership as one of the world’s 100 most sustainable corporations and one of Canada’s best 50 corporate
citizens by Corporate Knights. In addition, 2022 marked Gildan’s tenth consecutive inclusion on the Dow Jones
Sustainability Index and its third inclusion on CDP’s leadership band for its 2022 climate change disclosures. Finally, in
2022 Gildan launched Gildan Respects™ a broad marketing campaign to share and elevate our ESG story in a thoughtful
and authentic manner.
1
Compared to a 2018 baseline
GILDAN 2022 REPORT TO SHAREHOLDERS 8
MANAGEMENT'S DISCUSSION AND ANALYSIS
3.2.4 Sales, marketing and distribution
Our global sales and marketing office is located in Christ Church, Barbados, out of which we have established customer-
related functions, including sales management, marketing, customer service, credit management, sales forecasting,
production planning, inventory control and logistics, as well as supporting finance, human resources and information
technology functions. We also maintain sales support offices in the U.S. We have established extensive distribution
operations primarily through internally managed and operated large distribution centers and some smaller facilities in the
U.S., as well as a large distribution facility in Honduras. To supplement some of our distribution needs, we also use third-
party warehouses in North America, Europe, and Asia.
3.2.5 Employees and corporate office
We currently employ approximately 51,000 employees worldwide. Our corporate head office is located in Montreal,
Canada.
3.3 Competitive environment
The basic apparel market for our products is highly competitive. Competition is generally based upon service and product
availability, price, quality, comfort and fit, style, and brand. We compete on these factors by leveraging our competitive
strengths, including our strategically located and vertically integrated manufacturing supply chain, scale, cost structure,
global distribution, and our brand positioning in the markets we serve. We believe our manufacturing skill set, together
with our large-scale, low-cost vertically integrated supply chain infrastructure that we have developed by investing
significantly over time are key competitive strengths and differentiators from our competition.
We face competition from large and smaller U.S.-based and foreign manufacturers or suppliers of basic family apparel.
Among the larger competing North American-based manufacturers are Hanesbrands Inc., as well as Fruit of the Loom,
Inc., a subsidiary of Berkshire Hathaway Inc. which competes through its own brand offerings and those of its subsidiary,
Russell Corporation. These companies manufacture out of some of the same geographies as Gildan and compete
primarily within the same basic apparel product categories in similar channels of distribution in North America and
international markets. In socks and underwear, our competitors also include Renfro Corporation, Jockey International,
Inc., and Kayser Roth Corporation. In addition, we compete with smaller U.S.-based companies selling to or operating as
wholesale distributors of imprintables activewear products, including Next Level Apparel, Color Image Apparel, Inc. (owner
of the Bella + Canvas brand), and Delta Apparel Inc., as well as Central American and Mexican manufacturers that supply
products in the imprintables channel. Finally, although we also compete with some of our customers' own private brand
offerings, we also supply products to certain customers that are seeking strategic suppliers with our type of manufacturing
capabilities to support their private brand offerings.
4.0 STRATEGY
Gildan Sustainable Growth Strategy
Building on a strong foundation, in 2022 the Company launched its “Gildan Sustainable Growth” (GSG) strategy focused
on driving organic top and bottom-line growth through three key pillars – capacity expansion, innovation, and ESG. We
believe that by leveraging our competitive advantage as a low-cost, vertically integrated manufacturer and successfully
executing on well-defined capacity expansion plans, delivering value-driven and innovative products, and through leading
ESG practices we will be well positioned to drive strong revenue growth, profitability and effective asset utilization, all of
which are expected to allow us to deliver compelling shareholder value creation.
The three pillars of our GSG strategy are:
Capacity-driven growth: Leveraging our strong competitive advantage as a low-cost vertically integrated manufacturer
as we execute on well-defined plans to expand our global production capacity to support our long-term growth plans
To this end, we have added incremental textile and sewing capacity in our manufacturing hubs in Central America and the
Dominican Republic. Through the acquisition of Frontier Yarns, we have strengthened our vertical integration by
expanding our yarn-spinning capabilities. We are also in the process of consolidating and modernizing our overall U.S.
yarn spinning operations. Additionally, the Company is executing on the first phase of development of a large vertically
integrated textile and sewing complex in Bangladesh, as described in more detail in subsection 3.2.2 entitled
"Manufacturing" in this MD&A.
GILDAN 2022 REPORT TO SHAREHOLDERS 9
MANAGEMENT'S DISCUSSION AND ANALYSIS
Innovation: Driving leadership in innovation across the organization and all areas of operations aimed at delivering high-
quality, value-driven products, increased speed-to-market, operational efficiencies and a reduced environmental footprint
The Company has identified and defined specific key initiatives, as well as investments aimed at driving innovation in our
product-development and manufacturing processes, distribution and final products, including fabric features, product fit,
fabric adaptability to evolving printing and decorating techniques, and ESG-friendly product attributes. Further investments
will also be allocated to leverage digital tools, predictive analytics and artificial intelligence to better inform and accelerate
decision-making across the organization, streamline systems and processes, and enhance planning, forecasting and
market research.
ESG: Further increasing our ESG focus across all operations and leveraging our strong ESG standing and progress to
enhance our value proposition to all our stakeholders
With the launch of our Next Generation ESG strategy and the introduction of new long-term ESG targets, we are
heightening ESG efforts across the organization. Initiatives under our strategy are aimed at reducing our carbon footprint,
and water intensity (usage/withdrawal per kilogram produced), and fostering a circular economy, while driving increased
operational efficiencies. Additional initiatives build on supporting economic development in regions where we operate and
ensuring strong respect of human rights and high health and safety standards throughout our supply chain. Further, we
will be increasing investment in our people, driving diversity and inclusion across our operations and enhancing ESG
disclosure and transparency. All important areas of focus as we build on what is already a strong ESG proposition for all
stakeholders.
Successfully executing on all of the above initiatives underpinning the three pillars of our strategy is expected to position
the Company to generate long-term revenue growth, sustained profitability and effective asset utilization, all of which are
expected to deliver long-term value to our shareholders.
5.0 OPERATING RESULTS
This MD&A comments on our operations, financial performance, and financial condition as at and for the fiscal year ended
January 1, 2023 (fiscal 2022) and the fiscal year ended January 2, 2022 (fiscal 2021).
5.1 Non-GAAP financial measures
We use non-GAAP financial measures and ratios to assess our operating performance and liquidity. Securities regulations
require that companies caution readers that earnings and other measures adjusted to a basis other than IFRS do not have
standardized meanings and are unlikely to be comparable to similar measures used by other companies. Accordingly,
they should not be considered in isolation. In this MD&A, we use non-GAAP financial measures and ratios including
adjusted net earnings, adjusted diluted EPS, adjusted gross profit, adjusted gross margin, adjusted operating income,
adjusted operating margin, adjusted EBITDA and return on adjusted average net assets (Adjusted RONA) to measure our
performance and financial condition from one period to the next, which excludes the variation caused by certain
adjustments that could potentially distort the analysis of trends in our operating performance, and because we believe
such measures provide meaningful information to investors on the Company’s financial performance and financial
condition. We also use non-GAAP financial measures including free cash flow, total debt, net debt, net debt leverage ratio
and working capital.
We refer the reader to section 16.0 entitled “Definition and reconciliation of non-GAAP financial measures” in this MD&A
for the definition and complete reconciliation of all non-GAAP financial measures used and presented by the Company to
the most directly comparable IFRS measures.
5.2 Overview and business environment
In 2022, activewear sold to wholesale distributors, servicing the imprintables industry, benefited from the continued post-
pandemic recovery and the comeback of large gatherings, while activewear sold through our National account customers,
servicing retail end-markets, were hampered by a softening demand environment and ongoing inventory adjustments at
retailers. Our international markets continued to be impacted by difficult economic conditions in Europe and Asia, and the
strict Covid policy prevailing in China until late 2022. Further, as we moved through the year, our customers were
managing their inventory levels more cautiously, reflecting the prevalent economic uncertainty. While we are encouraged
by the continued recovery we have seen in our business, we believe demand levels have not yet normalized in all our
end-markets to pre-pandemic levels, on an annualized basis. Nevertheless, with our capacity investments in both yarn-
GILDAN 2022 REPORT TO SHAREHOLDERS 10
MANAGEMENT'S DISCUSSION AND ANALYSIS
spinning and textile operations, we increased our manufacturing flexibility enabling us to support our customer’s needs,
shifting gears from the tight manufacturing environment experienced in 2021. We have also rebuilt our inventories to
healthier levels and strengthened our relationships with distributors by improving serviceability. We managed successfully,
adapting to a changing environment, and delivering strong profitability by mitigating inflationary pressure through tight
control over our vertically integrated supply chain, and through effective pricing decisions. We are executing on our capital
allocation strategy, investing in capital projects, and returning capital to shareholders through dividends and active share
repurchases, while maintaining a healthy financial position throughout the year. We are pleased with the execution of our
"Gildan Sustainable Growth" (GSG) strategy which was instrumental in our ability to deliver strong results in 2022. We
believe we are well positioned to drive growth under the "Gildan Sustainable Growth" strategy, described in section 4 of
this MD&A. While we believe our vertically-integrated manufacturing model facilitates our ability to navigate through
various headwinds impacting the current market landscape, it is difficult to predict the impact on our business due to the
lagging effects of the pandemic, inflationary pressures, increased recessionary risks and other factors.
5.3 Business dispositions/acquisitions
Fiscal 2022 (year ended January 1, 2023)
During fiscal 2022 the Company sold a yarn spinning facility located in the U.S., which was the smallest of the four
facilities that the Company acquired on December 10, 2021 as part of the Frontier Yarns acquisition. The sale included the
disposition of inventory, equipment, goodwill and the transfer of a leasehold interest and related lease liability. Please refer
to note 5 to the 2022 audited annual consolidated financial statements.
During the fourth quarter of fiscal 2022, the Company sold its sheer inventory and trademarks for total proceeds of
$6 million, of which $1 million is being held in escrow subject to certain post-closing matters. The gain on disposal of these
assets was insignificant.
Fiscal 2021 (year ended January 2, 2022)
On December 10, 2021, the Company acquired 100% of the equity interest of Phoenix Sanford, LLC, the parent company
of Frontier Yarns, for cash consideration (net of cash acquired and net of the settlement of pre-existing relationships) of
$164 million. At the time of the acquisition, Frontier Yarns operations included four facilities located in North Carolina.
During 2021, approximately 40% of Frontier's production was dedicated to yarn sold to Gildan for textile manufacturing in
Central America and the Caribbean. The acquisition will allow the Company to build on its global vertically integrated
supply chain through further internalizing yarn production and is expected to support incremental yarn needs for Gildan’s
textile capacity expansion plans in Central America and the Caribbean.
The audited annual consolidated financial statements for fiscal 2021 included the results of Frontier from December 11,
2021 to January 2, 2022.
GILDAN 2022 REPORT TO SHAREHOLDERS 11
5.4 Select annual information
(in $ millions, except per share amounts or
otherwise indicated)
2022
2021
2020
$
%
$
%
Variation 2022-2021
Variation 2021-2020
MANAGEMENT'S DISCUSSION AND ANALYSIS
3,240.5
2,922.6
1,981.3
317.9
10.9 %
940.2
903.0
314.2
(2.6)
8.2
249.1
305.7
272.3
15.5
48.2
52.2
62.5
9.9
5.6 %
6.9 %
3.2 %
941.3
691.1
597.3
41.9
47.5 %
n.m.
n.m.
15.4 %
4.8
n.m.
(18.1)
n.m.
(7.7)
(93.9) %
(40.0)
(83.0) %
Net sales
Gross profit
Adjusted gross profit(1)
SG&A expenses
Impairment (Reversal of impairment) of trade
accounts receivable
Restructuring and acquisition-related costs
Impairment of goodwill and intangible assets
(Impairment reversal of intangible assets,
net of write-downs)
Operating income (loss)
Adjusted operating income(1)
Adjusted EBITDA(1)
Financial expenses
Income tax expense (recovery)
Net earnings (loss)
Adjusted net earnings (loss)(1)
Basic EPS (Loss per share)
Diluted EPS
Adjusted diluted EPS(1)
Gross margin(2)
Adjusted gross margin(1)
SG&A expenses as a percentage of sales(3)
Operating margin(4)
Adjusted operating margin(1)
992.4
965.5
324.1
2.2
0.5
62.3
603.4
639.3
764.2
37.0
24.9
541.5
574.7
2.94
2.93
3.11
30.6 %
29.8 %
10.0 %
18.6 %
19.7 %
(31.5)
94.0
93.8
n.m.
(125.5)
651.9
591.4
726.8
27.3
17.4
607.2
538.1
3.08
3.07
2.72
32.2 %
30.9 %
10.8 %
22.3 %
20.2 %
(180.8)
(48.5)
(7.4) %
832.7
18.0
165.1
48.5
(4.1)
47.9
37.4
9.7
7.5
8.1 %
573.4
5.1 %
561.7
35.5 %
(21.2)
(43.7) %
43.1 %
21.5
(225.3)
(65.7)
(10.8) %
832.5
6.8 %
574.4
(36.3)
(1.14)
(1.14)
(0.18)
12.6 %
15.3 %
13.7 %
(9.1) %
0.9 %
36.6
(0.14)
(0.14)
(4.5) %
(4.6) %
0.39
14.3 %
n/a
n/a
n/a
n/a
n/a
(1.6) pp
(1.1) pp
(0.8) pp
(3.7) pp
(0.5) pp
4.22
4.21
2.90
n/a
n/a
n/a
n/a
n/a
n.m.
n.m.
n.m.
n.m.
n.m.
n.m.
n.m.
n.m.
n.m.
n.m.
19.6 pp
15.6 pp
(2.9) pp
31.4 pp
19.3 pp
Total assets
3,440.2
3,136.7
3,020.9
Total non-current financial liabilities
Net debt(1)
Diluted weighted average number of
780.0
873.6
600.0
1,000.0
529.9
577.2
303.5
180.0
343.7
9.7 %
115.8
3.8 %
30.0 %
(400.0)
(40.0) %
64.9 %
(47.3)
(8.2) %
common shares outstanding (in ‘000s)
184,532
197,595
198,361
n/a
n/a
n/a
n/a
Return on adjusted average net assets
(Adjusted RONA)(1)
Annual cash dividends declared per common
share
Net debt leverage ratio(1)
21.0 %
23.1 %
1.0 %
n/a
(2.1) pp
n/a
22.1 pp
0.676
0.462
0.154
0.214
46.3 %
0.308
1.1
0.7
3.5
n/a
n/a
n/a
n.m.
n/a
n.m. = not meaningful
n/a = not applicable
(1) This is a non-GAAP financial measure or ratio. See section 16.0 "Definition and reconciliation of non-GAAP financial measures" in this
MD&A.
(2) Gross margin is defined as gross profit divided by net sales.
(3) SG&A as a percentage of sales is defined as SG&A divided by net sales.
(4) Operating margin is defined as operating income (loss) divided by net sales.
Certain minor rounding variances exist between the consolidated financial statements and this summary.
GILDAN 2022 REPORT TO SHAREHOLDERS 12
MANAGEMENT'S DISCUSSION AND ANALYSIS
5.5 Consolidated operating review
5.5.1 Net sales
(in $ millions, or otherwise indicated)
2022
2021
2020
$
%
$
%
Activewear
Hosiery and underwear(1)
2,762.5
2,364.7
1,498.4
397.8
16.8 %
866.3
57.8 %
478.0
557.8
482.9
(79.8)
(14.3) %
74.9
15.5 %
Total net sales
3,240.5
2,922.5
1,981.3
318.0
10.9 %
941.2
47.5 %
Variation 2022-2021 Variation 2021-2020
(1) Also includes intimates and other fringe products.
Certain minor rounding variances exist between the consolidated financial statements and this summary.
Fiscal 2022 compared to fiscal 2021
Record net sales for the year ended January 1, 2023, were $3,240 million in 2022, up 10.9% over the same period last
year, reflecting an increase in activewear sales, partly offset by lower sales in the hosiery and underwear category. The
year-over-year increase in activewear sales was primarily driven by higher net selling prices which were up on average in
the mid-teen range, and favourable product-mix. While sales volumes were up in the first nine months reflecting the
continuing demand recovery in imprintables and the impact of higher distributor replenishment to rebuild inventories to
more optimal levels (as customer inventories were impacted by our production constraints due to the 2020 hurricanes in
Central America and yarn labour shortages), these volume increases were offset in the fourth quarter by the absence of
inventory replenishment versus a year ago and lower point of sales ("POS") mainly in retail end-markets. The decline in
the hosiery and underwear category, where we generated sales of $478 million, primarily reflected the impact of lower unit
sales volumes due to weaker demand in retail and the continued impact of tight inventory management at the retailer
level.
Fiscal 2021 compared to fiscal 2020
Record net sales in 2021 reflected a significant recovery in demand from 2020, which had been hard hit by the effects of
the onset of the COVID-19 pandemic. The year-over-year increase in activewear sales where we generated sales of
$2,365 million was due to strong volume increases in all channels, favourable product-mix and higher net selling prices.
Higher imprintables sales volumes were driven by a strong recovery in POS and the impact of the non-recurrence of
significant inventory de-stocking by distributors which occurred in 2020. The overall sales increase in the hosiery and
underwear category where we generated $558 million was also driven by higher sales volumes in both underwear and in
sock products compared to last year, as well as favourable product mix.
Compared to 2019, fiscal 2020 overall net sales growth showed improvement through the year, with net sales in the
second half and for the full year above pre-pandemic levels.
5.5.2 Gross profit/margin and adjusted gross profit/margin
(in $ millions, or otherwise indicated)
Gross profit
Adjustment for:
Impact of strategic product line initiatives(1)
Discontinuance of PPE SKUs(1)
Net insurance gains(1)
Adjusted gross profit(2)
Gross margin
Adjusted gross margin(2)
2022
992.4
(1.0)
—
(25.9)
965.5
30.6 %
29.8 %
2021
940.2
2020
249.1
Variation
2022-2021
Variation
2021-2020
52.2
691.1
8.8
—
(46.0)
903.0
32.2 %
30.9 %
60.0
6.2
(9.6)
305.7
12.6 %
15.3 %
(9.8)
—
20.1
62.5
(1.6) pp
(1.1) pp
(51.2)
(6.2)
(36.4)
597.3
19.6 pp
15.6 pp
(1) See subsection entitled "Certain adjustments to non-GAAP measures" for additional information on adjustments in section 16.0
"Definition and reconciliation of non-GAAP financial measures" in this MD&A.
(2) This is a non-GAAP financial measure or ratio. See section 16.0 "Definition and reconciliation of non-GAAP financial measures" in this
MD&A.
Certain minor rounding variances exist between the consolidated financial statements and this summary.
GILDAN 2022 REPORT TO SHAREHOLDERS 13
MANAGEMENT'S DISCUSSION AND ANALYSIS
Gross profit is the result of our net sales less cost of sales. Gross margin reflects gross profit as a percentage of sales.
Our cost of sales includes all raw material costs, manufacturing conversion costs, including manufacturing depreciation
expense, sourcing costs, inbound freight and inter-facility transportation costs, and outbound freight to customers. Cost of
sales also includes the costs of purchased finished goods, costs relating to purchasing, receiving and inspection activities,
manufacturing administration, third-party manufacturing services, sales-based royalty costs, insurance, inventory write-
downs, and duties, as well as net insurance gains as described in note 17c to the audited consolidated financial
statements as at and for the year ended January 1, 2023. Our reporting of gross profit and gross margin may not be
comparable to these metrics as reported by other companies, since some entities include warehousing and handling costs
and/or exclude depreciation expense, outbound freight to customers, and royalty costs from cost of sales.
Fiscal 2022 compared to fiscal 2021
The increase in gross profit and non-GAAP adjusted gross profit in fiscal 2022 reflected higher sales partially offset by
lower margins. The decline in GAAP gross margin mainly reflected lower net insurance gains compared to last year (2022:
$26 million, 2021: $46 million) which had a 70 basis point impact on margins. These net insurance gains resulted from
accrued insurance recoveries from the Company's claim for losses relating to the two hurricanes in Central America in
November 2020. Both the GAAP gross margin and the adjusted gross margin reflected higher fiber costs and other
manufacturing costs, which more than offset the benefit of higher net selling prices and favourable product mix. The
change in GAAP and adjusted gross margins also reflected an $18 million or 60 basis point impact of the non-recurrence
of a one-time USDA payment in connection to its Pandemic Assistance for Cotton Users program recorded in the first
quarter of 2021.
Fiscal 2021 compared to fiscal 2020
The increase in gross and adjusted gross profit in fiscal 2021 reflected the meaningful recovery in sales and a 19.6
percentage point increase in gross margin and a 15.6 percentage point increase in adjusted gross margin compared to
fiscal 2020. The significant year-over-year improvement in gross and adjusted gross margin was mainly due to a much
stronger product-mix, the non-recurrence of COVID and certain Back to Basics related charges incurred primarily in the
first half of 2020, higher net selling prices, cost benefits from our Back to Basics initiatives and lower raw material costs.
The improvement in gross margin in 2021 also included the recognition of higher net insurance gains of $36 million related
to the 2020 hurricanes, as well as lower year-over-year SKU rationalization charges.
5.5.3 Selling, general and administrative expenses (SG&A)
(in $ millions, or otherwise indicated)
SG&A expenses
SG&A expenses as a percentage of sales
2022
324.1
2021
314.2
2020
272.3
10.0 %
10.8 %
13.7 %
(0.8) pp
Variation
2022-2021
Variation
2021-2020
9.9
41.9
(2.9) pp
Certain minor rounding variances exist between the consolidated financial statements and this summary.
Fiscal 2022 compared to fiscal 2021
The $10 million increase in SG&A expenses in fiscal 2022 compared to fiscal 2021 was primarily due to the impact of
inflation on overall costs, partially offset by lower variable compensation expenses and the benefit of our cost containment
measures. As a percentage of sales, the 80 basis point improvement in SG&A expenses primarily reflected the benefit of
sales leverage.
Fiscal 2021 compared to fiscal 2020
The $42 million increase in SG&A expenses in fiscal 2021 compared to fiscal 2020 was primarily due to higher variable
compensation expenses and higher volume-driven distribution costs, partly offset by cost savings stemming from our Back
to Basics initiatives. The 290-basis point improvement in SG&A expenses as a percentage of sales in fiscal 2021
compared to fiscal 2020 reflected the benefit of volume leverage and unit cost efficiencies.
GILDAN 2022 REPORT TO SHAREHOLDERS 14
MANAGEMENT'S DISCUSSION AND ANALYSIS
5.5.4 Impairment of trade accounts receivable
An impairment of trade accounts receivable of $2 million was recorded in fiscal 2022, compared to a reversal of
impairment of trade accounts receivable of $3 million in fiscal 2021 and an impairment of trade accounts receivable of $16
million in fiscal 2020. The impairment of trade accounts receivable for fiscal 2022, is mainly related to specific provisions
on higher risk customers, partially offset by lower provisions on lower risk customers due to the decrease in trade
accounts receivable. During fiscal 2021, the Company adjusted its provision matrix to decrease expected credit loss rates
as the economic environment improved, resulting in a $3 million reversal of impairment of trade accounts receivable. The
impairment of trade accounts receivable in fiscal 2020 of $16 million was mainly related to an increase in the estimate of
expected credit losses (ECLs) attributable to the heightened credit risk caused by the economic conditions related to the
COVID-19 pandemic.
5.5.5 Restructuring and acquisition-related costs
(in $ millions)
Employee termination and benefit costs
Exit, relocation and other costs
Net (gain) loss on disposal, write-downs and accelerated
depreciation of property, plant and equipment, right-of-use
assets, and software related to exit activities
Acquisition-related transaction costs
Restructuring and acquisition-related costs
2022
2021
2020
Variation
2022-2021
Variation
2021-2020
1.0
2.2
0.3
10.9
3.3
13.3
0.7
(1.1)
(10.6)
(10.0)
(3.3)
0.6
0.5
3.1
1.5
8.2
23.9
—
48.1
(6.4)
(0.9)
(7.7)
(20.8)
1.5
(39.9)
Certain minor rounding variances exist between the consolidated financial statements and this summary.
Restructuring and acquisition-related costs are comprised of costs directly related to significant exit activities, including the
closure of business locations or the relocation of business activities, significant changes in management structure, as well
as transaction, exit, and integration costs incurred pursuant to business acquisitions.
Restructuring and acquisition-related costs in fiscal 2022 related to the following: $5 million for the closure of a yarn-
spinning plant in the U.S, $2 million in accelerated depreciation of right-of-use assets relating to facilities no longer in use,
$1 million in employee termination and benefit costs related to the closure of a distribution center in the U.S., as well
$2 million related to the completion of previously initiated restructuring activities, partly offset by a gain of $6 million on
business dispositions (refer to note 5 of the consolidated financial statements), and a gain of $3 million on the sale of a
former manufacturing facility in Mexico.
Restructuring and acquisition-related costs in fiscal 2021 related to the following: $4 million for post-closure costs relating
to the Company's former textile manufacturing and sewing operations in Mexico; $2 million for a yarn-spinning plant in the
U.S., that was closed in 2020, including a lease exit charge; $1 million in transaction costs incurred in connection with the
acquisition of Frontier Yarns; and $1 million in other costs, to complete restructuring activities that were initiated in prior
years.
Restructuring and acquisition-related costs in fiscal 2020 related to the following: $23 million for the closure of a yarn-
spinning plant in the U.S., including accelerated depreciation of right-of-use assets and equipment; $11 million for the
closure of textile manufacturing and sewing operations in Mexico; $6 million for the exit of ship-to-the-piece activities,
including computer software write-downs and warehouse consolidation costs; $2 million for SG&A workforce reductions;
and $7 million in other costs, including costs incurred to complete restructuring activities that were initiated in fiscal 2019.
GILDAN 2022 REPORT TO SHAREHOLDERS 15
MANAGEMENT'S DISCUSSION AND ANALYSIS
5.5.6 Impairment of intangible assets/(Impairment reversal of intangible assets, net of write downs)
During fiscal 2022, based on the results of the impairment test performed on January 1, 2023, we recorded an impairment
charge for our hosiery cash-generating unit (CGU) of $62 million, relating to intangible assets (both definite and indefinite
life) acquired in previous business acquisitions, as described in note 11 to the audited annual consolidated financial
statements for the year ended January 1, 2023. The impairment charge results from a decline in the fair value of the
Hosiery CGU, mainly due to the impact of the current macroeconomic environment on market conditions.
During fiscal 2021, based on the results of the impairment test performed on January 2, 2022, the estimated recoverable
amount for the Hosiery cash-generating unit (CGU) was in excess of its carrying value, and as such the Company
recorded an impairment reversal of $56 million at January 2, 2022, relating to intangible assets (both definite and
indefinite life) acquired in previous business acquisitions, as described in note 11 to the audited annual consolidated
financial statements for the year ended January 1, 2023. The events and circumstances that led to this reversal included
improved margins and forecasted earnings, as well as the improvement of the economic environment and the prevailing
outlook for this category. The Company also wrote off certain intangible assets of $24 million, that were assessed as
having no future economic benefit. These asset write-offs related to the Company’s plan to exit its sheer panty hose,
tights, leggings, ladies shapewear, intimates, and accessories products, marketed under the Secret®, Silks®, Secret
Silky® and Therapy Plus® brands.
During the first quarter of fiscal 2020, due to the adverse impacts of the COVID-19 pandemic on global economic activity
and enterprise values of companies worldwide, including its impact on the Company’s business and share price, we
recorded an impairment charge for our Hosiery CGU of $94 million, relating to goodwill and intangible assets acquired
during previous sock and hosiery business acquisitions.
5.5.7 Operating income and adjusted operating income
(in $ millions, or otherwise indicated)
Operating income (loss)
Adjustment for:
Restructuring and acquisition-related costs(1)
Impairment of intangible assets (Impairment
reversal of intangible assets, net of write-
downs)(1)
Impact of strategic product line initiatives
Discontinuance of PPE SKUs
Net insurance gains
Adjusted operating income(2)
Operating margin
Adjusted operating margin(2)
2022
603.4
2021
651.9
2020
(180.8)
Variation
2022-2021
Variation
2021-2020
(48.5)
832.7
0.5
8.2
48.2
(7.7)
(40.0)
62.3
(1.0)
—
(25.9)
639.3
(31.5)
8.8
—
(46.0)
591.4
94.0
60.0
6.2
(9.6)
18.0
93.8
(9.8)
—
20.1
47.9
(125.5)
(51.2)
(6.2)
(36.4)
573.4
18.6 %
19.7 %
22.3 %
20.2 %
(9.1) %
0.9 %
(3.7) pp
(0.5) pp
31.4 pp
19.3 pp
(1) See subsection entitled "Certain adjustments to non-GAAP measures" for additional information on adjustments in section 16.0
"Definition and reconciliation of non-GAAP financial measures" in this MD&A.
(2) This is a non-GAAP financial measure or ratio. See section 16.0 "Definition and reconciliation of non-GAAP financial measures" in this
MD&A.
Certain minor rounding variances exist between the consolidated financial statements and this summary.
Fiscal 2022 compared to fiscal 2021
The decline in operating income reflected the non-cash impairment charge for our hosiery cash-generating unit (CGU)
taken in the fourth quarter compared to a reversal of impairment last year and lower insurance accounting gains
compared to last year (which accounted for most of the decline in operating margin), which more than offset the
contribution from higher sales. On an adjusted basis, we generated higher operating income which was driven primarily by
the year-over-year increase in sales, partly offset by a lower adjusted operating margin. The decrease of 50 basis points
on an adjusted basis largely reflected lower gross margins which offset the benefit of SG&A sales leverage.
GILDAN 2022 REPORT TO SHAREHOLDERS 16
MANAGEMENT'S DISCUSSION AND ANALYSIS
Fiscal 2021 compared to fiscal 2020
The improvement in operating and adjusted operating income in fiscal 2021 compared to fiscal 2020 was mainly due to
the significant year-over-year sales recovery, strong gross and adjusted gross margin performance, partially offset by
higher SG&A expenses. The operating income increase in fiscal 2021 was also due to lower restructuring and acquisition-
related costs and the benefit of the reversal of impairment of intangible assets in fiscal 2021 compared to a charge for the
impairment of goodwill and intangible assets recognized in fiscal 2020.
5.5.8 Financial expenses, net
(in $ millions)
Interest expense on financial liabilities recorded at
amortized cost
Bank and other financial charges
Interest accretion on discounted lease obligation
Interest accretion on discounted provisions
Foreign exchange (gain) loss
Financial expenses, net
2022
2021
2020
Variation
2022-2021
Variation
2021-2020
25.7
10.5
3.1
—
(2.3)
37.0
14.9
8.8
2.6
0.2
0.8
27.3
30.2
14.6
3.2
0.2
0.2
48.4
10.8
1.7
0.5
(0.2)
(3.1)
9.7
(15.3)
(5.8)
(0.6)
—
0.6
(21.1)
Certain minor rounding variances exist between the consolidated financial statements and this summary.
Fiscal 2022 compared to fiscal 2021
The increase in interest expense in fiscal 2022 compared to fiscal 2021 was mainly due to higher average borrowing
levels, as well as the impact of higher interest rates. The increase in bank and other financial charges was mainly due to
higher fees incurred relating to increased volumes in our receivable sale program. Foreign exchange gains and losses are
related primarily to the revaluation of net monetary assets denominated in foreign currencies.
Fiscal 2021 compared to fiscal 2020
The decrease in interest expense in fiscal 2021 compared to fiscal 2020 was mainly due to lower average borrowing
levels, as the Company fully repaid its $400 million unsecured two-year term loan on April 20, 2021. The decrease in bank
and other financial charges was mainly due to fees incurred in fiscal 2020 in connection with the amendments made in
June 2020 to the revolving long-term bank credit facility, both term loan facilities, and the privately issued notes.
5.5.9 Income taxes
The Company’s average effective tax rate is calculated as follows:
(in $ millions, or otherwise indicated)
Earnings (loss) before income taxes
Income tax expense (recovery)
Average effective income tax rate
n.m. = not meaningful
2022
566.4
24.9
4.4 %
2021
624.6
17.4
2.8 %
2020
(229.4)
(4.1)
1.8 %
Variation
2022-2021
Variation
2021-2020
(58.2)
7.5
1.6 pp
854.0
21.5
1.0 pp
Certain minor rounding variances exist between the consolidated financial statements and this summary.
Fiscal 2022 compared to fiscal 2021
The income tax expense of $25 million and $17 million in fiscal 2022 and fiscal 2021, respectively, both include income tax
recoveries relating to the re-recognition of previously de-recognized deferred income tax assets that we expect to recover
as a result of the Company's reassessment of the recoverability of its U.S. deferred income tax assets. In addition, fiscal
2022 includes income tax expenses relating to gains on asset disposals included within restructuring and acquisition-
related costs. Excluding the impact of the aforementioned income tax recoveries and excluding the impact of impairment
charges and reversals, net insurance gains and restructuring and acquisition related costs, the average adjusted effective
income tax rate for both years was comparable.
Fiscal 2021 compared to fiscal 2020
The income tax expense of $17 million in fiscal 2021 and the net income tax recovery of $4 million in fiscal 2020 both
include income tax recoveries relating to the re-recognition of previously de-recognized deferred income tax assets that
we expect to recover as a result of the Company's reassessment of the recoverability of its U.S. deferred income tax
assets. In addition, fiscal 2020 includes income tax recoveries relating to restructuring and acquisition-related costs and
strategic product line initiatives, as well as a tax recovery relating to the impairment charge of goodwill and intangible
GILDAN 2022 REPORT TO SHAREHOLDERS 17
MANAGEMENT'S DISCUSSION AND ANALYSIS
assets. Excluding these aforementioned income tax recoveries, the income tax expense was $26 million for fiscal 2021
compared to an income tax expense of $6 million for fiscal 2020 due to earnings incurred in fiscal 2021 compared to a net
loss incurred in fiscal 2020. Notwithstanding the consolidated net loss in fiscal 2020, the Company incurred income tax
expenses in certain subsidiaries that had taxable income in fiscal 2020.
The income tax recoveries in fiscal 2022 related to the re-recognition of previously de-recognized deferred income tax
assets were $10 million (2021 - $9 million and 2020 - $5 million). Other income tax expense and recoveries relating to
restructuring and acquisition-related costs, impairment charges and reversals, net insurance gains and strategic product
line initiatives were $7 million (2021 - nil, and 2020 - $5 million recovery).
5.5.10 Net earnings, adjusted net earnings, earnings per share measures, and other performance measures
(in $ millions, except per share amounts)
2022
2021
2020
Variation
2022-2021
Variation
2021-2020
Net earnings (loss)
Adjustments for:
541.5
607.2
(225.3)
(65.7)
832.5
Restructuring and acquisition-related costs
0.5
8.2
48.2
(7.7)
(40.0)
Impairment of goodwill and intangible assets
(Impairment reversal of intangible assets, net
of write-downs)
Impact of strategic product line initiatives
Discontinuance of PPE SKUs
Net insurance gains
Income tax expense (recovery) relating to the
above-noted adjustments
Income tax (recovery) expense related to the
revaluation of deferred income tax assets and
liabilities(1)
Adjusted net earnings (loss)(2)
Diluted EPS
Adjusted diluted EPS(2)
62.3
(1.0)
—
(31.5)
8.8
—
(25.9)
(46.0)
94.0
60.0
6.2
(9.6)
93.8
(9.8)
—
20.1
(125.5)
(51.2)
(6.2)
(36.4)
7.2
—
(4.6)
7.2
4.6
(9.9)
574.7
2.93
3.11
(8.6)
538.1
3.07
2.72
(5.2)
(36.3)
(1.14)
(0.18)
(1.3)
36.6
(0.14)
0.39
(3.4)
574.4
4.21
2.90
(1) Includes an income tax recovery of $9.9 million (2021 - $8.6 million, 2020 - $5.2 million) pursuant to the recognition of previously de-
recognized (in fiscal 2018 and fiscal 2017 pursuant to the organizational realignment plan) deferred income tax assets as a result of a re-
assessment of the probability of realization of such deferred income tax assets.
(2) This is a non-GAAP financial measure or ratio. See section 16.0 "Definition and reconciliation of non-GAAP financial measures" in this
MD&A.
Certain minor rounding variances exist between the consolidated financial statements and this summary.
Fiscal 2022 compared to fiscal 2021
The decline in net earnings and diluted EPS for 2022 was mainly due to the lower operating income and higher financial
and income tax expenses. Record adjusted net earnings for 2022 of $575 million reflected the increase in adjusted
operating income slightly offset by higher financial expenses. The record adjusted diluted EPS of $3.11 in 2022 also
reflected the benefit of a lower year-over-year share count resulting from Company repurchases of shares under its share
repurchase program.
Fiscal 2021 compared to fiscal 2020
Net earnings and adjusted net earnings generated in fiscal 2021 compared to the net loss and adjusted net loss incurred
in fiscal 2020 was mainly due to the economic recovery we saw in fiscal 2021 which drove strong year-over-year
operating and adjusted operating income performance, as well as lower net financial expenses, partly offset by higher
income taxes.
GILDAN 2022 REPORT TO SHAREHOLDERS 18
MANAGEMENT'S DISCUSSION AND ANALYSIS
5.6 Summary of quarterly results
The table below sets forth certain summarized unaudited quarterly financial data for the eight most recently completed
quarters. This quarterly information has been prepared in accordance with IFRS. The operating results for any quarter are
not necessarily indicative of the results to be expected for any future period.
For the three months ended
(in $ millions, except share and per share amounts or
otherwise indicated)
Net sales
Net earnings
Net earnings per share
Basic(1)
Diluted(1)
Weighted average number of shares
outstanding (in ‘000s)
Basic
Diluted
Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
720.0
850.0
895.6
774.9
784.3
801.6
747.2
589.6
83.9
153.0
158.2
146.4
173.9
188.3
146.4
98.5
0.47
0.47
0.84
0.84
0.85
0.85
0.77
0.77
0.90
0.89
0.95
0.95
0.74
0.74
0.50
0.50
179,680 181,980 185,506 189,344 193,841 197,334 198,464 198,418
179,897 182,239 185,869 190,214 194,760 198,059 199,050 198,582
(1) Quarterly EPS may not add to year-to-date EPS due to rounding.
Certain minor rounding variances exist between the consolidated financial statements and this summary.
5.6.1 Seasonality and other factors affecting the variability of results and financial condition
Throughout 2021, as the economy progressively reopened and Covid restrictions eased, improved market conditions
contributed to improving the Company's financial performance. In 2022, while the recovery continued to drive momentum
in the imprintables channel, with a return to travel and large events, retail-end markets were impacted by a softening
demand environment and the lingering effects of the pandemic on retailers. International markets continued to be
impacted by a challenging economic backdrop in Europe and Asia, as well as the strict Covid policy in China. Further, as
we moved through 2022, our customers managed their inventory levels more tightly as a result of the growing macro
economic uncertainty.
Our results of operations for interim and annual periods are impacted by the variability of certain factors, including, but not
limited to, changes in end-use demand and customer demand, our customers’ decisions to increase or decrease their
inventory levels, changes in our sales mix, and fluctuations in selling prices and raw material costs. While our products are
sold on a year-round basis, our business experiences seasonal changes in demand which result in quarterly fluctuations
in operating results. Although certain products have seasonal peak periods of demand, competitive dynamics may
influence the timing of customer purchases causing seasonal trends to vary somewhat from year to year. Historically,
demand for T-shirts is lowest in the fourth quarter and highest in the second quarter of the year, when distributors
purchase inventory for the peak summer selling season. Historically, demand for fleece is typically highest in advance of
the fall and winter seasons, in the second and third quarters of the year. Sales of hosiery and underwear are typically
higher during the second half of the year, during the back-to-school period and the Christmas holiday selling season.
These seasonal sales trends of our business also result in fluctuations in our inventory levels throughout the year.
Our results are also impacted by fluctuations in the price of raw materials and other input costs. Cotton and polyester
fibers are the primary raw materials used in the manufacture of our products, and we also use chemicals, dyestuffs, and
trims, which we purchase from a variety of suppliers. Cotton prices are affected by consumer demand, global supply,
which may be impacted by weather conditions in any given year, speculation on the commodities market, the relative
valuations and fluctuations of the currencies of producer versus consumer countries, and other factors that are generally
unpredictable. While we enter into purchase contracts and derivative financial instruments in advance of delivery to
establish firm prices for the cotton component of our yarn requirements, our realized cotton costs can fluctuate
significantly between interim and annual reporting periods. Energy costs in our results of operations are also affected by
fluctuations in crude oil, natural gas, and petroleum prices, which can also influence transportation costs and the cost of
related items used in our business, such as polyester fibers, chemicals, dyestuffs, and trims. Changes in raw material
costs are initially reflected in the cost of inventory and only impact net earnings when the respective inventories are sold.
Business acquisitions may affect the comparability of results. In addition, management decisions to consolidate or
reorganize operations, including the closure of facilities, may result in significant restructuring costs in an interim or annual
period. Subsection 5.5.5 entitled "Restructuring and acquisition-related costs" in this MD&A contains a discussion of costs
related to the Company’s restructuring actions and business acquisitions. Share repurchases have reduced our number
of shares outstanding and increased our Net earnings per share (EPS) in each of the last five quarters. The Company
may repurchase more shares in the future as deemed appropriate, but this remains uncertain. The effect of asset write-
GILDAN 2022 REPORT TO SHAREHOLDERS 19
MANAGEMENT'S DISCUSSION AND ANALYSIS
downs, including allowances for expected credit losses, provisions for discontinued inventories, and impairments of long-
lived assets can also affect the variability of our results. In the fourth quarter of fiscal 2022, we reported an impairment
charge of $62 million relating to our Hosiery cash-generating unit (CGU), compared to a reversal of impairment of
$32 million (net of specific asset write-offs) in the fourth quarter of fiscal 2021. Our results of operations over the past two
years also include net insurance gains resulting from accrued insurance recoveries for the Company’s claims for losses
relating to the two hurricanes in Central America in November 2020 (Q4 2020: $10 million; Q1 2021: $6 million; Q2 2021:
$13 million; Q3 2021: $30 million; Q1 2022: $0.3 million, Q4 2022: $25.6 million).
Our reported amounts for net sales, cost of sales, SG&A expenses, and financial expenses/income are impacted by
fluctuations in certain foreign currencies versus the U.S. dollar as described in the “Financial risk management” section of
this MD&A. The Company periodically uses derivative financial instruments to manage risks related to fluctuations in
foreign exchange rates.
5.7 Fourth quarter operating results
For the three months ended
(in $ millions, except per share amounts or otherwise indicated)
January 1,
2023
January 2,
2022
Variation $
Variation %
Net sales
Gross profit
Adjusted gross profit(1)
SG&A expenses
Impairment (Reversal of impairment) of trade accounts
receivable
Restructuring and acquisition-related costs
Impairment of intangible assets (Impairment reversal of
intangible assets, net of write-downs)
Operating income
Adjusted operating income(1)
Adjusted EBITDA(1)
Financial expenses
Income tax recovery
Net earnings
Adjusted net earnings(1)
Basic EPS
Diluted EPS
Adjusted diluted EPS(1)
Gross margin
Adjusted gross margin(1)
SG&A expenses as a percentage of sales
Operating margin
Adjusted operating margin(1)
Diluted weighted average number of common shares
outstanding (in ‘000s)
720.0
234.8
209.2
75.8
(2.2)
6.3
62.3
92.6
135.6
163.6
13.3
(4.6)
83.9
117.2
0.47
0.47
0.65
32.6 %
29.1 %
10.5 %
12.9 %
18.8 %
784.3
229.3
239.8
80.5
(1.0)
4.2
(31.5)
177.1
160.3
189.9
4.7
(1.5)
173.9
148.5
0.90
0.89
0.76
29.2 %
30.6 %
10.3 %
22.6 %
20.4 %
179,897
194,760
(64.3)
5.5
(30.6)
(4.7)
(1.2)
2.1
93.8
(84.5)
(24.7)
(26.3)
8.6
(3.1)
(90.0)
(31.3)
(0.43)
(0.42)
(0.11)
n/a
n/a
n/a
n/a
n/a
n/a
(8.2) %
2.4 %
(12.8) %
(5.8) %
n.m.
50.0 %
n.m.
(47.7) %
(15.4) %
(13.8) %
n.m.
n.m.
(51.8) %
(21.1) %
(47.8) %
(47.2) %
(14.5) %
3.4 pp
(1.5) pp
0.2 pp
(9.7) pp
(1.6) pp
n/a
n.m. = not meaningful
n/a = not applicable
(1) This is a non-GAAP financial measure or ratio. See section 16.0 "Definition and reconciliation of non-GAAP financial measures" in this
MD&A.
Certain minor rounding variances exist between the consolidated financial statements and this summary.
GILDAN 2022 REPORT TO SHAREHOLDERS 20
MANAGEMENT'S DISCUSSION AND ANALYSIS
Net sales for the fourth quarter ending January 1, 2023, of $720 million were down 8% over the prior year, consisting of
activewear sales of $595 million, down 5%, and sales of $125 million in the hosiery and underwear category, down 21%
compared to the prior year quarter. The decline in activewear sales was due to lower volumes resulting from a
combination of lower POS in retail end-markets, and to a lesser extent, at North American distributors, as well as the
absence of inventory replenishment versus a year ago, partly offset by higher net selling prices and the favorable impact
of mix. International sales in the quarter were up 16% over the prior year, benefiting from inventory replenishment and
higher net selling prices. In the hosiery and underwear category, the sales decline compared to last year was due to weak
POS in retail and the impact of retailers continuing to reduce inventory levels with these impacts slightly offset by higher
net selling prices.
Gross margin of 32.6% in the quarter was up 340 basis points over 2021 due mainly to the impact of $26 million in net
insurance gains relating to additional hurricane insurance recoveries recognized in the quarter, and the non-recurrence of
an $8 million strategic product line initiative charge in the fourth quarter of last year, partially offset by other factors noted
below. On an adjusted gross margin basis which excludes the impact of net insurance gains and the strategic product line
initiative charge noted above, adjusted gross margin of 29.1% was down 150 basis points compared to 30.6% last year.
The decline in adjusted gross margins over 2021 was primarily due to higher raw material costs and manufacturing costs
which more than offset higher net selling prices and favourable product-mix. These other factors also impacted gross
margins.
SG&A expenses for the fourth quarter of $76 million were down $5 million, or 6%, compared to last year due to lower
volumes, lower variable compensation expenses and cost containment efforts, which more than offset the impact of cost
inflation. SG&A expenses as a percentage of net sales increased slightly by 20 basis points to 10.5% compared to 10.3%
last year, as the benefit of lower expenses was more than offset by sales deleverage.
In the fourth quarter, we recorded a non-cash impairment charge for our Hosiery CGU of $62 million relating to intangible
assets acquired in previous sock and hosiery business acquisitions with this charge driven by current market conditions.
This charge compares to a net reversal of impairment of $32 million recorded in the fourth quarter of 2021 for the same
CGU. After reflecting the net impact of the above items for both years, operating income in the fourth quarter of $93 million
was down from $177 million last year.
On an adjusted basis, before reflecting the net impact of intangible asset impairment charges and reversals, accrued
insurance recoveries, and restructuring and acquisition related costs in both years, we generated adjusted operating
income of $136 million, or 18.8% of sales, compared to $160 million, or 20.4% of sales, in the fourth quarter of 2021. The
year-over-year decrease in adjusted operating income reflected lower sales and lower adjusted gross margin, partly offset
by lower SG&A expenses, while the 160 basis point decrease in adjusted operating margin was due to the decrease in
adjusted gross margin. Net financial expenses of $13 million were up $8 million over the prior year, mainly due to higher
interest rates on higher average borrowing levels. As a result, we reported net earnings of $84 million, or $0.47 per diluted
share, for the fourth quarter of 2022 and adjusted net earnings of $117 million, or $0.65 per diluted share. This compared
to net earnings of $174 million, or $0.89 per diluted share, and adjusted net earnings of $149 million, or $0.76 per diluted
share, respectively, in the fourth quarter last year.
GILDAN 2022 REPORT TO SHAREHOLDERS 21
6.0 FINANCIAL CONDITION
6.1 Current assets and current liabilities
(in $ millions)
Cash and cash equivalents
Trade accounts receivable
Inventories
Prepaid expenses, deposits and other current assets
Accounts payable and accrued liabilities
Current portion of lease obligations
Income taxes payable
Current portion of long-term debt
Total working capital(1)
Current ratio(2)
MANAGEMENT'S DISCUSSION AND ANALYSIS
January 1,
2023
January 2,
2022
Variation
150.4
248.8
1,225.9
101.8
(471.2)
(13.8)
(6.6)
(150.0)
1,085.3
2.7
179.2
330.0
774.4
163.7
(440.4)
(15.3)
(7.9)
—
983.7
3.1
(28.8)
(81.2)
451.5
(61.9)
(30.8)
1.5
1.3
(150.0)
101.6
n.m
n.m. = not meaningful
(1) This is a non-GAAP financial measure or ratio. See section 16.0 "Definition and reconciliation of non-GAAP financial measures" in this
MD&A.
(2) Current ratio is defined as current assets divided by current liabilities.
Certain minor rounding variances exist between the consolidated financial statements and this summary.
•
•
•
•
•
The decrease in cash and cash equivalents mainly reflects share repurchases under the Company's NCIB program
and the payment of dividends, partially offset by increases in amounts drawn under our revolving long-term bank
credit facilities and the free cash flow generated during fiscal 2022.
The decrease in trade accounts receivable (which are net of accrued sales discounts) was mainly due to the impact
of higher trade accounts receivables sold under the receivables purchase agreement and the impact of lower sales
during the fourth quarter of fiscal 2022 compared to fiscal 2021.
The increase in inventories during fiscal 2022 was mainly due to planned increases in overall unit volumes, in order to
improve inventory levels from the below optimal levels at the end of Q4 2021 that had resulted from production
constraints due to the impact of the 2020 hurricanes in Central America and yarn labour shortages. The increase in
inventories also reflected higher unit costs due to higher fiber costs and inflationary pressure on other materials,
freight and conversion costs. The Company expects that the impact of high unit costs in inventories at the end of
fiscal 2022 will negatively impact gross margins in the first half of fiscal 2023 relative to margins reported for the first
half of fiscal 2022.
Prepaid expenses, deposits and other current assets are lower mainly due to a decrease in the fair value of derivative
financial instrument assets which reflected the maturity of commodity forward swap contracts that were designated as
hedges for the Company's cotton purchases for fiscal 2022.
The increase in accounts payable and accrued liabilities is mainly the result of higher production, higher raw material
and freight costs, partially offset by the timing of remittances to banks of sold receivable collections, as well as lower
accruals for variable compensation.
• Working capital was $1,085 million as at January 1, 2023, compared to $984 million as at January 2, 2022. The
current ratio at the end of fiscal 2022 of 2.7 is lower than the current ratio of 3.1 at the end of fiscal 2021, mainly due
to $150 million of our long-term debt becoming current during the third quarter of fiscal 2022.
GILDAN 2022 REPORT TO SHAREHOLDERS 22
6.2 Property, plant and equipment, right-of-use assets, intangible assets, and goodwill
MANAGEMENT'S DISCUSSION AND ANALYSIS
(in $ millions)
Balance, January 2, 2022
Additions
Business dispositions
Purchase price allocation adjustment
Depreciation and amortization
Net carrying amounts of disposals
Property, plant
and equipment
Right-of-use
assets
Intangible
assets
Goodwill
985.1
242.5
—
—
(102.3)
(10.1)
92.4
11.7
(8.4)
—
(14.8)
—
306.6
5.2
—
—
(19.2)
(0.3)
(62.3)
230.0
283.8
—
(13.9)
1.8
—
—
—
271.7
Write-downs and impairments
Balance, January 1, 2023
Certain minor rounding variances exist between the consolidated financial statements and this summary.
—
1,115.2
(3.0)
77.9
•
•
•
•
Additions to property, plant and equipment are mainly due to expenditures related to the expansion of textile and
sewing manufacturing operations, including our Bangladesh expansion project, and modernization of the yarn-
spinning facilities acquired as part of the Frontier Yarns acquisition. Disposals are mainly due to the sale of one of our
U.S. yarn spinning facilities.
The decrease in right-of-use assets mainly reflects the disposal of our lease interest following the sale of one of our
smaller U.S. yarn spinning facilities that was acquired as part of the Frontier Yarns acquisition, as well as the impact
of depreciation, partially offset by manufacturing and distribution facility lease modifications entered into during 2022.
Intangible assets are comprised of customer contracts and relationships, trademarks, license agreements, non-
compete agreements, and computer software. The $77 million decrease in intangible assets mainly reflects the
impairment charge of $62 million taken relating to the Hosiery CGU and amortization of $19 million.
The $12 million decrease in goodwill reflects $14 million of goodwill disposed of in connection with the sale of one of
the Frontier Yarns spinning facilities, partially offset by a purchase price allocation adjustment due to a change in our
preliminary valuation of assets acquired and liabilities assumed in connection with the Frontier acquisition.
GILDAN 2022 REPORT TO SHAREHOLDERS 23
6.3 Other non-current assets and non-current liabilities
(in $ millions)
Deferred income tax assets
Other non-current assets
Long-term debt
Lease obligations
Other non-current liabilities(1)
MANAGEMENT'S DISCUSSION AND ANALYSIS
January 1,
2023
January 2,
2022
16.0
2.5
(780.0)
(80.2)
(56.2)
17.7
3.8
(600.0)
(93.8)
(59.9)
Variation
(1.7)
(1.3)
(180.0)
13.6
3.7
(1) Other non-current liabilities include provisions and employee benefit obligations.
Certain minor rounding variances exist between the consolidated financial statements and this summary.
•
•
See section 8.0 entitled “Liquidity and capital resources” in this MD&A for the discussion on long-term debt.
The decrease in lease obligations mainly reflects the payments made during the fiscal year, as well as the disposal of
our lease obligation which was sold as part of the sale of one of the Frontier Yarns spinning facilities, partially offset
by the impact of manufacturing and distribution facility lease renewals entered into during the year.
7.0 CASH FLOWS
7.1 Cash flows from (used in) operating activities
(in $ millions)
Net earnings
Adjustments for:
2022
2021
Variation
541.5
607.2
(65.7)
Depreciation and amortization
124.9
135.4
(10.5)
Non-cash restructuring (gains) costs related to property, plant
and equipment, right-of-use assets, and computer software
Impairment of intangible assets (Impairment reversal of
intangible assets, net of write-downs)
Timing differences between settlement of financial derivatives
and transfer of deferred gains and losses in accumulated OCI
to inventory and net earnings
Insurance recovery gain, net of loss on disposal of property,
plant and equipment
Share-based compensation
Other
Changes in non-cash working capital balances
Cash flows from operating activities
(3.3)
3.1
62.3
(31.5)
(6.4)
93.8
(11.3)
8.0
(19.3)
(34.2)
32.4
8.1
(307.1)
413.3
(43.7)
37.7
(2.0)
(96.7)
617.5
9.5
(5.3)
10.1
(210.4)
(204.2)
Certain minor rounding variances exist between the consolidated financial statements and this summary.
•
•
Cash flows from operating activities were $413 million in fiscal 2022, compared to $618 million in fiscal 2021.
Operating cash flows were mainly impacted in fiscal 2022 by a higher increase in non-cash working capital, as
explained below.
The net increase in non-cash working capital was $307 million in fiscal 2022, compared to a net increase of
$97 million during fiscal 2021. The higher increase in non-cash working capital compared to last year was mainly due
to a higher increase in inventories, partially offset by a decrease in trade accounts receivable in fiscal 2022 compared
to an increase in fiscal 2021.
GILDAN 2022 REPORT TO SHAREHOLDERS 24
7.2 Cash flows from (used in) investing activities
(in $ millions)
Purchase of property, plant and equipment
Purchase of intangible assets
Business dispositions (acquisitions)
Proceeds from insurance related to property, plant and equipment
(PP&E) and other disposals of PP&E
Cash flows used in investing activities
MANAGEMENT'S DISCUSSION AND ANALYSIS
2022
(239.1)
(5.4)
33.5
28.6
(182.4)
2021
Variation
(127.5)
(2.8)
(164.0)
106.4
(187.9)
(111.6)
(2.6)
197.5
(77.8)
5.5
Certain minor rounding variances exist between the consolidated financial statements and this summary.
•
•
The increase in cash flows used in investing activities in fiscal 2022 was due to planned higher capital spending, as
well as a decrease in insurance proceeds relating to property, plant and equipment damaged from the 2020
hurricanes in Central America, partially offset by the proceeds from the sale of one of our U.S. yarn spinning facilities.
Capital expenditures1 during fiscal 2022 are described in section 6.2 of this MD&A entitled "6.2 Property, plant and
equipment, right-of-use assets, intangible assets, and goodwill", and our projected capital expenditures for the next
fiscal year are discussed in section 8.0 entitled “Liquidity and capital resources” in this MD&A.
7.3 Free cash flow
(in $ millions)
2022
2021
Variation
Cash flows from operating activities
Cash flows used in investing activities
Adjustment for:
Business (dispositions) acquisitions
Free cash flow(1)
(1) This is a non-GAAP financial measure or ratio. See section 16.0 "Definition and reconciliation of non-GAAP financial measures" in
this MD&A.
617.5
(187.8)
413.5
(182.4)
164.0
593.7
(33.5)
197.6
(197.5)
(396.1)
(204.0)
5.4
Certain minor rounding variances exist between the consolidated financial statements and this summary.
•
For fiscal 2022, the year-over-year decrease in free cash flow of $396 million was mainly due to lower operating cash
flows of 204 million, as well as the higher capital expenditures compared to the same period last year, and a decrease
in insurance proceeds relating to damaged equipment.
1 Capital expenditures include purchases of property, plant & equipment and intangible assets.
GILDAN 2022 REPORT TO SHAREHOLDERS 25
MANAGEMENT'S DISCUSSION AND ANALYSIS
7.4 Cash flows from (used in) financing activities
(in $ millions)
2022
2021
Variation
Increase in amounts drawn under revolving long-term bank credit
facility long-term bank credit facilities
Payment of term loan
Payment of lease obligations
Dividends paid
Proceeds from the issuance of shares
Repurchase and cancellation of shares
Share repurchases for settlement of non-Treasury RSUs
Withholding taxes paid pursuant to the settlement of non-Treasury
RSUs
Cash flows used in financing activities
330.0
—
(16.6)
(123.8)
15.0
(449.2)
(8.3)
(5.5)
(258.4)
—
(400.0)
(21.5)
(90.5)
9.4
(245.1)
(4.3)
(2.8)
(754.8)
330.0
400.0
4.9
(33.3)
5.6
(204.1)
(4.0)
(2.7)
496.4
Certain minor rounding variances exist between the consolidated financial statements and this summary.
•
•
Cash flows used in financing activities for fiscal 2022 mainly reflected the repurchase and cancellation of common
shares under NCIB programs as discussed in section 8.5 of this MD&A, the payment of dividends, and payments
made during the period on lease obligations, partially offset by cash inflows of $330 million from funds drawn on our
long-term bank credit facilities. See section 8.0 of this MD&A entitled “Liquidity and capital resources” for the
discussion on long-term debt.
The Company paid $124 million of dividends during fiscal 2022 compared to $90 million of dividends during fiscal
2021. The year-over-year increase is due to the 10% increase in the amount of the quarterly dividend approved by
the Board of Directors on May 4, 2022, as well the impact of the reinstatement of the Company's quarterly dividend
during the second quarter of fiscal 2021, partially offset by the impact of lower common shares outstanding as a result
of the repurchase and cancellation of common shares executed since fiscal 2018 under NCIB programs.
8.0 LIQUIDITY AND CAPITAL RESOURCES
8.1 Capital allocation framework
Historically, our primary uses of funds have been for working capital requirements, capital expenditures, business
acquisitions, and the payment of dividends and share repurchases, which we have funded with cash generated from
operations and with funds drawn from our long-term debt facilities. We have established a capital allocation framework
intended to enhance sales and earnings growth as well as shareholder returns. After funding working capital needs, our
first priority of cash use is to fund our organic growth with the required capital investments. Beyond these requirements,
our next priorities for capital allocation are to support our dividends and for opportunistic complementary acquisitions with
a preference towards opportunities that could enhance our supply chain model. In addition, we have used excess cash to
repurchase shares under normal course issuer bid programs.
The Company has set a fiscal year-end net debt leverage target ratio1 of one to two times pro-forma adjusted EBITDA for
the trailing twelve months, which it believes will provide an efficient capital structure and a framework within which it can
execute on its capital allocation priorities. We expect that cash flows from operating activities and the unutilized financing
capacity under our long-term debt facilities will continue to provide us with sufficient liquidity to fund our organic growth
strategy, including anticipated working capital and projected capital expenditures averaging 6% to 8% of annual sales,
repay or refinance the portion of our notes payable coming due in August 2023, and allow for the continued payment of
dividends and continued share repurchases in line with our leverage framework and value considerations. Refer to note
26 of the audited annual consolidated financial statements for the year ended January 1, 2023 for an update on the
Company’s liquidity risk.
1 This is a non-GAAP financial measure or ratio. See section 16.0 "Definition and reconciliation of non-GAAP financial measures" in this
MD&A.
GILDAN 2022 REPORT TO SHAREHOLDERS 26
MANAGEMENT'S DISCUSSION AND ANALYSIS
8.2 Long-term debt and net debt and net debt leverage ratio
The Company's long-term debt as at January 1, 2023 is described below.
(in $ millions, or otherwise indicated)
Non-current portion of long-term debt
Effective
interest
rate (1)
Principal amount
January 1,
2023
January 2,
2022
Maturity
date
Revolving long-term bank credit facility, interest at variable U.S. interest
rate(2)(3)
3.4%
330.0
—
Term loan, interest at variable U.S. interest rate, payable monthly(2)(4)
3.0%
300.0
300.0
Notes payable, interest at fixed rate of 2.70%, payable semi-annually(5)
Notes payable, interest at Adjusted LIBOR plus a spread of 1.53%,
payable quarterly(5)(6)
n/a
n/a
—
—
100.0
50.0
Notes payable, interest at fixed rate of 2.91%, payable semi-annually(5)
2.9%
100.0
100.0
Notes payable, interest at Adjusted LIBOR plus a spread of 1.57%,
payable quarterly(5)(6)
2.9%
50.0
50.0
780.0
600.0
Current portion of long-term debt
Notes payable, interest at fixed rate of 2.70%, payable semi-annually(5)
2.7%
100.0
Notes payable, interest at Adjusted LIBOR plus a spread of 1.53%,
payable quarterly(5)(6)
2.7%
Long-term debt
50.0
150.0
930.0
—
—
—
600.0
March
2027
June
2026
August
2023
August
2023
August
2026
August
2026
August
2023
August
2023
(1) Represents the annualized effective interest rate for the year ended January 1, 2023, including the cash impact of interest rate swaps,
where applicable.
(2) SOFR advances at adjusted Term SOFR (includes a 0.00% to 0.25% reference rate adjustment) plus a spread ranging from 1% to
3%.
(3) The Company’s committed unsecured revolving long-term bank credit facility of $1 billion provides for an annual extension which is
subject to the approval of the lenders. The spread added to the adjusted Term SOFR is a function of the total net debt to EBITDA ratio (as
defined in the credit facility agreement and its amendments). In addition, an amount of $43.9 million (January 2, 2022 - $51.1 million) has
been committed against this facility to cover various letters of credit.
(4) The unsecured term loan is non-revolving and can be prepaid in whole or in part at any time with no penalties. The spread added to
the adjusted Term SOFR is a function of the total net debt to EBITDA ratio (as defined in the term loan agreements and its amendments).
(5) The unsecured notes issued for a total aggregate principal amount of $300 million to accredited investors in the U.S. private
placement market can be prepaid in whole or in part at any time, subject to the payment of a prepayment penalty as provided for in the
Note Purchase Agreement.
(6) Adjusted LIBOR rate is determined on the basis of floating rate notes that bear interest at a floating rate plus a spread of 1.53%.
On June 30, 2022, the Company amended its notes purchase agreement to include LIBOR fallback provisions to replace
LIBOR with adjusted term SOFR, adjusted daily simple SOFR or any relevant alternate rate selected by the note holders
and the Company upon a benchmark transition event or early opt-in election.
On March 25, 2022, the Company amended and extended its unsecured revolving long-term bank credit facility of
$1 billion to March 2027. As part of the amendment, LIBOR references were replaced with Term Secured Overnight
Financing Rate (‘‘Term SOFR’’) and the revolving facility includes a sustainability-linked loan ("SLL") structure, whereby its
applicable margins are adjusted upon achievement of certain sustainability targets, commencing in 2023. Revolving
facility advances made prior to these amendments continue to apply LIBOR rates until the end of their term.
On March 25, 2022, the Company amended its $300 million term loan to replace LIBOR references by Term SOFR
references.
GILDAN 2022 REPORT TO SHAREHOLDERS 27
MANAGEMENT'S DISCUSSION AND ANALYSIS
On April 20, 2021, the Company fully repaid its $400 million unsecured two-year term loan which was due on
April 6, 2022. In June 2021, the Company amended its unsecured term loan of $300 million to extend the maturity dates
from April 2025 to June 2026.
On June 26, 2020, given the rapidly changing environment and level of uncertainty created by the COVID-19 pandemic,
the Company amended its various loans and note agreements to modify its covenants and provide increased financial
flexibility. The amendments effected changes to certain provisions and financial covenants during the period beginning
March 30, 2020 and ending April 4, 2021 (the “covenant relief period”), and included restrictions with respect to dividends,
share repurchases, and capital expenditures. Effective April 5, 2021, a covenant relief period expired, and the Company
subsequently reinstated its quarterly dividend, as explained in section 8.4 of this MD&A entitled "Declaration of dividend",
and also reinstated its share repurchase program during the third quarter of 2021, as explained in section 8.5 of this
MD&A entitled “Normal course issuer bid (NCIB)”.
The Company was in compliance with all financial covenants as at January 1, 2023. The Company expects to maintain
compliance with its covenants over the next twelve months, based on its current expectations and forecasts.
(in $ millions)
Long-term debt (including current portion)
Bank indebtedness
Lease obligations (including current portion)
Total debt(1)
Cash and cash equivalents
Net debt(1)
January 1,
2023
January 2,
2022
930.0
—
94.0
1,024.0
(150.4)
873.6
600.0
—
109.1
709.1
(179.2)
529.9
(1) This is a non-GAAP financial measure or ratio. See section 16.0 "Definition and reconciliation of non-GAAP financial measures" in this
MD&A.
Certain minor rounding variances exist between the consolidated financial statements and this summary.
The primary measure used by the Company to monitor its financial leverage is its net debt leverage ratio as defined in
section 16.0 "Definition and reconciliation of non-GAAP financial measures" in this MD&A. Gildan’s net debt leverage ratio
as at January 1, 2023, was 1.1 times (January 2, 2022 - 0.7 times). The Company’s net debt leverage ratio is calculated
as follows:
(in $ millions, or otherwise indicated)
Adjusted EBITDA for the trailing twelve months(1)
Adjustment for:
Business acquisitions
Pro-forma adjusted EBITDA for the trailing twelve months(1)
Net debt(1)
Net debt leverage ratio(1)(2)
January 1,
2023
January 2,
2022
764.2
726.8
—
764.2
873.6
1.1
22.8
749.6
529.9
0.7
(1) This is a non-GAAP financial measure or ratio. See section 16.0 "Definition and reconciliation of non-GAAP financial measures" in this
MD&A.
(2) The Company's net debt to EBITDA ratio for purposes of its loan and note agreements was 1.3 at January 1, 2023
Certain minor rounding variances exist between the consolidated financial statements and this summary.
The total net debt to EBITDA ratios (as defined in the credit facility agreement and its amendments) vary from the
definition of the Company’s non-GAAP ratio and non-GAAP financial measures “net debt leverage ratio” and “adjusted
EBITDA”, respectively, as presented in this MD&A in certain respects. The definitions in the loan and note agreements are
based on accounting for all leases in accordance with previous accounting principles whereby the Company’s leases for
premises were accounted for as operating leases, while the Company’s reported net debt leverage ratio reflects lease
accounting in accordance with the Company’s current accounting policies. In addition, adjustments permitted to EBITDA in
the loan and note agreements vary from the adjustments used by the Company in calculating its adjusted EBITDA non-
GAAP financial measure, and EBITDA as calculated in the loan and note agreements was also impacted by certain
GILDAN 2022 REPORT TO SHAREHOLDERS 28
MANAGEMENT'S DISCUSSION AND ANALYSIS
provisions applicable during the covenant relief period. As a result of these differences, our total net debt to EBITDA ratio
for purposes of our loan and note agreements was 1.3 at the end of fiscal 2022 (2021 - 0.8).
The Company, upon approval from its Board of Directors, may issue or repay long-term debt, issue or repurchase shares,
or undertake other activities as deemed appropriate under the specific circumstances.
8.3 Outstanding share data
Our common shares are listed on the New York Stock Exchange (NYSE) and the Toronto Stock Exchange (TSX) under
the symbol GIL. As at February 21, 2023, there were 179,721,939 common shares issued and outstanding along with
2,734,343 stock options and 72,601 dilutive restricted share units (Treasury RSUs) outstanding. Each stock option entitles
the holder to purchase one common share at the end of the vesting period at a pre-determined option price. Each
Treasury RSU entitles the holder to receive one common share from treasury at the end of the vesting period, without any
monetary consideration being paid to the Company. Treasury RSUs are used exclusively for one-time awards to attract
candidates or for retention purposes and their vesting conditions, including any performance objectives, are determined by
the Board of Directors at the time of grant.
8.4 Declaration of dividend
The Company paid dividends of $123.8 million during the year ended January 1, 2023. On February 21, 2023, the Board
of Directors approved a 10% increase in the amount of the current quarterly dividend and declared a cash dividend of
$0.186 per share for an expected aggregate payment of $33 million which will be paid on April 10, 2023, on all of the
issued and outstanding common shares of the Company, rateably and proportionately, to the holders of record on
March 14, 2023. This dividend is an “eligible dividend” for the purposes of the Income Tax Act (Canada) and any other
applicable provincial legislation pertaining to eligible dividends.
As part of the Company's capital allocation framework as described in section 8.1 of this MD&A, the Board of Directors
considers several factors when deciding to declare quarterly cash dividends, including the Company’s present and future
earnings, cash flows for working capital requirements, capital expenditures, debt covenant and repayment obligations,
capital requirements, the macro-economic environment, and present and/or future regulatory and legal restrictions.
The Company's dividend payout policy and the declaration of dividends are subject to the discretion of the Board of
Directors and, consequently, there can be no assurances that Gildan's dividend policy will be maintained or that dividends
will be declared in respect of any quarter or other future periods. The declaration of dividends by the Board of Directors is
ultimately dependent on the Company’s operations and financial results which are, in turn, subject to various assumptions
and risks, including those set out in this MD&A.
8.5 Normal course issuer bid (NCIB)
On August 4, 2021, the Company received Board and Toronto Stock Exchange (TSX) approval for the reinstatement of its
normal course issuer bid to purchase for cancellation a maximum of 9,926,177 common shares, representing 5% of the
Company's issued and outstanding common shares, as at July 31, 2021 (the reference date for the NCIB). The Company
was authorized to make purchases under the normal course issuer bid during the period from August 9, 2021 to
August 8, 2022 in accordance with the requirements of the TSX.
On February 22, 2022, the Company received approval from the Toronto Stock Exchange (TSX) to amend its current
NCIB, which commenced on August 9, 2021, in order to increase the maximum number of common shares that may be
repurchased from 9,926,177, or 5% of the Company’s issued and outstanding common shares as at July 31, 2021 (the
reference date for the NCIB), to 19,477,744 common shares, representing 10% of the public float as at July 31, 2021. No
other terms of the NCIB were amended.
The automatic share purchase plan (ASPP) entered into with a designated broker on August 9, 2021, also remains
unchanged. The ASPP allows for the purchase of common shares under the NCIB at times when the Company would
ordinarily not be permitted to purchase its common shares due to regulatory restrictions or self-imposed trading blackout
periods. Outside of the pre-determined blackout periods, common shares may be purchased under the NCIB based on
the discretion of the Company’s management, in compliance with TSX rules and applicable securities laws.
In August 2022, the Company received approval from the TSX to renew its normal course issuer bid (NCIB) program
commencing on August 9, 2022, to purchase for cancellation a maximum of 9,132,337 common shares, representing 5%
of the Company's issued and outstanding common shares, as at July 31, 2022 (the reference date for the NCIB).
GILDAN 2022 REPORT TO SHAREHOLDERS 29
MANAGEMENT'S DISCUSSION AND ANALYSIS
Under the NCIB, the Company is authorized to make purchases under the normal course issuer bid during the period from
August 9, 2022 to August 8, 2023 in accordance with the requirements of the TSX. Purchases can be made by means of
open market transactions on both the TSX and the New York Stock Exchange (NYSE), or alternative Canadian trading
systems, if eligible, or by such other means as may be permitted by securities regulatory authorities, including pre-
arranged crosses, exempt offers, private agreements under an issuer bid exemption order issued by securities regulatory
authorities and block purchases of common shares. During the third quarter, the Company completed share repurchases
under its NCIB ending August 8, 2022 and following the renewal of the Company's NCIB, effective August 9, 2022, the
Company continued to repurchase shares.
During the fiscal year ended January 1, 2023, the Company repurchased for cancellation a total of 13,096,866 common
shares under its NCIB programs for a total cost of $444 million, $13 million was charged to share capital and the balance
was charged to retained earnings.
9.0 LEGAL PROCEEDINGS
9.1 Claims and litigation
The Company is a party to claims and litigation arising in the normal course of operations. The Company does not expect
the resolution of these matters to have a material adverse effect on the financial position or results of operations of the
Company.
10.0 FINANCIAL RISK MANAGEMENT
The Company is exposed to risks arising from financial instruments, including credit risk, liquidity risk, foreign currency
risk, interest rate risk, commodity price risk, as well as risks arising from changes in the price of our common shares under
our share-based compensation plans. Please refer to note 26 of the audited annual consolidated financial statements for
the year ended January 1, 2023 for additional details.
10.1 Off-balance sheet arrangements and maturity analysis of contractual obligations
In the normal course of business, we enter into contractual obligations that will require us to disburse cash over future
periods. Our material short-term cash requirements include payments under our lease obligations, purchase obligations;
related to capital expenditures, cotton commitments as well as raw material and finished goods inventory, and other
working capital needs. Working capital, defined as total current assets less total current liabilities, fluctuates depending on
effective management of receivables from our customers, inventory levels and payables to our suppliers, as well as
commodity pricing.
Our long-term material cash requirements from currently known obligations include repayment of outstanding borrowings,
interest payment obligations under our credit agreement, settlements on our outstanding derivative hedge contracts, long
term lease obligations, as well as minimum royalty payments.
All commitments have been reflected in our consolidated statements of financial position except for purchase obligations,
as well as minimum royalty payments, which are included in the table of contractual obligations below. We have no off-
balance sheet arrangements, other than as discussed in this section. The following table sets forth the maturity of our
contractual obligations by period as at January 1, 2023.
(in $ millions)
amount
cash flows
fiscal year
fiscal years fiscal years
fiscal years
Carrying Contractual Less than 1
1 to 3
4 to 5 More than 5
Accounts payable and accrued liabilities
471.2
Long-term debt
Interest obligations(1)
Purchase and other obligations
Lease obligations
Total contractual obligations
930.0
—
—
471.2
930.0
168.4
598.5
471.2
150.0
47.1
335.8
94.0
1,495.2
114.9
2,283.0
19.3
1,023.4
—
—
84.1
132.5
29.2
245.8
—
780.0
37.2
87.7
22.8
927.7
—
—
—
42.5
43.6
86.1
(1) Interest obligations include expected interest payments on long-term debt as at January 1, 2023 (assuming balances remain
outstanding through to maturity). For variable rate debt, the Company has applied the rate applicable at January 1, 2023 to the currently
established maturity dates.
GILDAN 2022 REPORT TO SHAREHOLDERS 30
MANAGEMENT'S DISCUSSION AND ANALYSIS
As disclosed in note 24 to our 2022 audited annual consolidated financial statements, we have granted financial
guarantees, irrevocable standby letters of credit, and surety bonds to third parties to indemnify them in the event the
Company and some of its subsidiaries do not perform their contractual obligations. As at January 1, 2023, the maximum
potential liability under these guarantees was $153 million, of which $17 million was for surety bonds and $136 million was
for financial guarantees and standby letters of credit.
11.0 CRITICAL ACCOUNTING ESTIMATES AND JUDGMENTS
Our significant accounting policies are described in note 3 to our fiscal 2022 audited annual consolidated financial
statements. The preparation of financial statements in conformity with IFRS requires management to make estimates and
assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income, and
expenses. Actual results may differ from these estimates.
Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are
recognized in the period in which the estimates are revised and in any future periods affected.
11.1 Critical judgments in applying accounting policies
The following are critical judgments that management has made in the process of applying accounting policies and that
have the most significant effect on the amounts recognized in the consolidated financial statements:
Determination of cash-generating units (CGUs)
The identification of CGUs and grouping of assets into the respective CGUs is based on currently available information
about actual utilization experience and expected future business plans. Management has taken into consideration various
factors in identifying its CGUs. These factors include how the Company manages and monitors its operations, the nature
of each CGU’s operations, and the major customer markets each CGU serves. As such, the Company has identified two
CGUs for purposes of testing the recoverability and impairment of non-financial assets: Textile & Sewing, and Hosiery.
Income taxes
The Company’s income tax provisions and income tax assets and liabilities are based on interpretations of applicable tax
laws, including income tax treaties between various countries in which the Company operates, as well as underlying rules
and regulations with respect to transfer pricing. These interpretations involve judgments and estimates and may be
challenged through government taxation audits, the Company being regularly subject to such audits. New information may
become available that causes the Company to change its judgment regarding the adequacy of existing income tax assets
and liabilities; such changes will impact net earnings in the period that such a determination is made.
11.2 Key sources of estimation uncertainty
Key sources of estimation uncertainty that have a significant risk of resulting in a material adjustment to the carrying
amount of assets and liabilities within the next financial year are as follows:
Inventory valuation
The cost of inventories may no longer be recoverable if inventories are discontinued, damaged, in excess quantities, or if
their selling prices or estimated forecast of product demand decline. Discontinued, damaged, and excess inventories are
carried at the net realizable value, as those inventories are sold below cost in liquidation channels. In determining the net
realizable value of finished goods, the Company considers recent recovery rates and current market conditions in these
channels. The Company regularly reviews inventory quantities on hand, current production plans, and forecasted future
sales, and inventories are written down to net realizable value when it is determined that they are no longer fully
recoverable. There is estimation uncertainty in relation to the identification of excess inventories and in the expected
selling prices used in establishing the net realizable value. As at January 1, 2023, a 10% decrease or increase in the
expected selling prices used to establish the net realizable value of discontinued, damaged, and excess inventories would
result in either a decrease or an increase in inventories of approximately $1.6 million, with a corresponding adjustment to
cost of sales. If actual market conditions are less favorable than previously projected or if liquidation of the inventory which
is no longer deemed fully recoverable is more difficult than anticipated, additional write-downs may be required.
GILDAN 2022 REPORT TO SHAREHOLDERS 31
MANAGEMENT'S DISCUSSION AND ANALYSIS
Recoverability and impairment of non-financial assets
The calculation of fair value less costs of disposal or value in use for purposes of measuring the recoverable amount of
non-financial assets involves the use of significant assumptions and estimates with respect to a variety of factors,
including expected sales, gross margins, SG&A expenses, cash flows, capital expenditures, and the selection of an
appropriate earnings multiple or discount rate, all of which are subject to inherent uncertainties and subjectivity. The
assumptions are based on annual business plans and other forecasted results, earnings multiples obtained by using
market comparables as references, and discount rates which are used to reflect market-based estimates of the risks
associated with the projected cash flows, based on the best information available as of the date of the impairment test.
Changes in circumstances, such as technological advances, adverse changes in third-party licensing arrangements,
changes to the Company’s business strategy, and changes in economic and market conditions can result in actual useful
lives and future cash flows that differ significantly from estimates and could result in increased charges for amortization or
impairment. Revisions to the estimated useful lives of finite-life non-financial assets or future cash flows constitute a
change in accounting estimate and are applied prospectively. There can be no assurance that the estimates and
assumptions used in the impairment tests will prove to be accurate predictions of the future. If the future adversely differs
from management’s best estimate of key economic assumptions and the associated cash flows materially decrease, the
Company may be required to record material impairment charges or accelerated depreciation and amortization charges
related to its non-financial assets. Please refer to note 11 of the audited annual consolidated financial statements for the
year ended January 1, 2023 for additional details on the recoverability of the Company’s cash-generating units.
12.0 ACCOUNTING POLICIES AND NEW ACCOUNTING STANDARDS NOT YET APPLIED
12.1 Accounting policies
The Company’s audited consolidated financial statements for fiscal 2022 were prepared in accordance with IFRS as
issued by the International Accounting Standards Board (IASB), using the same accounting policies as those applied in its
fiscal 2021 audited annual consolidated financial statements.
12.2 New accounting standards and interpretations not yet applied
The following new accounting standards are not effective for the year ended January 1, 2023 and have not been applied
in preparing the audited annual consolidated financial statements.
Amendments to IAS 1, Presentation of Financial Statements
On January 23, 2020, the IASB issued narrow-scope amendments to IAS 1, Presentation of Financial Statements, to
clarify how to classify debt and other liabilities as current or non-current. The amendments (which affect only the
presentation of liabilities in the statement of financial position) clarify that the classification of liabilities as current or non-
current should be based on rights that are in existence at the end of the reporting period to defer settlement by at least
twelve months and make explicit that only rights in place at the end of the reporting period should affect the classification
of a liability; clarify that classification is unaffected by expectations about whether an entity will exercise its right to defer
settlement of a liability; and make clear that settlement refers to the transfer to the counterparty of cash, equity
instruments, other assets, or services. On October 31, 2022, the IASB issued Non-current Liabilities with Covenants
(Amendments to IAS 1). These further amendments clarify how to address the effects on classification and disclosure of
covenants which an entity is required to comply with on or before the reporting date and covenants which an entity must
comply with only after the reporting date.
These amendments will be effective for annual periods beginning on or after January 1, 2024, with earlier application
permitted and are to be applied retrospectively. The Company is currently evaluating the impact of these amendments on
its consolidated financial statements.
Amendments to IAS 1 and IFRS Practice Statement 2, Disclosure of Accounting Policy Information
In February 2021, the IASB issued amendments to IAS 1 Presentation of Financial Statements and IFRS Practice
Statement 2 Making Materiality Judgements. The amendments help entities provide accounting policy disclosures that are
more useful to primary users of financial statements by:
– Replacing the requirement to disclose “significant” accounting policies under IAS 1 with a requirement to disclose
“material” accounting policies. Under this, an accounting policy would be material if, when considered together
with other information included in an entity’s financial statements, it can reasonably be expected to influence
decisions that primary users of general purpose financial statements make on the basis of those financial
statements.
GILDAN 2022 REPORT TO SHAREHOLDERS 32
MANAGEMENT'S DISCUSSION AND ANALYSIS
–
Providing guidance in IFRS Practice Statement 2 to explain and demonstrate the application of the four-step
materiality process to accounting policy disclosures.
The amendments shall be applied prospectively. The amendments to IAS 1 are effective for annual periods beginning on
or after January 1, 2023. Earlier application is permitted. Once an entity applies the amendments to IAS 1, it is also
permitted to apply the amendments to IFRS Practice Statement 2. The Company is currently evaluating the impact of the
amendment on its consolidated financial statements.
Amendments to IAS 8, Definition of Accounting Estimates
In February 2021, the IASB amended IAS 8 Accounting Policies, Changes in Accounting Estimates and Errors to
introduce a new definition of “accounting estimates” to replace the definition of “change in accounting estimates” and also
include clarifications intended to help entities distinguish changes in accounting policies from changes in accounting
estimates. This distinction is important because changes in accounting policies must be applied retrospectively while
changes in accounting estimates are accounted for prospectively. The amendments are effective for annual periods
beginning on or after January 1, 2023. Earlier application is permitted. The Company is currently evaluating the impact of
the amendment on its consolidated financial statements.
Amendments to IAS 12, Deferred Tax related to Assets and Liabilities arising from a Single Transaction
On May 7, 2021, the IASB amended IAS 12 Income Taxes, to narrow the scope of the initial recognition exemption so that
it does not apply to transactions that give rise to equal and offsetting temporary differences. The amendments are
effective for annual periods beginning on or after January 1, 2023. The Company is currently evaluating the impact of the
amendment on its consolidated financial statements.
13.0 DISCLOSURE CONTROLS AND PROCEDURES
As stated in the Canadian Securities Administrators’ National Instrument 52-109, Certification of Disclosure in Issuers’
Annual and Interim Filings and Rules 13a-15(e) and 15d-15(e) under the U.S. Securities Exchange Act of 1934, as
amended, disclosure controls and procedures means controls and other procedures of an issuer that are designed to
provide reasonable assurance that information required to be disclosed by the issuer in its annual filings, interim filings, or
other reports filed or submitted by it under securities legislation is recorded, processed, summarized, and reported within
the time periods specified in the securities legislation and include controls and procedures designed to ensure that
information required to be disclosed by an issuer in its annual filings, interim filings, or other reports filed or submitted
under securities legislation is accumulated and communicated to the issuer’s management, including its certifying officers,
as appropriate to allow timely decisions regarding required disclosure.
An evaluation of the effectiveness of our disclosure controls and procedures as of January 1, 2023 was carried out under
the supervision of, and with the participation of, our management, including our Chief Executive Officer and our Chief
Financial Officer. Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that our
disclosure controls and procedures were effective as of January 1, 2023.
GILDAN 2022 REPORT TO SHAREHOLDERS 33
MANAGEMENT'S DISCUSSION AND ANALYSIS
14.0 INTERNAL CONTROL OVER FINANCIAL REPORTING
14.1 Management’s annual report on internal control over financial reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as
such term is defined in Rules 13(a)-15(f) and 15(d)-15(f) under the U.S. Securities Exchange Act of 1934 and under
National Instrument 52-109.
Our internal control over financial reporting means a process designed by, or under the supervision of, an issuer’s
certifying officers, and effected by the issuer’s board of directors, management, and other personnel, to provide
reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with the issuer’s GAAP and includes those policies and procedures that: (1) pertain to the
maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our
assets; (2) are designed to provide reasonable assurance that transactions are recorded as necessary to permit
preparation of financial statements in accordance with International Financial Reporting Standards, and that our receipts
and expenditures are being made only in accordance with authorization of our management and directors; and (3) are
designed to provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or
disposition of our assets that could have a material effect on the annual financial statements or interim financial reports.
The design of any system of controls and procedures is based in part upon certain assumptions about the likelihood of
certain events. There can be no assurance that any design will succeed in achieving its stated goals under all potential
future conditions, regardless of how remote. As a result, due to its inherent limitations, internal control over financial
reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods
are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of
compliance with the policies or procedures may deteriorate.
Under the supervision and with the participation of our Chief Executive Officer and our Chief Financial Officer,
management conducted an evaluation of the effectiveness of our internal control over financial reporting, as at January 1,
2023, based on the framework set forth in Internal Control-Integrated Framework (2013) issued by the Committee of
Sponsoring Organizations of the Treadway Commission (COSO). Based on that evaluation under this framework, our
Chief Executive Officer and our Chief Financial Officer concluded that our internal control over financial reporting was
effective as of January 1, 2023.
14.2 Attestation report of independent registered public accounting firm
KPMG LLP, an independent registered public accounting firm, which audited and reported on our consolidated financial
statements, has issued an unqualified report on the effectiveness of our internal control over financial reporting as of
January 1, 2023.
14.3 Changes in internal control over financial reporting
There have been no changes that occurred during the quarter beginning on October 3, 2022 and ended January 1, 2023
in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our
internal control over financial reporting.
GILDAN 2022 REPORT TO SHAREHOLDERS 34
MANAGEMENT'S DISCUSSION AND ANALYSIS
15.0 RISKS AND UNCERTAINTIES
In addition to the risks previously described under the sections “Financial risk management”, “Critical accounting
estimates and judgments”, and those described elsewhere in this MD&A, this section describes the principal risks that
could have a material and adverse effect on our financial condition, results of operations, business, cash flows, or the
trading price of our common shares, as well as cause actual results to differ materially from our expectations expressed in
or implied by our forward-looking statements. The risks listed below are not the only risks that could affect the Company.
Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial may also materially
and adversely affect our financial condition, results of operations, cash flows, or business.
Our ability to implement our growth strategies and plans
The growth of our business depends on the successful execution of key strategic initiatives as part of the Gildan
Sustainable Growth strategy, which is described in section 4.0 entitled "Strategy" of this MD&A. We are implementing our
plan or plan to execute on various initiatives aimed at significantly expanding our global production capacity and
maintaining or enhancing our cost structure, driving innovation across the organization, in our manufacturing and product-
development processes, distribution and final products, as well as initiatives defined under our Next Generation ESG
strategy as described in subsection 3.2.3 entitled "Environmental, Social and Governance (ESG) Program" of this MD&A.
Our ability to implement our growth strategy and plans is dependent upon a number of factors, some of which are beyond
our control, and include but are not limited to our ability to leverage the Company's strengths, general economic conditions
and other risk factors as described in this MD&A. Further, achieving these objectives will require significant investments
which may result in both short-term and long-term costs. The Company relies on cash generated from its operating
activities and its credit facilities as its primary source of liquidity. To support the Company’s business and execute on its
growth strategy, the Company will need to continue to generate significant amounts of cash from operations, including
funds to increase the Company’s manufacturing capacity. If the Company’s business does not generate cash flow from
operating activities sufficient to fund these activities, and if sufficient funds are not otherwise available from its credit
facilities, the Company may need to seek additional capital to fund its business or execute its growth strategy in which
case there is no assurance the Company will be successful in obtaining such additional capital on favorable terms or at
all. There can be no assurance that we will be successful in the execution of these strategic initiatives, including the timely
expansion of our manufacturing capacity to pursue growth or that the successful execution of these strategic initiatives will
deliver the results we expect or grow our business. If we fail to effectively implement our strategy, our financial condition,
results of operations, business or cash flows could be adversely affected.
Our ability to compete effectively
The markets for our products are highly competitive and evolving rapidly. Competition is generally based upon service and
product availability, price, quality, comfort and fit, style, and brand. Our competitive strengths include our expertise in
building and operating large-scale, vertically integrated manufacturing hubs which allows us to operate efficiently and
reduce costs, offer competitive pricing, and provide a reliable supply chain. As discussed in section 4.0 of this MD&A
entitled "Strategy", we intend to increase our global production capacity, and any failure or delay in efficiently
implementing or managing such increase in capacity, or doing so in a cost-effective manner, could negatively impact our
cost manufacturing and distribution structure, which would negatively impact our ability to compete. There can be no
assurance that we will be able to maintain our low cost manufacturing and distribution structure and remain competitive.
As discussed in section 3.3 of this MD&A, we compete with domestic and international manufacturers, brands of well-
established U.S. apparel and sportswear companies, as well as our own customers, including retailers and wholesale
distributors that are selling basic apparel products under their own private label brands that compete directly with our
brands. In addition, customer preferences continue to shift to online shopping through the use of computers, tablets,
mobile phones and other devices and the Internet continues to facilitate competitive entry and comparison shopping.
Failure to compete effectively and respond to evolving trends in the market, including intensifying competition from private
label brands and e-commerce, and failure to adapt our operations to service the changing needs of our customers could
have a negative impact on our business and results of operations. Any changes in our ability to compete effectively in the
future may result in the loss of customers to competitors, reduction in customer orders or shelf space, lower prices or the
need for additional customer price incentives, and other forms of marketing support to our customers, all of which could
have a negative effect on our sales volumes or profitability if we are unable to offset such negative impacts with new
business or cost reductions.
GILDAN 2022 REPORT TO SHAREHOLDERS 35
MANAGEMENT'S DISCUSSION AND ANALYSIS
Our ability to integrate acquisitions
The Company’s strategic opportunities may include potential complementary acquisitions that could support, strengthen,
or expand our business. The integration of newly acquired businesses may prove to be more challenging, take more time
than originally anticipated, or result in significant additional costs and/or operational issues, all of which could negatively
affect our financial condition and results of operations. In addition, we may not be able to fully realize anticipated
synergies and other benefits expected from acquisitions.
We may be negatively impacted by changes in general economic and financial conditions
General economic and financial conditions, globally or in one or more of the markets we serve, may negatively affect our
business. If there is a decline in economic growth and in consumer and commercial activity, and/or adverse financial
conditions exist in the credit markets, as in the case of the global credit crisis in 2008 and 2009 or the COVID-19
coronavirus (as described below), this may lead to lower demand for our products resulting in sales volume reductions
and lower selling prices and may cause us to operate at levels below our optimal production capacity, which would result
in higher unit production costs, all of which could negatively affect our profitability and reduce cash flows from operations.
Weak economic and financial conditions could also negatively affect the financial condition of our customers, which could
result in lower sales volumes and increased credit risk.
The novel COVID-19 coronavirus which was recognized as a global pandemic by the World Health Organization in March
2020 has had an adverse impact on the global economy, disrupted global supply chains and consumer spending and has
caused significant volatility and disruption of financial markets. The pandemic significantly reduced economic activity and
negatively affected markets around the world as governmental authorities responded with the implementation of
numerous restrictive measures in order to limit the spread of the virus, including travel bans and restrictions, quarantines,
shelter-in-place orders and mandated business shutdowns. In 2020, as a result of the effects of the pandemic, the
Company experienced a major reduction in sales and incurred significant costs resulting from the idling of manufacturing
facilities and other actions it took in an effort to navigate through the pandemic, as explained in section 5.0 of this MD&A
(in particular, the subsection entitled “Impact of COVID-19 pandemic and other developments”). Although we have since
then observed a recovery in global economies and consequently in the demand for our products with the easing of
restrictions, rapid vaccine deployment, and resumption of travel, social gatherings, sporting, and other events at varying
levels, the pandemic still impacts our business, including as a result of certain countries maintaining strict COVID-related
policies through 2022. The extent of the impact of the COVID-19 pandemic on our business and our ability to execute our
business strategies will depend on future developments, including the duration, severity and any resurgences of the
pandemic, the implementation of containment measures, as well as vaccination rates in the markets in which we or our
suppliers operate, all of which are uncertain and cannot be predicted. Accordingly, the evolving pandemic and its impacts
may continue to have an adverse effect on our sales, results of operations and cash flows. In addition, any resurgence of
the COVID-19 pandemic could significantly impact our supply chain. While our manufacturing facilities have reopened, we
may face new or prolonged periods of facility shutdowns or work shortages with respect to some or all of our operations or
the operations of the third party suppliers we rely on, due to, among other factors, a resurgence of infections of COVID-19
and variants of the virus. If there is a prolonged economic downturn resulting from the COVID-19 pandemic, including the
current inflationary environment, including as a result of the potential emergence of other variants of the virus in the future,
or if any of the Company’s major customers do not have sufficient liquidity to allow them to continue to operate through a
prolonged economic downturn, the Company may incur operating losses, which may adversely affect the Company’s
financial position, including cash operating losses, and potential additional asset write-downs and impairments. Further,
weak demand for our products may lead to lower selling prices for our products and could negatively affect our margins
and cash flow from operations. The COVID-19 pandemic and the current economic environment also exacerbate many of
the other risks that are disclosed in this MD&A and listed above, as well as liquidity risk and credit risk that are described
in section 10.0 of this MD&A entitled “Financial Risk Management”. Any estimate of the continued effects and severity of
these developments is subject to significant uncertainty, and accordingly estimates of the extent to which the COVID-19
pandemic may materially and adversely affect the Company's financial condition, results of operations, cash flows, or
business in future periods are also subject to significant uncertainty and cannot be predicted.
GILDAN 2022 REPORT TO SHAREHOLDERS 36
MANAGEMENT'S DISCUSSION AND ANALYSIS
We rely on a small number of significant customers
We rely on a small number of customers for a significant portion of our total sales. In fiscal 2022, our top three customers
accounted for 18.6%, 18.1%, and 10.7% (2021 - 15.9%, 13.9%, and 5.9%) of total sales respectively, and our top ten
customers accounted for 67.9% (2021 - 58.8%) of total sales. We expect that these customers will continue to represent a
significant portion of our sales in the future.
Future sales volumes and profitability could be negatively affected should one or more of the following events occur:
•
•
•
•
•
a significant customer substantially reduces its purchases or ceases to buy from us, or we elect to reduce the
volume of business with or cease to sell to a significant customer, and we cannot replace that business with
sales to other customers on similar terms;
a large customer exercises its purchasing power to negotiate lower prices or higher price discounts or requires
us to incur additional service and other costs;
a customer experiences operational disruptions due to fires, extreme weather conditions, natural disasters or
pandemics (such as COVID-19), information system failures or incidents, and other factors;
further industry consolidation leads to greater customer concentration and competition; and
a customer encounters financial difficulties and is unable to meet its financial obligations.
Our customers do not commit to purchase minimum quantities
Our contracts with our customers do not require them to purchase a minimum quantity of our products or commit to
minimum shelf space allocation for our products. If any of our customers experience a significant business downturn or fail
to remain committed to our products, they may reduce or discontinue purchases from us. Although we have maintained
long-term relationships with many of our wholesale distributor and retail customers, there can be no assurance that
historic levels of business from any of our customers will continue in the future.
Our ability to anticipate, identify, or react to changes in consumer preferences and trends
While we currently focus on basic products, the apparel industry, particularly within the retail channel, is subject to
evolving consumer preferences and trends. Our success may be negatively impacted by changes in consumer
preferences which do not fit with Gildan’s core competency of marketing and large-scale manufacturing of basic apparel
products. If we are unable to successfully anticipate, identify or react to changing styles or trends, or misjudge the market
for our products, our sales could be negatively impacted and we may be faced with unsold inventory which could
negatively impact our profitability. In addition, when introducing new products for our customers we may incur additional
costs and transitional manufacturing inefficiencies as we ramp-up production or upgrade manufacturing capabilities to
support such customer programs, which could negatively impact our profitability.
Our ability to manage production and inventory levels effectively in relation to changes in customer demand
Demand for our products may vary from year to year. We aim to appropriately balance our production and inventory with
our ability to meet market demand. Based on discussions with our customers and internally generated projections
reflecting our analysis of factors impacting industry demand, we produce and carry finished goods inventory to meet the
expected demand for delivery of specific product categories. If, after producing and carrying inventory in anticipation of
deliveries, demand is significantly less than expected, we may have to carry inventory for extended periods of time or sell
excess inventory at reduced prices. In either case, our profits would be reduced. Excess inventory could also result in
lower production levels, resulting in lower plant and equipment utilization and lower absorption of fixed operating costs.
Alternatively, we are also exposed to loss of sales opportunities and market share if we produce insufficient inventory to
satisfy our customers’ demand for specific product categories as a result of underestimating market demand or not
meeting production targets, in which case our customers could seek to fulfill their product needs from competitors and
reduce the amount of business they do with us.
GILDAN 2022 REPORT TO SHAREHOLDERS 37
MANAGEMENT'S DISCUSSION AND ANALYSIS
We may be negatively impacted by fluctuations and volatility in the price of raw materials used to manufacture
our products
Cotton and polyester fibers are the primary raw materials used in the manufacture of our products. We also use
chemicals, dyestuffs, and trims which we purchase from a variety of suppliers. The price of cotton fluctuates and is
affected by consumer demand, global supply, which may be impacted by weather conditions in any given year,
speculation in the commodities market, the relative valuations and fluctuations of the currencies of producer versus
consumer countries, and other factors that are generally unpredictable and beyond our control, including the overall state
of the economy and expectations for economic growth (including as a result of the current inflationary environment and
COVID-19 pandemic). In addition, fluctuations in crude oil or petroleum prices affect our energy consumption costs and
can also influence transportation costs and the cost of related items used in our business, such as polyester fibers,
chemicals, dyestuffs, and trims. Fluctuations in energy prices are partly influenced by government policies to address
climate change, which could increase our energy costs beyond our current expectations. The Company purchases cotton
and polyester fibers through its yarn-spinning facilities, and also purchases processed cotton yarn and blended yarn from
outside vendors, at prices that are correlated with the price of cotton and polyester fibers. The Company may enter into
contracts up to twenty-four months in advance of future delivery dates to establish fixed prices for cotton, cotton-based
yarn, and polyester fiber purchases and reduce the effect of price fluctuations in the cost of cotton and polyester fibers
used in the manufacture of its products. For future delivery periods where such fixed price contracts have been entered
into, the Company will be protected against cotton and polyester fiber price increases but would not be able to benefit
from cotton or polyester fiber price decreases. Conversely, in the event that we have not entered into sufficient fixed priced
contracts for cotton or polyester fibers, or have not made other arrangements to lock in the price of cotton or polyester
fibers in advance of delivery, we will not be protected against price increases, but will be in a position to benefit from any
price decreases. A significant increase in raw material costs, particularly cotton and polyester fiber costs, could have a
negative effect on our business, results of operations, and financial condition, if the increase or part of the increase is not
mitigated through additional manufacturing and distribution cost reductions and/or higher selling prices, or if resulting
selling price increases negatively impact demand for the Company’s products. In addition, when the Company fixes its
cotton and polyester fiber costs for future delivery periods and the cost of cotton or polyester fibers subsequently
decreases significantly for that delivery period, the Company may need to reduce selling prices, which could have a
negative effect on our business, results of operations and financial condition.
We rely on key suppliers
Our ability to meet our customers’ needs depends on our ability to maintain an uninterrupted supply of raw materials and
finished goods from third-party suppliers. More specifically, we source cotton, cotton-based yarns, polyester fibers,
chemicals, dyestuffs, and trims primarily from a limited number of outside suppliers. In addition, a substantial portion of the
products sold under the Gold Toe® portfolio of brands and licensed brands are purchased from a number of third-party
suppliers. Our business, results of operations, and financial condition could be negatively affected if there is a significant
change in our relationship with any of our principal suppliers of raw materials or finished goods, or if any of these key
suppliers have difficulty sourcing cotton fibers and other raw materials, experience production disruptions, fail to maintain
production quality, fail to qualify under our social compliance program, experience transportation disruptions or encounter
financial difficulties. These events can result in lost sales, cancellation charges, or excessive markdowns, all of which can
have a negative effect on our business, results of operations, and financial condition.
We may be negatively impacted by climate, political, social, and economic risks, natural disasters, pandemics,
and endemics in the countries in which we operate or from which we source production
The majority of our products are manufactured in Central America, primarily in Honduras and Nicaragua, as well as the
Caribbean and Bangladesh, as described in the section entitled “Our operations” in this MD&A. We also purchase
significant volumes of socks from third-party suppliers in Asia. Some of the countries in which we operate or source from
have experienced political, social, and economic instability in the past, and we cannot be certain of their future stability. In
addition, most of our facilities and those of our key suppliers are located in geographic regions that are exposed to the risk
of, and have experienced in the past, hurricanes, floods, earthquakes, pandemics, and endemics. Any such events in the
future could have a negative impact on our business.
The following conditions or events could disrupt our supply chain, interrupt operations at our facilities or those of our
suppliers and customers, increase our cost of sales and other operating expenses, result in a loss of sales, asset losses,
or require additional capital expenditures to be incurred:
•
fires, extraordinary weather conditions, or natural disasters, such as hurricanes, tornadoes, floods, extreme heat,
droughts, tsunamis, typhoons, and earthquakes;
GILDAN 2022 REPORT TO SHAREHOLDERS 38
MANAGEMENT'S DISCUSSION AND ANALYSIS
•
•
•
•
pandemics, such as COVID-19 as described under the risk entitled "We may be negatively impacted by changes in
general economic and financial conditions", or endemics
political instability, social and labour unrest, human rights violations, war, or terrorism;
disruptions in port activities, shipping and freight forwarding services; and
interruptions in the availability of basic services and infrastructure, including power and water shortages.
Our insurance programs do not cover every potential loss associated with our operations, including potential damage to
assets, lost sales and profits, and liability that could result from the aforementioned conditions or events. In addition, our
insurance may not fully cover the consequences resulting from a loss event, due to insurance limits, sub-limits, or policy
exclusions. Furthermore, we may not always be able to obtain adequate insurance coverage in regions in which we
operate that have a higher likelihood of experiencing natural disasters. Any occurrence not fully covered by insurance
could have a negative effect on our business.
Compliance with laws and regulations in the various countries in which we operate and the potential negative
effects of litigation and/or regulatory actions
Our business is subject to a wide variety of laws and regulations across all of the countries in which we do business,
which involves the risk of legal and regulatory actions regarding such matters as international trade, competition, taxation,
environmental, health and safety, product liability, employment practices, patent and trademark infringement, corporate
and securities legislation, licensing and permits, data privacy, bankruptcies, and other claims. Some of these compliance
risks are further described in this "Risks and uncertainties" section of the MD&A. In the event of non-compliance with such
laws and regulations, we may be subject to regulatory actions, claims and/or litigation which could result in fines,
penalties, claim settlement costs or damages awarded to plaintiffs, legal defense costs, product recalls and related costs,
remediation costs, incremental operating costs and capital expenditures to improve future/ongoing compliance, and
damage to the Company’s reputation. In addition, non-compliance with certain laws and regulations could result in
regulatory actions that could temporarily or permanently restrict or limit our ability to conduct operations as planned,
potentially resulting in lost sales, closure costs, and asset write-offs. Due to the inherent uncertainties of litigation or
regulatory actions in both domestic and foreign jurisdictions, we cannot accurately predict the ultimate outcome of any
such proceedings.
Laws and regulations are constantly changing and are often complex, and future compliance cannot be assured. Changes
necessary to maintaining compliance with these laws and regulations may increase future compliance costs and have
other negative impacts on our business, results of operations, and financial condition.
As part of the regulatory and legal environments in which we operate, Gildan is subject to anti-bribery laws that prohibit
improper payments directly or indirectly to government officials, authorities, or persons defined in those anti-bribery laws
in order to obtain business or other improper advantages in the conduct of business. Failure by our employees,
subcontractors, suppliers, agents, and/or partners to comply with anti-bribery laws could impact Gildan in various ways
that include, but are not limited to, criminal, civil and administrative legal sanctions, negative publicity, and could have a
negative effect on our reputation as well as our business, results of operations, and financial condition.
We rely on certain international trade (including multilateral and bilateral) agreements and preference programs
and are subject to evolving international trade regulations
As a multinational corporation, we are affected by import tariffs, including the potential imposition of anti-dumping or
countervailing duties or other trade remedies on our raw materials and finished goods, international trade legislation, and
bilateral and multilateral trade agreements and trade preference programs in the countries in which we operate, source,
and sell products. To remain globally competitive, we have situated our manufacturing facilities in strategic locations to
benefit from various free trade agreements and trade preference programs. Furthermore, management continuously
monitors new developments and evaluates risks relating to duties including anti-dumping and countervailing duties,
including anti-dumping and countervailing duties, tariffs, quantitative limitations and proposed trade restrictions that could
impact our approach to global manufacturing and sourcing, and adjusts as needed.
GILDAN 2022 REPORT TO SHAREHOLDERS 39
MANAGEMENT'S DISCUSSION AND ANALYSIS
The Company relies on a number of preferential trade programs which provide duty free access to the U.S. market for
goods meeting specified rules of origin, including the Dominican Republic - Central America - United States Free Trade
Agreement (CAFTA-DR), the Caribbean Basin Trade Partnership Act (CBTPA), and the Haiti Economic Lift Program
(HELP) previously referred to as the Haitian Hemispheric Opportunity through Partnership Encouragement Act (HOPE).
Collectively, these agreements strengthen U.S. economic relations and expand trade with Central America, the Dominican
Republic, and Haiti, where we have substantial manufacturing operations and activities. The Company also relies on
preferential trade agreements to access the European Union, Canada, and other markets. Changes to trade agreements
or trade preference programs on which the Company currently relies on or the entry into force of trade-restricting
legislation may negatively impact our global competitive position. The likelihood that the agreements and preference
programs around which we have built our manufacturing supply chain will be modified, repealed, or allowed to expire, and
the extent of the impact of such changes on our business, cannot be determined with certainty.
Recently there has been an increasing focus on U.S. domestic manufacturing that has drawn worldwide attention. While a
significant proportion of our costs to manufacture our products originate in the United States, the Company also has
significant operations outside the United States. There can be no assurance that the recent and continuing focus in this
area may not attract negative publicity on the Company and its activities, lead to adverse changes in the international
trade agreements and preference programs on which the Company currently relies, the implementation of anti-dumping or
countervailing duties or additional tariffs on imports of our raw materials or finished goods into the United States, or further
U.S. tax reform that could increase our effective income tax rate. Furthermore, the imposition of non-tariff barriers by the
countries into which we sell our products internationally may also impact our ability to service such markets. Any of these
outcomes could negatively impact our ability to compete effectively and negatively affect our results of operations.
Many trade agreements provide for the application of special safeguards in the form of reinstatement of normal duties if
increased imports constitute a substantial cause of serious injury, or threat thereof, to a domestic industry. The likelihood
that a safeguard will be adopted and the extent of its impact on our business cannot be determined with certainty.
Furthermore, the imposition of any new import tariffs in any of the countries in which we operate may also negatively
impact our global competitive position. For example, United States domestic laws provide for the application of anti-
dumping or countervailing duties on imports of products into the United States where determinations are made by the
relevant agencies that such imported products have been subsidized and/or are being sold at less than “fair value” in the
case of anti-dumping determinations, or have been subsidized by a foreign government, in the case of countervailing duty
determinations, and that such imports are causing a material injury to the domestic industry. The mechanism to implement
anti-dumping and countervailing duties is available to every World Trade Organization member country. The impact of the
imposition of such duties on products we import into the United States or other markets cannot be determined with
certainty.
The United States withdrew from the Trans-Pacific Partnership Agreement (TPP) in 2017, but the other negotiating
countries went on to conclude the Comprehensive Progressive Trans-Pacific Partnership (CPTPP) in 2018. Thus far,
Australia, Canada, Japan, Mexico, New Zealand, Peru, Singapore, Vietnam, and Malaysia have ratified and implemented
CPTPP. Brunei and Chile will not benefit until they complete their ratification processes. CPTPP may negatively affect our
competitive position in some of the countries in which we sell our products.
The European Union has an Association Agreement with Central America, including Honduras and Nicaragua, where we
have production operations. The European Union also has preferential trade arrangements with other countries. Further,
the European Union maintains a Generalized System of Preferences (GSP) and the Everything But Arms programs
(EBA). These programs allow free or reduced duty entry into the European Union of qualifying articles, including apparel,
from developing countries and least developed countries where we have manufacturing operations, including Haiti and
Bangladesh. The European Union also affords preference to qualifying apparel from notable production venues including
Vietnam, Myanmar and Pakistan, which could negatively impact our competitive position in the European Union. Any
changes to these agreements, could have a negative impact on our operations.
On June 23, 2016, the United Kingdom (“UK”) voted to leave the EU (“Brexit”). The transition period for the UK’s
withdrawal ended on December 31, 2020, and the UK formally left the EU on January 1, 2021. While the UK has entered
into continuity agreements with Central American and CARIFOROM trade partners and has officially published regulations
governing the new UK Generalized System of Preferences program, the competitiveness or our supply chain in the UK
and the EU could be negatively impacted if the UK fails to effectively implement these agreements and programs or make
them permanent.
GILDAN 2022 REPORT TO SHAREHOLDERS 40
MANAGEMENT'S DISCUSSION AND ANALYSIS
China extends duty-free and quota-free trade benefits to apparel under the Asia-Pacific Trade Agreement and under a
special preferential tariff program for least developed countries, including to chief-weight cotton apparel from Bangladesh.
Changes to the agreement or preference program could have a negative impact on our operations. In 2021, the United
Nations General Assembly passed a resolution to “graduate” Bangladesh from the least developed country category to the
developing country category. The resolution established a five-year grace period. This change in Bangladesh’s status
could lead to a reduction or loss of trade preferences for its imports into Canada, the EU, the United Kingdom, Japan,
Australia, and other countries. Bangladesh’s reduction or loss of trade preferences and benefits may negatively affect our
competitive position in some of the countries in which we sell our products.
Many Chinese imports into the United States are subject to additional trade remedy duties under section 301 of the Trade
Act of 1974. The items on Lists 3, 4A, and 4B under this action include textiles and apparel. Currently, goods on List 4A,
which include many apparel articles, are subject to 7.5 percent additional duty. However, China has reportedly failed to
meet its commitments under the January 15, 2020 “Phase 1” agreement with the United States, which could result in
tariffs for goods on List 4A increasing from 7.5% to 15%. Goods on List 4B, which include the majority of apparel articles,
are currently not subject to additional duties, however the United States may decide to impose tariffs on these goods as
well or take other measures against Chinese goods. These changes, or the imposition of any further duties on Chinese
goods, could negatively impact our operations.
The United States has determined that the mass detention and treatment of Uyghurs and other ethnic minorities in the
Xinjiang Uyghur Autonomous Region (XUAR) of China includes and gives rise to forced labour. On December 23, 2021,
United States President Biden signed into law the Uyghur Forced Labor Prevention Act (UFLPA), which establishes a
presumption that any goods produced or manufactured in whole or in part in XUAR were made with forced labour and are
inadmissible into the United States unless importers present clear and convincing evidence that the goods were not made
with forced labour. Under the law, which came into effect on June 21, 2022, the U.S. Department of Homeland Security
chairs a government task force charge with developing and implementing an enforcement strategy. The strategy that has
been announced identifies apparel and cotton products as high priority sectors of enforcement. This enforcement strategy
and the broad new legal authority of the UFLPA follows previously expanded enforcement against the importation of
goods made with forced labour. The UFLPA supersedes the withhold release order (WRO) on cotton and products
containing cotton from the XUAR, under which U.S. Customs and Border Protection (CBP) was instructed to detain cotton
products including apparel, textiles and other products containing cotton grown or produced in the XUAR. CBP can detain,
exclude, or seize shipments. Legislation focused on eradicating forced labour is pending in the United Kingdom, Canada,
and the European Union. While we do not source product from the XUAR region and have taken increased actions to
ensure our entire supply chain is free of any forced labour, there is nonetheless a risk, given the presence of XUAR origin
cotton in global supply chains, that our business could be affected by these restrictions.
The U.S. Generalized System of Preferences program expired on December 31, 2020. Although the expired program did
not include duty-free preference for textile and apparel products, any renewal of the program incorporating duty-free
access of textiles and apparel into the U.S. for beneficiary countries could adversely impact our competitiveness in the
United States.
The Regional Comprehensive Economic Partnership (RCEP) is a free trade agreement among Australia, Brunei,
Cambodia, China, Indonesia, Japan, Laos, Malaysia, Myanmar, New Zealand, the Philippines, Singapore, South Korea,
Thailand, and Vietnam. On January 1, 2022, the agreement entered into force among Australia, Brunei, Cambodia, China,
Japan, Laos, New Zealand, Singapore, Thailand and Vietnam. RCEP then entered into force for the South Korea on
February 1, 2022, for Malaysia on March 18, 2022, and for Indonesia on January 2, 2023. Once ratified by all signatories,
RCEP will be the world’s largest free trade agreement based on member’s GDP. As the RCEP is implemented and
utilized, it may negatively affect our competitive position in some of the countries in which we sell our products.
Japan's Generalized System of Preferences scheme currently allows duty-free entry of qualifying goods from Bangladesh.
Any change to Japan’s GSP preference program could negatively impact our operations.
Overall, changes to trade agreements or trade preference programs that we leverage in our key country markets, or new
agreements that liberalize access for our competitors, could negatively impact our competitiveness in those markets. The
likelihood of such changes, or of modification, suspension, or termination of the agreements and preference programs
around which we have built our manufacturing supply chain, and the extent of the impact on our business, cannot be
determined with certainty.
GILDAN 2022 REPORT TO SHAREHOLDERS 41
MANAGEMENT'S DISCUSSION AND ANALYSIS
In addition, the Company is subject to customs audits as well as valuation and origin verifications in the various countries
in which it operates. Although we believe that our customs compliance programs are effective at ensuring the eligibility of
all goods manufactured for the preferential treatment claimed upon importation, and compliance with other applicable
customs requirements, we cannot predict the outcome of any governmental audit or inquiry.
The Company operates two U.S. foreign trade zones (FTZs) at two of its distribution warehouses in North Carolina and
South Carolina. FTZs enhance efficiencies in the customs entry process and allow for the non-application of duty on
certain goods distributed internationally. FTZs are highly regulated operations and while the Company believes it has
adequate systems and controls in place to manage the regulatory requirements associated with its FTZ, we cannot predict
the outcome of any governmental audit or examination of its FTZ.
Over the past two decades, governmental bodies have responded to the increased threat of terrorist activity by requiring
greater levels of inspection of imported goods and imposing security requirements on importers, carriers, and others in the
global supply chain. These added requirements can sometimes cause delays and increase costs in bringing imported
goods to market. We believe we have effectively addressed these requirements to maximize velocity in our supply chain,
but changes in security requirements or tightening of security procedures, for example, in the aftermath of a terrorist
incident, could cause delays in our goods reaching the markets in which we distribute our products.
Textile and apparel articles are generally not subject to specific export restrictions or licensing requirements in the
countries where we manufacture and distribute goods. However, the creation of export licensing requirements, imposition
of restrictions on export quantities, or specification of minimum export prices could negatively impact our business. In
addition, unilateral and multilateral sanctions on dealings with certain countries and persons are unpredictable, and they
continue to evolve in response to economic and political events, and could impact our trading relationships with vendors
or customers.
Factors or circumstances that could increase our effective income tax rate
The Company benefits from a low overall effective corporate tax rate as the majority of its profits are earned and the
majority of its sales, marketing, and manufacturing operations are carried out in low tax rate jurisdictions in Central
America and the Caribbean. The Company’s income tax filing positions and income tax provisions are based on
interpretations of applicable tax laws in the jurisdictions in which it operates, including income tax treaties between various
countries in which the Company operates as well as underlying rules and regulations with respect to transfer pricing.
These interpretations involve judgments and estimates and may be challenged through government taxation audits that
the Company is regularly subject to. Although the Company believes its tax filing positions are sustainable, we cannot
predict with certainty the outcome of any audit undertaken by taxation authorities in any jurisdictions in which we operate,
and the final result may vary compared to the estimates and assumptions used by management in determining the
Company’s consolidated income tax provision and in valuing its income tax assets and liabilities. Depending on the
ultimate outcome of any such audit, there may be a negative impact on the Company’s financial condition, results of
operations, and cash flows. In addition, if the Company were to receive a tax reassessment by a taxation authority prior to
the ultimate resolution of an audit, the Company could be required to submit an advance deposit on the amount
reassessed.
The Company's overall effective income tax rate may also be adversely affected by the following: changes to current
domestic laws in the countries in which the Company operates; changes to or terminations of the income tax treaties the
Company currently relies on; an increase in income and withholding tax rates; changes to free trade and export
processing zone rules in certain countries where the Company is currently not subject to income tax; changes in domestic
laws and income tax treaties that may result from the Organization for Economic Co-operation and Development (OECD)
initiatives against base erosion and profit shifting (BEPS), including the implementation of a global minimum tax which is
discussed in greater detail below; changes to guidance regarding the interpretation and application of domestic laws, free
trade and export processing zones, and income tax treaties; increases in the proportion of the Company's overall profits
being earned in higher tax rate jurisdictions due to changes in the locations of the Company's operations; or other factors.
GILDAN 2022 REPORT TO SHAREHOLDERS 42
MANAGEMENT'S DISCUSSION AND ANALYSIS
In October 2021, 136 jurisdictions, including Canada, agreed to the OECD’s BEPS initiative that aims to provide a two-
pillar solution to the tax challenges arising from the digitalization of the economy. The agreement consists of two pillars,
known as Pillar One and Pillar Two. Generally, Pillar One makes changes to the profit allocation and nexus rules
applicable to business profits and would apply to multinational enterprises with annual global revenues greater than 20
billion euros and profitability above 10%, with the revenue threshold expected to be reduced to 10 billion euros over time.
Based on the minimum revenue threshold, the Company is currently expected to be outside the scope of Pillar One. Pillar
Two provides for a 15% global minimum tax and would apply to multinational enterprises with annual global revenues
greater than 750 million euros. On December 20, 2021, the OECD published detailed model rules to assist jurisdictions in
the domestic implementation of Pillar Two in a manner consistent with the agreement reached in October 2021 and
released commentary to those rules in March 2022. Many jurisdictions are currently proposing to implement the main
component of Pillar Two by the start of 2024, and the European Union member states have recently unanimously adopted
a Council Directive which requires the main component of Pillar Two to be transposed into member states’ domestic laws
by the start of 2024. If Pillar Two is enacted by the various jurisdictions in which the Company operates, including but not
limited to Canada, United States, Barbados, Honduras, United Kingdom and the European Union, it could significantly
increase the Company’s low effective income tax rate and would result in a material increase to our tax provisions and
annual income tax expense, which would adversely affect our results of operations and cash flows.
We have not recognized a deferred income tax liability for the undistributed profits of our subsidiaries, as we currently
have no intention to repatriate these profits. If our expectations or intentions change in the future, we could be required to
recognize a charge to earnings for the tax liability relating to the undistributed profits of our subsidiaries, which would also
result in a corresponding cash outflow in the years in which the earnings would be repatriated. As at January 1, 2023, the
estimated income tax liability that would result in the event of a full repatriation of these undistributed profits is
approximately $67 million.
Provisions for uncertain tax positions are measured at the best estimate of the amounts expected to be paid upon ultimate
resolution. The Company’s overall effective income tax rate is impacted by its assessment of uncertain tax positions and
whether additional taxes and interest may be due. The Company’s assessment of uncertain tax positions may be
negatively affected as a result of new information, a change in management’s assessment of the technical merits of its
positions, changes to tax laws, administrative guidance, and the conclusion of tax audits.
Compliance with environmental and health and safety regulations
We are subject to various federal, state, and local environmental, social and occupational health and safety laws and
regulations in the jurisdictions in which we operate, concerning, among other things, environmental licenses, wastewater
discharges, air emissions, storm water flows, waste disposal, and fire permits. Our manufacturing plants generate some
quantities of waste, which are recycled, repurposed, or disposed of by licensed waste management companies, in cases
of hazardous waste. Through our Global Environment & Energy Policy, Restricted Substances Code of Practice and
Environmental Management System, we seek not only to comply with all applicable laws and regulations, but also to
reduce our environmental footprint through an efficient use of our resources, landfill reduction and the prioritization of
reusing and recycling. Although we believe that we are currently in compliance in all material respects with the regulatory
requirements of those jurisdictions in which our facilities are located, the extent of our liability, if any, for failures to comply
with laws, regulations, and permits applicable to our operations cannot be reasonably determined.
In line with our commitment to the environment, as well as to the health and safety of our employees, we incur capital and
other expenditures each year that are aimed at achieving compliance with current environmental standards. There can be
no assurance that future changes in federal, state, local, or other regulations, interpretations of existing regulations or the
discovery of currently unknown problems or conditions will not require substantial additional environmental remediation
expenditures, fines/penalties, or result in a disruption to our supply chain, any of which could have an adverse effect on
our business.
GILDAN 2022 REPORT TO SHAREHOLDERS 43
MANAGEMENT'S DISCUSSION AND ANALYSIS
Global climate change could have an adverse impact on our business
In recent years we have seen certain effects related to climate change largely driven by extreme weather events (e.g.,
hurricanes, flooding, fires, severe storms, cyclones, water scarcity etc.), which may have financial implications for the
business. Our operations in Central America, the Caribbean, North America, and Asia have been subjected to an increase
in severe weather events. For example, in November 2020, our Central American operations were impacted by back-to-
back hurricanes, necessitating a temporary shutdown of these facilities. While the Company is making additional
investments to improve the resiliency of its manufacturing facilities to extreme weather events, nonetheless, such future
events could slow and/or halt production due to physical damage to our assets; result in increased employee absenteeism
and reduced worker productivity in order to address incremental safety measures during extreme weather conditions; and/
or result in supply chain disruptions limiting transportation of supplies or delivery of goods. Additionally, longer-term,
chronic shifts in weather patterns may result in rising sea levels, or declining freshwater availability and quality, extreme
heat as well as increased duration, intensity and frequency of weather events, all of which could restrict the capacity and
cost effectiveness of our operations and impact the cost and availability of key raw materials such as cotton.
In recent years, stakeholders have increased their expectations of companies regarding climate change which has led to
increased public support and scrutiny towards climate change actions, increased receptivity, and requirements towards
low-carbon solutions. Response from governments around the world include favoring the adoption of emission reduction
targets and legislation, which includes supporting climate specific legislation. As a result, Gildan could be affected by
climate-related transitional risks, which include business related risks following societal and economic shifts towards a low
carbon economy. Climate-related transition risks that we could be exposed to (but are not limited to) include the following:
the impact of changes in government policies, laws and regulations; changes in market conditions; consumer preferences
and attitudes affecting their spending behavior; increased reputational risk for failing to meet evolving stakeholder and
consumer expectations; and impacts related to adopting new technologies. In some of the regions in which we operate,
government policies are quickly evolving to support the transitioning to a low carbon economy by implementing climate
and sustainability-related legislation and regulations, including carbon pricing proposals, mandates for emission
reductions and supply chain mapping disclosures.
Gildan has established an ESG strategy which in part is aimed at meeting stakeholder expectations and mitigating the
various climate change risks. This strategy includes setting and pursuing targets as further described in section 3.2.3 of
this MD&A entitled “Environmental, Social and Governance (ESG) Program.” Our ability to lower GHG emissions on both
an absolute basis and in respect of our 2030 reduction targets is subject to numerous risks and uncertainties, including
our ability to identify, develop and implement new technologies and processes at a reasonable long-term cost that aligns
with our low-cost production model; securing key management expertise specific to required technologies; and our ability
to continue to finance these investments over the long-term. Additionally, there can be no assurance that we will achieve
our targets on a timely basis or at all, or that achieving our targets will meet the expectations of our stakeholders or satisfy
evolving government legislation. Also, our actions taken to implement these objectives may expose us to certain additional
heightened financial and operational risks, including potentially limiting capacity expansion plans, business acquisition
opportunities and other growth initiatives. Additionally, costs related to implementing our ESG strategy as it relates to
climate change and environmental initiatives may be higher than anticipated, and we may not be able to pass on higher
costs to our customers.
Increasingly, investors and other stakeholders are monitoring and assessing companies on climate-related performance.
Failure to achieve our GHG targets, or a perception among investors that our targets lack ambition and/or are deemed to
be insufficient, could adversely affect the Company’s reputation and ability to attract capital. The Company’s ability to
access capital may also be negatively affected in the event that financial institutions, investors, rating agencies and/or
lenders adopt more restrictive decarbonization policies that the Company may not meet.
Overall, the physical and transitional risks relating to the effects of climate change on our business both in the short and
long term are complex and highly uncertain. There can be no assurance that we will be successful in mitigating these
risks, and if we are not successful in this regard, such outcome could heighten other business risks described in this
MD&A and have an adverse effect on our future sales, competitive position and market share, financial position,
profitability, cost structure, capital expenditure requirements, capacity, growth plans, distribution network, supply chain,
sources of financing, reputation, and our ability to achieve our strategic financial and ESG objectives.
GILDAN 2022 REPORT TO SHAREHOLDERS 44
MANAGEMENT'S DISCUSSION AND ANALYSIS
Compliance with product safety regulations
We are subject to consumer product safety laws and regulations that could affect our business. In the United States, we
are subject to the Consumer Product Safety Act, as amended by the Consumer Product Safety Improvement Act of 2008,
the Federal Hazardous Substances Act, the Flammable Fabrics Act, the Toxic Substances Control Act, and associated
rules and regulations. Such laws provide for substantial penalties for non-compliance. These statutes and regulations
include requirements for testing and certification for flammability of wearing apparel, for lead content and lead in surface
coatings in children’s products, and for phthalate content in childcare articles, including plasticized components of
children’s sleepwear. We are also subject to similar laws and regulations, and to additional warning and reporting
requirements, in specific U.S. states in which we sell our products.
In Canada, we are subject to similar laws and regulations, including the Hazardous Products Act and the Canada
Consumer Product Safety Act. In the European Union, we are also subject to the General Product Safety Directive and
the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), which places responsibility on all
manufacturers to identify and manage the risks that chemical substances may pose to human health and to the
environment. We are also subject to similar laws and regulations in the other jurisdictions in which we sell our products.
Compliance with existing and future product safety laws and regulations and enforcement policies may require that we
incur capital and other costs, which may be significant. Non-compliance with applicable product safety laws and
regulations may result in substantial fines and penalties, costs related to the recall, replacement and disposal of non-
compliant products, as well as negative publicity which could harm our reputation and result in a loss of sales. Our
customers may also require us to meet existing and additional consumer safety requirements, which may result in our
inability to provide the products in the manner required. Although we believe that we comply in all material respects with
applicable product safety laws and regulations in the jurisdictions in which we operate, the extent of our liability and risk of
business interruption, if any, due to failures to comply with laws, regulations, and permits applicable to our operations
cannot be reasonably determined.
We may be negatively impacted by changes in our relationship with our employees or changes to domestic and
foreign employment regulations
We employ approximately 51,000 employees worldwide. As a result, changes in domestic and foreign laws governing our
relationships with our employees, including wage and human resources laws and regulations, fair labour standards,
overtime pay, unemployment tax rates, workers’ compensation rates, and payroll taxes, would likely have a direct impact
on our operating costs. The majority of our employees are employed outside Canada and the United States. A significant
increase in wage rates or the cost of benefit programs in the countries in which we operate could have a negative impact
on our operating costs.
The Company has historically been able to operate in a productive manner in all of its manufacturing facilities without
experiencing significant labour disruptions, such as strikes or work stoppages. Many of our employees are members of
labour organizations, and the Company is party to a number of collective bargaining agreements, primarily relating to its
sewing operations in Nicaragua and Honduras. If labour relations were to change or deteriorate at any of our facilities or
any of our third-party contractors’ facilities, this could negatively affect the productivity and cost structure of the Company’s
manufacturing operations.
We may experience negative publicity as a result of actual, alleged, or perceived violations of labour laws or
international labour standards, unethical labour, and other business practices
We are committed to ensuring that all of our operations and contractor operations comply with our strict internal Code of
Conduct, local and international laws, and the codes and principles to which we subscribe, including those of the Fair
Labor Association (FLA) and the Worldwide Responsible Accredited Production (WRAP). While the majority of our
manufacturing operations are conducted through Company-owned facilities, we also utilize third-party contractors, which
we do not control, to complement our vertically integrated production. If one of our own manufacturing operations or one
of our third-party contractors or sub-contractors violates or is accused of violating local or international labour laws or
other applicable regulations, or engages in labour or other business practices that would be viewed, in any market in
which our products are sold, as unethical, we could experience negative publicity which could harm our reputation or the
social acceptability of our products, which could impact our ability to retain existing customers or attract new ones and
result in a loss of sales, which, in turn, could have a material adverse effect on our financial condition, results of
operations, business or cash flows.
GILDAN 2022 REPORT TO SHAREHOLDERS 45
MANAGEMENT'S DISCUSSION AND ANALYSIS
We may be negatively impacted by changes in third-party licensing arrangements and licensed brands
A number of products are designed, manufactured, sourced, and sold under trademarks that we license from third parties,
under contractual licensing relationships that are subject to periodic renewal. Because we do not control the brands
licensed to us, our licensors could make changes to their brands or business models that could result in a significant
downturn in a brand’s business, negatively affecting our sales and results of operations. If any licensor fails to adequately
maintain or protect their trademarks, engages in behaviour with respect to the licensed marks that would cause us
reputational harm, or if any of the brands licensed to us violates the trademark rights of a third-party or are deemed to be
invalid or unenforceable, we could experience a significant downturn in that brand’s business, negatively affecting our
sales and results of operations, and we may be required to expend significant amounts on public relations, advertising,
legal, and other related costs. In addition, if any of these licensors choose to cease licensing these brands to us in the
future, our sales and results of operations would be negatively affected.
Our ability to protect our intellectual property rights
Our trademarks are important to our marketing efforts and have substantial value. We aggressively protect these
trademarks from infringement and dilution through appropriate measures including court actions and administrative
proceedings; however, the actions we have taken and expect to continue to take to establish and protect our trademarks
and other intellectual property may not be adequate. We cannot be certain that others will not imitate our products or
infringe our intellectual property rights. Infringement or counterfeiting of our products could diminish the value of our
brands or otherwise negatively affect our business. In addition, unilateral actions in the United States or other countries,
such as changes to or the repeal of laws recognizing trademark or other intellectual property rights, could have an impact
on our ability to enforce those rights.
From time to time, we are involved in opposition and cancellation proceedings with respect to our intellectual property,
which could affect its validity, enforceability, and use. The value of our intellectual property could diminish if others assert
rights in, or ownership of, or oppose our applications to register our trademarks and other intellectual property rights. In
some cases, there may be trademark owners who have prior rights to our trademarks or to similar trademarks, which
could harm our ability to sell products under or register such trademarks. In addition, we have registered trademarks in
certain foreign jurisdictions and the laws of foreign countries may not protect our intellectual property rights to the same
extent as do the laws of the United States or Canada. We do not own trademark rights to all of our brands in all
jurisdictions, which may limit the future sales growth of certain branded products in such jurisdictions. Furthermore,
actions we have taken to protect our intellectual property rights may not be adequate to prevent others from seeking to
invalidate our trademarks or block sales of our products as a violation of the trademarks and intellectual property rights of
others.
In some cases, litigation may be necessary to protect our trademarks and other intellectual property rights, to enforce our
rights or defend against claims by third parties alleging that we infringe, dilute, misappropriate, or otherwise violate third-
party trademark or other intellectual property rights. Any litigation or claims brought by or against us, whether with or
without merit, and whether successful or not, could result in substantial costs and diversion of our resources, which could
have a negative effect on our business, financial condition, results of operation and cash flows. Any intellectual property
litigation claims against us could result in the loss or compromise of our intellectual property rights, could subject us to
significant liabilities, require us to seek licenses on unfavorable terms, if available at all, and/or require us to rebrand our
products and services, any of which could negatively affect our business, results of operations, financial condition, and
cash flows.
We rely significantly on our information systems for our business operations
We place significant reliance on our information systems. Our information systems consist of a full range of supply chain
and financial systems. The systems include applications related to product development, planning, manufacturing,
distribution, sales, human resources, analytics, and financial reporting. We depend on our information systems to operate
our business and make key decisions. These activities include forecasting demand, purchasing raw materials and
supplies, designing products, scheduling and managing production, selling to our customers, responding to customer,
supplier and other inquiries, managing inventories, shipping goods on a timely basis, managing our employees, and
summarizing results. There can be no assurance that we will not experience operational problems with our information
systems as a result of system failures, viruses, information security incidents, cyber security incidents, disasters or other
causes, or in connection with upgrades to our systems or implementation of new systems. In addition, there can be no
assurance that we will be able to timely modify or adapt our systems to meet evolving requirements for our business. Any
material disruption or slowdown of our systems could cause operational delays and other impacts that could negatively
affect our business and results of operations.
GILDAN 2022 REPORT TO SHAREHOLDERS 46
MANAGEMENT'S DISCUSSION AND ANALYSIS
We may be negatively impacted by data security breaches or data privacy violations
Our business involves the regular collection and use of sensitive and confidential information regarding employees,
customers, business partners, vendors, and other third parties. These activities are highly regulated, and privacy and
information security laws are complex and constantly changing. Non-compliance with these laws and regulations can lead
to legal liability and reputational risk. Furthermore, an information technology system failure or non-availability, cyber
security incident, or breach of systems could disrupt our operations, cause the loss of, corruption of, or unauthorized
access to business information and data, compromise confidential information, or expose us to regulatory investigation,
litigation, or contractual penalties. Divergent technology systems inherited through business acquisitions increase
complexity and potential exposure. We use a risk-based approach to mitigating information security risk and data privacy
risk. We continue to invest in and improve our data privacy practices, data security threat protection, detection and
mitigation policies, procedures and controls, and awareness campaigns to enhance data protection. We seek to detect
and investigate all incidents and to prevent their occurrence or recurrence. Senior leadership provides updates to the
Corporate Governance and Social Responsibility Committee of any major data security or privacy issues on a quarterly
basis, provides quarterly information security reports to the Audit and Finance Committee, provides strategic updates to
the Board of Directors on an annual basis, and has a process in place to communicate time sensitive issues to the Board
on an as-needed basis. We are unaware of any material data security or privacy issues over the past three years, and
expenses incurred from data security breaches and privacy violations have been negligible over this period. However,
given the highly evolving nature and sophistication of security threats and data privacy laws, the impact of any future
incident cannot be easily predicted or mitigated, and the costs related to such incidents may not be fully insured or
indemnified by other means.
We depend on key management and our ability to attract and/or retain key personnel
Our success depends upon the continued contributions of our key management, some of whom have unique talents and
experience and would be difficult to replace in the short term. The loss or interruption of the services of a key executive
could have a negative effect on our business during the transitional period that would be required to restructure the
organization or for a successor to assume the responsibilities of the key management position. Our future success will
also depend on our ability to attract, hire and retain key managers, sales people, and other personnel. Experienced and
highly skilled employees are in high demand and competition for these employees can be intense, and our ability to
attract, hire and retain them depends on our ability to provide competitive compensation. We may not be able to attract,
hire or retain these employees, which could negatively affect our business.
GILDAN 2022 REPORT TO SHAREHOLDERS 47
MANAGEMENT'S DISCUSSION AND ANALYSIS
16.0 Definition and reconciliation of non-GAAP financial measures
We use non-GAAP financial measures, as well as non-GAAP ratios to assess our operating performance and financial
condition. The terms and definitions of the non-GAAP financial measures used in this MD&A and a reconciliation of each
non-GAAP measure to the most directly comparable GAAP measure are provided below. The non-GAAP financial
measures are presented on a consistent basis for all periods presented in this MD&A. These measures do not have any
standardized meanings prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by
other companies. Accordingly, they should not be considered in isolation or as a substitute for measures of performance
prepared in accordance with IFRS.
Non-GAAP financial measures and related ratios
In this MD&A we use non-GAAP financial measures including adjusted net earnings, adjusted operating income, adjusted
gross profit, adjusted EBITDA, as well as non-GAAP ratios including adjusted diluted EPS, adjusted operating margin,
adjusted gross margin and return on adjusted average net assets (Adjusted RONA). These financial metrics are used to
measure our performance and financial condition from one period to the next, which excludes the variation caused by
certain adjustments that could potentially distort the analysis of trends in our operating performance, and because we
believe such measures provide meaningful information on the Company’s financial performance and financial condition.
Excluding these items does not imply they are necessarily non-recurring. We also use non-GAAP financial measures
including free cash flow, total debt, net debt, net debt leverage ratio and working capital.
Certain adjustments to non-GAAP measures
As noted above certain of our non-GAAP financial measures and ratios exclude the variation caused by certain
adjustments that affect the comparability of the Company's financial results and could potentially distort the analysis of
trends in its business performance. Adjustments which impact more than one non-GAAP financial measure and ratio are
explained below:
Restructuring and acquisition-related costs
Restructuring and acquisition-related costs are comprised of costs directly related to significant exit activities, including the
closure of business locations and sale of business locations or the relocation of business activities, significant changes in
management structure, as well as transaction, exit, and integration costs incurred pursuant to business acquisitions.
Restructuring and acquisition-related costs is included as an adjustment in arriving at adjusted operating income, adjusted
operating margin, adjusted net earnings, adjusted diluted EPS, and adjusted EBITDA. Restructuring and acquisition-
related costs were $0.5 million for the fiscal year ended January 1, 2023 (2021 - $8 million, 2020 - $48 million).
Subsection 5.5.5 entitled “Restructuring and acquisition-related costs” in this MD&A contains a detailed discussion of
these costs.
Impairment of goodwill and intangible assets or impairment reversal of intangible assets, net of write-downs
During the first quarter of fiscal 2020 we recorded an impairment charge for our Hosiery cash-generating unit (CGU) of
$94 million, relating to goodwill and intangible assets acquired during previous sock and hosiery business acquisitions.
During the fourth quarter of fiscal 2021 we reported a $32 million credit to income, as a result of an impairment reversal of
$56 million and a $24 million write-off of certain intangible assets relating to the Company's Hosiery CGU. During the
fourth quarter of fiscal 2022 we reported an impairment charge of $62 million relating to the Company's Hosiery CGU.
These impairment charges and impairment reversals are included as adjustments in arriving at adjusted operating
income, adjusted operating margin, adjusted net earnings, adjusted diluted EPS, and adjusted EBITDA.
Net insurance losses (gains)
Net insurance gains of $26 million (2021 - $46 million, 2020 - $10 million) for the fiscal year ended January 1, 2023,
related to the two hurricanes which impacted the Company’s operations in Central America in November 2020. The net
insurance gains reflected costs of $7 million (2021 - $55 million, 2020 - $101 million) (mainly attributable to equipment
repairs, salary and benefits continuation for idle employees, and other costs and charges), which were more than offset by
related accrued insurance recoveries of $33 million (2021 - $101 million, 2020 - $111 million) during fiscal 2022. The
insurance gains primarily relate to accrued insurance recoveries at replacement cost value for damaged equipment in
excess of the write-off of the net book value of property plant and equipment, as well as the recognition of insurance
recoveries for business interruption, when applicable. Net insurance gains is included as an adjustment in arriving at
adjusted gross profit and adjusted gross margin, adjusted operating income, adjusted operating margin, adjusted net
earnings, adjusted diluted EPS, and adjusted EBITDA.
GILDAN 2022 REPORT TO SHAREHOLDERS 48
MANAGEMENT'S DISCUSSION AND ANALYSIS
Discontinuance of personal protective equipment (PPE) stock keeping units (SKUs)
A charge of $6 million for the three and twelve months ended January 3, 2021 (included in cost of sales) reflects the
discontinuance of these PPE SKUs given that they are not in the Company’s normal product line and that these shortages
have now been addressed. Discontinuance of PPE SKUs is included as an adjustment in arriving at adjusted gross profit
and adjusted gross margin, adjusted operating income, adjusted operating margin, adjusted net earnings, adjusted diluted
EPS, and adjusted EBITDA.
Impact of strategic product line initiatives
In the fourth quarter of fiscal 2019, the Company launched a strategic initiative to significantly reduce its imprintables
product line SKU count. In the fourth quarter of fiscal 2020 the Company expanded this strategic initiative to include a
significant reduction in its retail product line SKU count. The objectives of this strategic initiative include exiting all ship to-
the-piece activities, discontinuing overlapping and less productive styles and SKUs between brands, simplifying the
Company's product portfolio and reducing complexity in its manufacturing and warehouse distribution activities. The
impact of this initiative has included inventory write-downs to reduce the carrying value of discontinued SKUs to liquidation
values, sales return allowances for product returns related to discontinued SKUs, and in the fourth quarter of fiscal 2021,
the write-down of production equipment and other assets relating to discontinued SKUs. The impact of strategic product
line initiatives is included as an adjustment in arriving at adjusted gross profit and adjusted gross margin, adjusted
operating income, adjusted operating margin, adjusted net earnings, adjusted diluted EPS, and adjusted EBITDA.
The charges related to this initiative in fiscal 2020, 2021 and 2022, were as follows:
•
•
•
Fiscal 2020 includes a charge of $26 million of inventory write-downs included in cost of sales related to retail
product line discontinued SKUs. Fiscal 2020 also includes $29 million of inventory write-downs included in cost of
sales and the $5 million gross profit impact of a sales return allowance for anticipated product returns related to
imprintables product line discontinued SKUs (the sales return allowance reduced net sales by $11 million and
cost of sales by $6 million).
Fiscal 2021 includes $9 million of charges included in cost of sales, consisting of $4 million in inventory write-
downs related primarily to the Company's plan to discontinue its legwear and intimates product line, and the
write-down of production equipment and other assets relating to discontinued SKUs of $5 million in the fourth
quarter of 2021.
Fiscal 2022 includes $1 million gain related to the reversal of a reserve relating to Company's strategic initiatives
to significantly reduce its product line SKU counts.
GILDAN 2022 REPORT TO SHAREHOLDERS 49
MANAGEMENT'S DISCUSSION AND ANALYSIS
Adjusted net earnings and adjusted diluted EPS
Adjusted net earnings are calculated as net earnings before restructuring and acquisition-related costs, impairment of
goodwill and intangible assets (and reversal of impairments on intangible assets), net insurance gains, the discontinuance
of PPE SKUs, the impact of the Company's strategic product line initiatives, and income tax expense or recovery relating
to these items. Adjusted net earnings also excludes income taxes related to the re-assessment of the probability of
realization of previously recognized or de-recognized deferred income tax assets, and income taxes relating to the
revaluation of deferred income tax assets and liabilities as a result of statutory income tax rate changes in the countries in
which we operate. Adjusted diluted EPS is calculated as adjusted net earnings divided by the diluted weighted average
number of common shares outstanding. The Company uses adjusted net earnings and adjusted diluted EPS to measure
its net earnings performance from one period to the next, and in making decisions regarding the ongoing operations of its
business, without the variation caused by the impacts of the items described above. The Company excludes these items
because they affect the comparability of its net earnings and diluted EPS and could potentially distort the analysis of net
earnings trends in its business performance. The Company believes adjusted net earnings and adjusted diluted EPS are
useful to investors because they help identify underlying trends in our business that could otherwise be masked by certain
expenses, write-offs, charges, income or recoveries that can vary from period to period. Excluding these items does not
imply they are necessarily non-recurring. These measures do not have any standardized meanings prescribed by IFRS
and are therefore unlikely to be comparable to similar measures presented by other companies.
(in $ millions, except per share amounts)
Net earnings (loss)
Adjustments for:
Three months ended
January 1,
2023
January 2,
2022
Twelve months ended
January 2,
2022
January 1,
2023
January 3,
2021
83.9
173.9
541.5
607.2
(225.3)
Restructuring and acquisition-related costs
6.3
4.2
0.5
8.2
48.2
Impairment of goodwill and intangible assets
(Impairment reversal of intangible assets, net of
write-downs)
Impact of strategic product line initiatives
Discontinuance of PPE SKUs
Net insurance (gains) losses
Income tax expense (recovery) relating to the above-
noted adjustments
Income tax recovery related to the revaluation of
deferred income tax assets and liabilities(1)
Adjusted net earnings (loss)
Diluted EPS
Adjusted diluted EPS(2)
62.3
(31.5)
—
—
(25.6)
7.6
—
2.9
62.3
(1.0)
—
(31.5)
8.8
—
94.0
60.0
6.2
(25.9)
(46.0)
(9.6)
0.2
—
7.2
—
(4.6)
(9.9)
117.2
0.47
0.65
(8.6)
148.5
0.89
0.76
(9.9)
574.7
2.93
3.11
(8.6)
538.1
3.07
2.72
(5.2)
(36.3)
(1.14)
(0.18)
(1) Includes an income tax recovery of $9.9 million (2021 - $8.6 million, 2020 - $5.2 million) pursuant to the recognition of previously de-
recognized (in fiscal 2018 and fiscal 2017 pursuant to the organizational realignment plan) deferred income tax assets as a result of a re-
assessment of the probability of realization of such deferred income tax assets.
(2) This is a non-GAAP ratio. It is calculated as adjusted net earnings (loss) divided by the diluted weighted average number of common
shares outstanding.
Certain minor rounding variances exist between the consolidated financial statements and this summary.
GILDAN 2022 REPORT TO SHAREHOLDERS 50
MANAGEMENT'S DISCUSSION AND ANALYSIS
Adjusted gross profit and adjusted gross margin
Adjusted gross profit is calculated as gross profit excluding the impact of net insurance gains, the discontinuance of PPE
SKUs, and the impact of the Company's strategic product line initiatives. The Company uses adjusted gross profit and
adjusted gross margin to measure its performance at the gross margin level from one period to the next, without the
variation caused by the impacts of the items described above. The Company excludes these items because they affect
the comparability of its financial results and could potentially distort the analysis of trends in its business performance.
Excluding these items does not imply they are necessarily non-recurring. The Company believes adjusted gross profit and
adjusted gross margin are useful to management and investors because they help identify underlying trends in our
business in how efficiently the Company uses labor and materials for manufacturing goods to our customers, that could
otherwise be masked by the impact of our strategic product line initiatives and net insurance gains that can vary from
period to period. These measures do not have any standardized meanings prescribed by IFRS and are therefore unlikely
to be comparable to similar measures presented by other companies.
(in $ millions, or otherwise indicated)
Gross profit
Adjustments for:
Impact of strategic product line initiatives
Discontinuance of PPE SKUs
Net insurance (gains) losses
Adjusted gross profit
Net sales
Sales return allowance for anticipated product returns
Net sales excluding the allowance for anticipated
product returns related to discontinued SKUs
Gross margin
Adjusted gross margin(1)
Three months ended
January 1,
2023
January 2,
2022
Twelve months ended
January 2,
2022
January 1,
2023
January 3,
2021
234.8
229.3
992.4
940.2
249.1
—
—
(25.6)
209.2
720.0
—
7.6
—
2.9
239.8
784.3
—
(1.0)
—
(25.9)
965.5
8.8
—
(46.0)
903.0
60.0
6.2
(9.6)
305.7
3,240.5
—
2,922.6
—
1,981.3
11.2
720.0
784.3
3,240.5
2,922.6
1,992.5
32.6 %
29.1 %
29.2 %
30.6 %
30.6 %
29.8 %
32.2 %
30.9 %
12.6 %
15.3 %
(1) This is a non-GAAP ratio. It is calculated as adjusted gross profit divided by net sales excluding the sales return allowance for
anticipated product returns related to discontinued SKUs. Net sales excluding the sales return allowance for anticipated product returns
related to discontinued SKUs is a non-GAAP measure used in the denominator of the adjusted margin ratios to reverse the full effect of
the SKU rationalization adjustments.
Certain minor rounding variances exist between the consolidated financial statements and this summary.
GILDAN 2022 REPORT TO SHAREHOLDERS 51
MANAGEMENT'S DISCUSSION AND ANALYSIS
Adjusted operating income and adjusted operating margin
Adjusted operating income is calculated as operating income before restructuring and acquisition-related costs. Adjusted
operating income also excludes impairment of goodwill and intangible assets, net insurance gains, the discontinuance of
PPE SKUs, and the impact of the Company's strategic product line initiatives. Adjusted operating margin is calculated as
adjusted operating income divided by net sales, excluding the sales return allowance for anticipated product returns
related to discontinued SKUs. Management uses adjusted operating income and adjusted operating margin to measure its
performance at the operating income level as we believe it provides a better indication of our operating performance and
facilitates the comparison across reporting periods, without the variation caused by the impacts of the items described
above. The Company excludes these items because they affect the comparability of its financial results and could
potentially distort the analysis of trends in its operating income and operating margin performance. The Company believes
adjusted operating income and adjusted operating margin are useful to investors because they help identify underlying
trends in our business in how efficiently the Company generates profit from its primary operations that could otherwise be
masked by the impact of restructuring and acquisition-related costs, our strategic product line initiatives and net insurance
gains that can vary from period to period. Excluding these items does not imply they are necessarily non-recurring. These
measures do not have any standardized meanings prescribed by IFRS and are therefore unlikely to be comparable to
similar measures presented by other companies.
(in $ millions, or otherwise indicated)
Operating income (loss)
Adjustments for:
Three months ended
January 1,
2023
January 2,
2022
Twelve months ended
January 2,
2022
January 1,
2023
January 3,
2021
92.6
177.1
603.4
651.9
(180.8)
Restructuring and acquisition-related costs
6.3
4.2
0.5
8.2
48.2
Impairment of goodwill and intangible assets
(Impairment reversal of intangible assets,
net of write-downs)
Impact of strategic product line initiatives
Discontinuance of PPE SKUs
Net insurance (gains) losses
Adjusted operating income
Operating margin
Adjusted operating margin(1)
62.3
—
—
(25.6)
135.6
12.9 %
18.8 %
(31.5)
7.6
—
2.9
160.3
22.6 %
20.4 %
62.3
(1.0)
—
(25.9)
639.3
18.6 %
19.7 %
(31.5)
8.8
—
(46.0)
591.4
22.3 %
20.2 %
94.0
60.0
6.2
(9.6)
18.0
(9.1) %
0.9 %
(1) This is a non-GAAP ratio. It is calculated as adjusted operating income divided by net sales excluding the sales return allowance for
anticipated product returns related to discontinued SKUs. Net sales excluding the sales return allowance for anticipated product returns
related to discontinued SKUs is a non-GAAP measure used in the denominator of the adjusted margin ratios to reverse the full effect of
the SKU rationalization adjustments.
Certain minor rounding variances exist between the consolidated financial statements and this summary.
GILDAN 2022 REPORT TO SHAREHOLDERS 52
MANAGEMENT'S DISCUSSION AND ANALYSIS
Adjusted EBITDA
Adjusted EBITDA is calculated as earnings before financial expenses net, income taxes, and depreciation and
amortization, and excludes the impact of restructuring and acquisition-related costs. Adjusted EBITDA also excludes
impairment of goodwill and intangible assets and reversal of impairments on intangible assets, net insurance gains, the
discontinuance of PPE SKUs, and the impact of the Company's strategic product line initiative. Management uses
adjusted EBITDA, among other measures, to facilitate a comparison of the profitability of its business on a consistent
basis from period-to-period and to provide a more complete understanding of factors and trends affecting our business.
The Company also believes this measure is commonly used by investors and analysts to assess profitability and the cost
structure of companies within the industry, as well as measure a company’s ability to service debt and to meet other
payment obligations, or as a common valuation measurement. The Company excludes depreciation and amortization
expenses, which are non-cash in nature and can vary significantly depending upon accounting methods or non-operating
factors. Excluding these items does not imply they are necessarily non-recurring. This measure does not have any
standardized meanings prescribed by IFRS and is therefore unlikely to be comparable to similar measures presented by
other companies.
(in $ millions)
Net earnings (loss)
Restructuring and acquisition-related costs
Impairment of goodwill and intangible assets
(Impairment reversal of intangible assets, net of
write-downs)
Impact of strategic product line initiatives
Discontinuance of PPE SKUs
Net insurance (gains) losses
Depreciation and amortization
Financial expenses, net
Income tax (recovery) expense
Adjusted EBITDA
Three months ended
Twelve months ended
January 1,
2023
January 2,
2022
January 1,
2023
January 2,
2022
January 3,
2021
83.9
6.3
173.9
541.5
607.2
(225.3)
4.2
0.5
8.2
48.2
62.3
(31.5)
—
—
(25.6)
28.0
13.3
(4.6)
7.6
—
2.9
29.6
4.7
(1.5)
62.3
(1.0)
—
(25.9)
124.9
37.0
24.9
(31.5)
8.8
—
(46.0)
135.4
27.3
17.4
94.0
60.0
6.2
(9.6)
147.2
48.5
(4.1)
163.6
189.9
764.2
726.8
165.1
Certain minor rounding variances exist between the consolidated financial statements and this summary.
Free cash flow
Free cash flow is defined as cash from operating activities, less cash flow used in investing activities excluding cash flows
relating to business acquisitions/dispositions. The Company considers free cash flow to be an important indicator of the
financial strength and liquidity of its business, and it is a key metric used by management in managing capital as it
indicates how much cash is available after capital expenditures to repay debt, to pursue business acquisitions, and/or to
redistribute to its shareholders. Management believes that free cash flow also provides investors with an important
perspective on the cash available to us to service debt, fund acquisitions, and pay dividends. In addition, free cash flow is
commonly used by investors and analysts when valuing a business and its underlying assets. This measure does not
have any standardized meanings prescribed by IFRS and is therefore unlikely to be comparable to similar measures
presented by other companies.
(in $ millions)
Cash flows from operating activities
Cash flows used in investing activities
Adjustment for:
Business (dispositions) acquisitions
Free cash flow
2022
2021
2020
413.5
(182.4)
617.5
(187.8)
415.0
(57.5)
(33.5)
197.6
164.0
593.7
—
357.5
Certain minor rounding variances exist between the consolidated financial statements and this summary.
GILDAN 2022 REPORT TO SHAREHOLDERS 53
MANAGEMENT'S DISCUSSION AND ANALYSIS
Total debt and net debt
Total debt is defined as the total bank indebtedness, long-term debt (including any current portion), and lease obligations
(including any current portion), and net debt is calculated as total debt net of cash and cash equivalents. The Company
considers total debt and net debt to be important indicators for management and investors to assess the financial position
and liquidity of the Company, and measure its financial leverage. These measures do not have any standardized
meanings prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other
companies.
(in $ millions)
Long-term debt (including current portion)
Bank indebtedness
Lease obligations (including current portion)
Total debt
Cash and cash equivalents
Net debt
January 1,
2023
January 2,
2022
January 3,
2021
930.0
600.0
1,000.0
—
94.0
—
109.1
—
82.5
1,024.0
709.1
1,082.5
(150.4)
873.6
(179.2)
529.9
(505.3)
577.2
Certain minor rounding variances exist between the consolidated financial statements and this summary.
Net debt leverage ratio
The net debt leverage ratio is defined as the ratio of net debt to pro-forma adjusted EBITDA for the trailing twelve months,
all of which are non-GAAP measures. The pro-forma adjusted EBITDA for the trailing twelve months reflects business
acquisitions made during the period, as if they had occurred at the beginning of the trailing twelve month period. The
Company has set a fiscal year-end net debt leverage target ratio of one to two times pro-forma adjusted EBITDA for the
trailing twelve months. The net debt leverage ratio serves to evaluate the Company's financial leverage and is used by
management in its decisions on the Company's capital structure, including financing strategy. The Company believes that
certain investors and analysts use the net debt leverage ratio to measure the financial leverage of the Company, including
our ability to pay off our incurred debt. The Company's net debt leverage ratio differs from the net debt to EBITDA ratio
that is a covenant in our loan and note agreements due primarily to adjustments in the latter related to lease accounting,
and therefore the Company believes it is a useful additional measure. This measure does not have any standardized
meanings prescribed by IFRS and is therefore unlikely to be comparable to similar measures presented by other
companies.
(in $ millions, or otherwise indicated)
Adjusted EBITDA for the trailing twelve months
Adjustment for:
Business acquisitions
Pro-forma adjusted EBITDA for the trailing twelve months
Net debt
Net debt leverage ratio(1)
January 1,
2023
January 2,
2022
January 3,
2021
764.2
726.8
165.1
—
764.2
873.6
1.1
22.8
749.6
529.9
0.7
—
165.1
577.2
3.5
(1) The Company's total net debt to EBITDA ratio for purposes of its loan and note agreements was 1.3 at January 1, 2023. Refer to
section 8.2 of this MD&A.
Certain minor rounding variances exist between the consolidated financial statements and this summary.
GILDAN 2022 REPORT TO SHAREHOLDERS 54
MANAGEMENT'S DISCUSSION AND ANALYSIS
Return on adjusted average net assets
Return on adjusted average net assets (Adjusted RONA) is defined as the ratio of return to adjusted average net assets
for the last five quarters. Return is defined as adjusted net earnings, excluding net financial expenses and the amortization
of intangible assets (excluding software), net of income tax recoveries related thereto. Average is computed as the sum of
the five quarters divided by five. Adjusted average net assets are defined as the sum of average total assets, excluding
average cash and cash equivalents, average net deferred income taxes, and the average accumulated amortization of
intangible assets excluding software, less average total current liabilities excluding the current portion of lease obligations.
Adjusted average net assets and return are non-GAAP measures used as components of Adjusted RONA. The Company
uses Adjusted RONA as a performance indicator to measure the efficiency of its invested capital. Management believes
Adjusted RONA is useful to investors as a measure of performance and the effectiveness of our use of capital. Adjusted
RONA is not a measure of financial performance under IFRS and may not be defined and calculated by other companies
in the same manner.
(in $ millions)
January 1,
2023
January 2,
2022
January 3,
2021
Average total assets
Average cash and cash equivalents
Average net deferred income taxes
Average accumulated amortization of intangible assets, excluding software
Average total current liabilities, excluding the current portion of lease
obligations and debt
Adjusted average net assets
3,344.4
(118.8)
(12.9)
254.9
(485.3)
2,982.3
3,050.8
(384.1)
(15.6)
254.8
(400.1)
2,505.8
3,226.9
(354.7)
(13.1)
233.2
(364.5)
2,727.8
(in $ millions, or otherwise indicated)
2022
2021
2020
Adjusted net earnings
Financial expenses, net (nil income taxes in all years)
Amortization of intangible assets, excluding software, net (nil income taxes
in all three years)
Return
574.7
37.0
13.8
625.5
538.1
27.3
12.8
578.2
(36.3)
48.5
14.3
26.5
Return on adjusted average net assets (Adjusted RONA)
21.0 %
23.1 %
1.0 %
Certain minor rounding variances exist between the consolidated financial statements and this summary.
Working capital
Working capital is a non-GAAP financial measure and is defined as current assets less current liabilities. Management
believes that working capital, in addition to other conventional financial measures prepared in accordance with IFRS,
provides information that is helpful to understand the financial condition of the Company. The objective of using working
capital is to present readers with a view of the Company from management’s perspective by interpreting the material
trends and activities that affect the short-term liquidity and financial position of the Company, including its ability to
discharge its short-term liabilities as they come due. This measure is not necessarily comparable to similarly titled
measures used by other public companies.
(in $ millions)
Cash and cash equivalents
Trade accounts receivable
Income taxes receivable
Inventories
Prepaid expenses, deposits and other current assets
Accounts payable and accrued liabilities
Income taxes payable
Current portion of lease obligations
Current portion of long-term debt
Working capital
January 1,
2023
January 2,
2022
January 3,
2021
150.4
248.8
—
1,225.9
101.8
(471.2)
(6.6)
(13.8)
(150.0)
1,085.3
179.2
330.0
—
774.4
163.7
(440.4)
(7.9)
(15.3)
—
983.7
505.3
196.5
4.6
728.0
110.1
(343.7)
—
(15.9)
—
1,184.9
Certain minor rounding variances exist between the consolidated financial statements and this summary.
GILDAN 2022 REPORT TO SHAREHOLDERS 55
CONSOLIDATED FINANCIAL STATEMENTS
MANAGEMENT’S RESPONSIBILITY FOR FINANCIAL REPORTING
The accompanying consolidated financial statements have been prepared by management and approved by the Board of
Directors of the Company. The consolidated financial statements were prepared in accordance with International Financial
Reporting Standards as issued by the International Accounting Standards Board and, where appropriate, reflect
management’s best estimates and judgments. Where alternative accounting methods exist, management has chosen
those methods deemed most appropriate in the circumstances. Management is responsible for the accuracy, integrity and
objectivity of the consolidated financial statements within reasonable limits of materiality, and for maintaining a system of
internal controls over financial reporting as described in “Management’s annual report on internal control over financial
reporting” included in Management’s Discussion and Analysis for the fiscal year ended January 1, 2023. Management is
also responsible for the preparation and presentation of other financial information included in the 2022 Annual Report and
its consistency with the consolidated financial statements.
The Audit and Finance Committee, which is appointed annually by the Board of Directors and comprised exclusively of
independent directors, meets with management as well as with the independent auditors and internal auditors to satisfy
itself that management is properly discharging its financial reporting responsibilities and to review the consolidated
financial statements and the independent auditors’ report. The Audit and Finance Committee reports its findings to the
Board of Directors for consideration in approving the consolidated financial statements for presentation to the
shareholders. The Audit and Finance Committee considers, for review by the Board of Directors and approval by the
shareholders, the engagement or reappointment of the independent auditors.
The consolidated financial statements have been independently audited by KPMG LLP, on behalf of the shareholders, in
accordance with the standards of the Public Company Accounting Oversight Board (United States). Their report outlines
the nature of their audit and expresses their opinion on the consolidated financial statements of the Company. In addition,
our auditors have issued a report on the Company’s internal controls over financial reporting as of January 1, 2023.
KPMG LLP has direct access to the Audit and Finance Committee of the Board of Directors.
(Signed: Glenn J. Chamandy)
Glenn J. Chamandy
President and Chief Executive
Officer
February 21, 2023
(Signed: Rhodri J. Harries)
Rhodri J. Harries
Executive Vice-President,
Chief Financial and Administrative
Officer
GILDAN 2022 REPORT TO SHAREHOLDERS 56
CONSOLIDATED FINANCIAL STATEMENTS
KPMG LLP
600 de Maisonneuve Blvd. West
Suite 1500, Tour KPMG
Montréal (Québec) H3A 0A3
Canada
Telephone
Fax
Internet
(514) 840-2100
(514) 840-2187
www.kpmg.ca
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders and Board of Directors of Gildan Activewear Inc.:
Opinion on the Consolidated Financial Statements
We have audited the accompanying consolidated statements of financial position of Gildan Activewear Inc. (the
"Company") as of January 1, 2023 and January 2, 2022, the related consolidated statements of earnings and
comprehensive income, changes in equity, and cash flows for the years ended January 1, 2023 and January 2, 2022, and
the related notes (collectively, the "consolidated financial statements"). In our opinion, the consolidated financial
statements present fairly, in all material respects, the consolidated financial position of the Company as of January 1,
2023 and January 2, 2022 and its consolidated financial performance and its consolidated cash flows for the years ended
January 1, 2023 and January 2, 2022, in conformity with International Financial Reporting Standards as issued by the
International Accounting Standards Board.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United
States) ("PCAOB"), the Company’s internal control over financial reporting as of January 1, 2023, based on criteria
established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of
the Treadway Commission, and our report dated February 21, 2023 expressed an unqualified opinion on the effectiveness
of the Company’s internal control over financial reporting.
Basis for Opinion
These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to
express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm
registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S.
federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the
PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and
perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material
misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material
misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that
respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and
disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used
and significant estimates made by management, as well as evaluating the overall presentation of the consolidated
financial statements. We believe that our audits provide a reasonable basis for our opinion.
KPMG LLP, an Ontario limited liability partnership and member firm of the KPMG global organization of independent
member firms affiliated with KPMG International Limited, a private English company limited by guarantee. KPMG
Canada provides services to KPMG LLP.
GILDAN 2022 REPORT TO SHAREHOLDERS 57
CONSOLIDATED FINANCIAL STATEMENTS
Page 2
Critical Audit Matters
The critical audit matters communicated below are matters arising from the current period audit of the consolidated
financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate
to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially
challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our
opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit
matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they
relate.
Assessment and allocation of inventories costs
As discussed in Note 8 to the consolidated financial statements, the inventories balance as of January 1, 2023 was
$1,225.9 million, of which work in process and finished goods represented $974.2 million. As discussed in Note 3(e) to the
consolidated financial statements, inventories are stated at the lower of cost, determined on a first-in first-out basis, and
net realizable value. As the Company manages its day-to-day production costs and inventories using a standard costing
system, variances arise between these standard costs and the actual manufacturing costs. Adjustments are therefore
required at period end to measure inventories at their actual cost. This involves accumulating manufacturing variances at
each stage of the Company’s vertically-integrated manufacturing process and identifying costs to be expensed
immediately to cost of sales. Such costs include additional costs incurred as a result of operating below normal capacity
and abnormal costs. The Company then applies a variance deferral factor, based primarily on the number of days of
inventories on hand, to estimate the variances to be included in ending inventories. The determination of the variance
deferral factor involves estimation. The combination of automated and non-automated systems and processes using data
obtained from different geographical locations results in complexity in accumulation of manufacturing costs and in the
identification of costs to be expensed immediately.
We identified the assessment of costs directly related to the conversion of raw materials to finished goods and the
allocation of manufacturing variances to the carrying value of inventories as a critical audit matter. A higher degree of
auditor judgment and audit effort was required in testing the costs included in the carrying value of inventories and
evaluating the variance deferral factor used in allocating the manufacturing variances given the complexity of the process.
The following are the primary procedures we performed to address this critical audit matter. We evaluated the design and
tested the operating effectiveness of certain internal controls related to the Company’s inventory costing process,
including controls related to: (1) identifying costs to be expensed immediately; and (2) establishing the variance deferral
factor. We tested the eligibility of costs for recognition in inventories by: (1) assessing the nature of costs included in
inventories by inspecting a sample of transactions recorded as manufacturing costs and tracing them to underlying
documentation; (2) analyzing manufacturing variances to identify the existence of costs to be expensed immediately; and
(3) assessing changes in production activity to identify costs to be expensed immediately. We assessed the variance
deferral factor based on the number of days of inventory on hand determined by reference to the most recent past
production, which included testing certain of the inputs to the calculation.
GILDAN 2022 REPORT TO SHAREHOLDERS 58
CONSOLIDATED FINANCIAL STATEMENTS
Page 3
Assessment of the carrying value of intangible assets in the Hosiery cash generating unit (“CGU”)
As discussed in Note 11 to the consolidated financial statements, the intangible asset balances as of January 1, 2023 in
aggregate was $230.0 million, of which $100.2 million related to the Hosiery CGU. As discussed in Notes 3(j) and 3(dd) to
the consolidated financial statements, the Company performs impairment testing on an annual basis or whenever events
or changes in circumstances indicate that the carrying value of a CGU might exceed its recoverable amount, which is
determined using the fair value less costs of disposal method. The Company’s assessment of the recoverable amount
incorporates assumptions including estimated sales volumes, selling prices, input costs and selling, general and
administrative ("SG&A") expenses in determining the risk adjusted forecasted recurring earnings before financial
expenses, income taxes, depreciation and amortization, and restructuring and acquisition-related costs ("adjusted
EBITDA") and the multiple applied to the adjusted EBITDA ("adjusted EBITDA multiple"). During the year ended
January 1, 2023, the Company recorded an impairment charge of $62.3 million in the Hosiery CGU.
We identified the assessment of the carrying value of intangible assets in the Hosiery CGU as a critical audit matter. There
was a high degree of subjective auditor judgment required to evaluate the above noted assumptions used in determining
the recoverable amount. The sensitivity of reasonably possible changes to those assumptions could have a significant
impact on the determination of the recoverable amount of the Hosiery CGU and the Company’s recorded impairment
charge in the Hosiery CGU as of January 1, 2023.
The following are the primary procedures we performed to address this critical audit matter. We evaluated the design and
tested the operating effectiveness of certain internal controls related to the Company’s impairment assessment process,
including controls related to (1) determining the adjusted EBITDA and the assumptions underlying its determination; and
(2) identifying comparable peer companies and determining the adjusted EBITDA multiple. We evaluated the adjusted
EBITDA for the Hosiery CGU by comparing the Company’s historical adjusted EBITDA forecasts to actual results and by
examining the historical trend analysis of both increases and decreases in actual revenue, input costs and SG&A
expenses as compared to the forecasted amounts. We challenged the adjustments made to historical data by evaluating
the reasonableness of adjustments through independent corroboration. We involved valuation professionals with
specialized skills and knowledge, who assisted in evaluating the adjusted EBITDA multiple used by the Company by
comparing to publicly available EBITDA multiples for comparable entities.
We have served as the Company’s auditor since 1996.
Montréal, Canada
February 21, 2023
GILDAN 2022 REPORT TO SHAREHOLDERS 59
CONSOLIDATED FINANCIAL STATEMENTS
KPMG LLP
600 de Maisonneuve Blvd. West
Suite 1500, Tour KPMG
Montréal (Québec) H3A 0A3
Canada
Telephone
Fax
Internet
(514) 840-2100
(514) 840-2187
www.kpmg.ca
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders and Board of Directors of Gildan Activewear Inc.
Opinion on Internal Control Over Financial Reporting
We have audited Gildan Activewear Inc.’s (the "Company") internal control over financial reporting as of January 1, 2023,
based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring
Organizations of the Treadway Commission. In our opinion, the Company maintained, in all material respects, effective
internal control over financial reporting as of January 1, 2023, based on criteria established in Internal Control – Integrated
Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United
States) ("PCAOB"), the consolidated statements of financial position of the Company as of January 1, 2023 and
January 2, 2022, the related consolidated statements of earnings and comprehensive income, changes in equity, and
cash flows for the years ended January 1, 2023 and January 2, 2022, and the related notes (collectively, the consolidated
financial statements), and our report dated February 21, 2023 expressed an unqualified opinion on those consolidated
financial statements.
Basis for Opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its
assessment of the effectiveness of internal control over financial reporting, included in the accompanying “Management’s
annual report on internal control over financial reporting” included in Management’s Discussion and Analysis for the year
ended January 1, 2023. Our responsibility is to express an opinion on the Company’s internal control over financial
reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be
independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and
regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and
perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was
maintained in all material respects. Our audit of internal control over financial reporting included obtaining an
understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing
and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also
included performing such other procedures as we considered necessary in the circumstances. We believe that our audit
provides a reasonable basis for our opinion.
KPMG LLP, an Ontario limited liability partnership and member firm of the KPMG global organization of independent
member firms affiliated with KPMG International Limited, a private English company limited by guarantee. KPMG
Canada provides services to KPMG LLP.
GILDAN 2022 REPORT TO SHAREHOLDERS 60
CONSOLIDATED FINANCIAL STATEMENTS
Page 2
Definition and Limitations of Internal Control Over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial statements for external purposes in accordance with
generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and
procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the
transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are
recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting
principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of
management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely
detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the
financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also,
projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become
inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may
deteriorate.
Montréal, Canada
February 21, 2023
GILDAN 2022 REPORT TO SHAREHOLDERS 61
GILDAN ACTIVEWEAR INC.
CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
(in thousands of U.S. dollars)
CONSOLIDATED FINANCIAL STATEMENTS
Current assets:
Cash and cash equivalents (note 6)
Trade accounts receivable (note 7)
Inventories (note 8)
Prepaid expenses, deposits and other current assets
Total current assets
Non-current assets:
Property, plant and equipment (note 9)
Right-of-use assets (note 10(a))
Intangible assets (note 11)
Goodwill (note 11)
Deferred income taxes (note 19)
Other non-current assets
Total non-current assets
Total assets
Current liabilities:
Accounts payable and accrued liabilities
Income taxes payable
Current portion of lease obligations (note 10(b))
Current portion of long-term debt (note 12)
Total current liabilities
Non-current liabilities:
Long-term debt (note 12)
Lease obligations (note 10(b))
Other non-current liabilities (note 13)
Total non-current liabilities
Total liabilities
Commitments, guarantees and contingent liabilities (note 24)
Equity (note 14):
Share capital
Contributed surplus
Retained earnings
Accumulated other comprehensive income (note 15)
Total equity attributable to shareholders of the Company
Total liabilities and equity
See accompanying notes to consolidated financial statements.
On behalf of the Board of Directors:
January 1,
2023
January 2,
2022
$
150,417
248,785
1,225,940
101,810
1,726,952
1,115,169
77,958
229,951
271,677
16,000
2,507
1,713,262
$
179,246
329,967
774,358
163,662
1,447,233
985,073
92,447
306,630
283,815
17,726
3,758
1,689,449
$ 3,440,214
$ 3,136,682
$
471,208
6,637
13,828
150,000
641,673
780,000
80,162
56,217
916,379
$
440,401
7,912
15,290
—
463,603
600,000
93,812
59,862
753,674
1,558,052
1,217,277
202,329
79,489
1,590,499
9,845
1,882,162
191,732
58,128
1,604,736
64,809
1,919,405
$ 3,440,214
$ 3,136,682
(Signed: Glenn J. Chamandy)
Glenn J. Chamandy
Director
(Signed: Luc Jobin)
Luc Jobin
Director
GILDAN 2022 REPORT TO SHAREHOLDERS 62
GILDAN ACTIVEWEAR INC.
CONSOLIDATED STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME
Fiscal years ended January 1, 2023 and January 2, 2022
(in thousands of U.S. dollars, except per share data)
CONSOLIDATED FINANCIAL STATEMENTS
Net sales (note 27)
Cost of sales (note 17(c))
Gross profit
Selling, general and administrative expenses (note 17(a))
Impairment (Reversal of impairment) of trade accounts receivable (note 7)
Restructuring and acquisition-related costs (note 18)
Impairment of intangible assets (Impairment reversal of intangible assets, net of
write-downs) (note 11)
Operating income
Financial expenses, net (note 15(c))
Earnings before income taxes
Income tax expense (note 19)
Net earnings
Other comprehensive (loss) income, net of related income taxes:
Cash flow hedges (note 15(d))
Actuarial gain (loss) on employee benefit obligations (note 13(a))
Comprehensive income
Earnings per share (note 20):
Basic
Diluted
See accompanying notes to consolidated financial statements.
2022
2021
$
3,240,482
$
2,922,570
2,248,070
1,982,361
992,412
324,108
2,150
479
62,290
603,385
36,957
566,428
24,888
541,540
(54,964)
8,094
(46,870)
940,209
314,171
(2,617)
8,225
(31,459)
651,889
27,331
624,558
17,375
607,183
73,847
(21,678)
52,169
$
494,670
$
659,352
$
$
2.94
2.93
$
$
3.08
3.07
GILDAN 2022 REPORT TO SHAREHOLDERS 63
GILDAN ACTIVEWEAR INC.
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
Fiscal years ended January 1, 2023 and January 2, 2022
(in thousands or thousands of U.S. dollars)
CONSOLIDATED FINANCIAL STATEMENTS
Share capital
Number
Amount
Contributed
surplus
Accumulated
other
comprehensive
income (loss)
Retained
earnings
Total
Equity
198,407
$ 183,938
$
24,936
$
(9,038)
$ 1,359,061
$ 1,558,897
Shares repurchased for cancellation
(note 14(d))
(6,475)
(6,182)
Balance, January 3, 2021
Share-based compensation
Shares issued under employee share
purchase plan
Shares issued pursuant to exercise of stock
options
Shares issued or distributed pursuant to
vesting of restricted share units
Share repurchases for settlement of non-
Treasury RSUs (note 14(e))
Deferred compensation to be settled in non-
Treasury RSUs
Dividends declared
Transactions with shareholders of the
Company recognized directly in equity
Cash flow hedges (note 15(d))
Actuarial gain on employee benefit
obligations (note 13(a))
Net earnings
Comprehensive income
Balance, January 2, 2022
Share-based compensation
Shares issued under employee share
purchase plan
Shares issued pursuant to exercise of stock
options
Shares issued or distributed pursuant to
vesting of restricted share units
Share repurchases for settlement of non-
Treasury RSUs (note 14(e))
Deferred compensation to be settled in non-
Treasury RSUs
Dividends declared
Transactions with shareholders of the
Company recognized directly in equity
Cash flow hedges (note 15(d))
Actuarial loss on employee benefit
obligations (note 13(a))
Net earnings
Comprehensive income
—
41
295
132
—
37,526
1,406
—
9,907
(1,753)
2,762
(5,599)
(133)
(99)
—
—
—
—
—
—
2,075
943
—
—
—
—
—
—
—
—
—
—
—
—
—
37,526
1,406
8,154
(2,837)
(244,257)
(250,439)
(4,168)
(4,267)
—
2,075
(91,405)
(90,462)
(339,830)
(298,844)
(6,140)
7,794
33,192
—
—
—
—
—
—
—
—
—
—
—
—
73,847
—
73,847
—
—
73,847
(21,678)
(21,678)
607,183
585,505
607,183
659,352
192,267
$ 191,732
$
58,128
$
64,809
$ 1,604,736
$ 1,919,405
—
48
—
32,248
1,568
—
490
16,985
(3,440)
229
5,556
(11,054)
(228)
(177)
—
—
—
—
—
—
2,110
1,497
(12,558)
10,597
21,361
—
—
—
—
—
—
—
—
—
—
—
—
—
32,248
1,568
13,545
(5,498)
(430,524)
(443,859)
(8,081)
(8,258)
—
2,110
(125,266)
(123,769)
(563,871)
(531,913)
—
—
—
—
—
—
—
—
—
—
—
—
(54,964)
—
(54,964)
—
—
(54,964)
8,094
541,540
549,634
8,094
541,540
494,670
Shares repurchased for cancellation
(note 14(d))
(13,097)
(13,335)
Balance, January 1, 2023
179,709
$ 202,329
$
79,489
$
9,845
$ 1,590,499
$ 1,882,162
See accompanying notes to consolidated financial statements.
GILDAN 2022 REPORT TO SHAREHOLDERS 64
GILDAN ACTIVEWEAR INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
Fiscal years ended January 1, 2023 and January 2, 2022
(in thousands of U.S. dollars)
CONSOLIDATED FINANCIAL STATEMENTS
Cash flows from (used in) operating activities:
Net earnings
Adjustments for:
Depreciation and amortization (note 21)
Non-cash restructuring charges related to property, plant and equipment, right-of-use
assets, and computer software (note 18)
Impairment of intangible assets (Impairment reversal of intangible assets, net of write-
downs) (note 11)
2022
2021
$ 541,540 $ 607,183
124,926
135,402
(3,259)
3,136
62,290
(31,459)
Timing differences between settlement of financial derivatives and transfer of deferred
gains or losses in accumulated OCI to inventory and net earnings
(11,253)
8,012
(Gain) Loss on disposal of property, plant and equipment, including insurance
recoveries
Share-based compensation
Other (note 22 (a))
Changes in non-cash working capital balances (note 22 (c))
Cash flows from operating activities
Cash flows from (used in) investing activities:
Purchase of property, plant and equipment
Purchase of intangible assets
Business dispositions (acquisitions) (note 5)
Proceeds from insurance related to property, plant and equipment (PP&E) and other
disposals of PP&E
Cash flows used in investing activities
Cash flows from (used in) financing activities:
Increase in amounts drawn under revolving long-term bank credit facility
Payment of term loan
Payment of lease obligations (note 10(b))
Dividends paid
Proceeds from the issuance of shares
Repurchase and cancellation of shares (note 14(d))
Share repurchases for settlement of non-Treasury RSUs (note 14(e))
Withholding taxes paid pursuant to the settlement of non-Treasury RSUs
Cash flows used in financing activities
Effect of exchange rate changes on cash and cash equivalents denominated in foreign
currencies
Net (decrease) increase in cash and cash equivalents during the fiscal year
Cash and cash equivalents, beginning of fiscal year
Cash and cash equivalents, end of fiscal year
Cash paid (included in cash flows from operating activities):
Interest
Income taxes, net of refunds
Supplemental disclosure of cash flow information (note 22)
See accompanying notes to consolidated financial statements.
(34,195)
32,393
8,140
(307,094)
413,488
(43,660)
37,659
(2,024)
(96,739)
617,510
(239,128)
(5,426)
33,543
(127,457)
(2,766)
(163,968)
28,607
(182,404)
106,358
(187,833)
330,000
—
(16,559)
(123,769)
14,968
(449,158)
—
(400,000)
(21,474)
(90,462)
9,427
(245,140)
(8,258)
(5,498)
(258,274)
(4,267)
(2,837)
(754,753)
(942)
(1,639)
(326,018)
(28,829)
179,246
505,264
$ 150,417 $ 179,246
$ 29,979 $ 22,201
5,744
26,527
GILDAN 2022 REPORT TO SHAREHOLDERS 65
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Fiscal years ended January 1, 2023 and January 2, 2022
(Tabular amounts in thousands or thousands of U.S. dollars except per share data, unless otherwise indicated)
1. REPORTING ENTITY:
Gildan Activewear Inc. (the "Company" or "Gildan") is domiciled in Canada and is incorporated under the Canada
Business Corporations Act. Its principal business activity is the manufacture and sale of activewear, hosiery and
underwear. The Company's fiscal year ends on the Sunday closest to December 31 of each year.
The address of the Company’s registered office is 600 de Maisonneuve Boulevard West, Suite 3300, Montreal, Quebec.
These consolidated financial statements are as at and for the fiscal years ended January 1, 2023 (fiscal 2022) and
January 2, 2022 (fiscal 2021) and include the accounts of the Company and its subsidiaries. The Company is a publicly
listed entity and its shares are traded on the Toronto Stock Exchange and New York Stock Exchange under the symbol
GIL.
2. BASIS OF PREPARATION:
(a) Statement of compliance:
These consolidated financial statements have been prepared in accordance with International Financial Reporting
Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”).
These consolidated financial statements for the fiscal year ended January 1, 2023 were authorized for issuance by
the Board of Directors of the Company on February 21, 2023.
(b) Basis of measurement:
These consolidated financial statements have been prepared on the historical cost basis except for the following
items in the consolidated statements of financial position:
•
•
Derivative financial instruments which are measured at fair value;
Employee benefit obligations related to defined benefit plans which are measured at the present value of the
defined benefit obligations, net of advance payments made to employees thereon;
Liabilities for cash-settled share-based payment arrangements which are measured at fair value, and equity-
classified share-based payment arrangements which are measured at fair value at grant date pursuant to IFRS
2, Share-based payment;
Discontinued, damaged, and excess finished inventories which are carried at the net realizable value;
Provisions for decommissioning, site restoration costs, and onerous contracts which are measured at the present
value of the expenditures expected to be required to settle the obligation; and
Identifiable assets acquired and liabilities assumed in connection with a business combination which are initially
measured at fair value.
•
•
•
•
These consolidated financial statements are presented in U.S. dollars, which is the Company's functional currency.
GILDAN 2022 REPORT TO SHAREHOLDERS 66
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
2. BASIS OF PREPARATION (continued):
(c) Initial application of new or amended accounting standards:
During the year ended January 2, 2022, the Company adopted the following new or amended accounting standards:
Interest Rate Benchmark Reform
On August 27 2020, the IASB published "Interest Rate Benchmark Reform - Phase 2 (Amendments to IFRS 9, IAS
39, IFRS 7, IFRS 4 and IFRS 16)" to address issues relating to the modification of financial assets, financial liabilities
and lease liabilities, specific hedge accounting requirements, and disclosure requirements when an existing interest
rate benchmark is actually replaced. The amendment introduced a practical expedient for modifications required by
the reform (modifications required as a direct consequence of the IBOR reform and made on an economically
equivalent basis). These modifications are accounted for by updating the effective interest rate. All other modifications
are accounted for using the current IFRS requirements. A similar practical expedient is available for interest rate
reform for lessee accounting under IFRS 16. Under the amendments, hedge accounting is not discontinued solely
because of the IBOR reform. Hedging relationships (and related documentation) must be amended to reflect
modifications to the hedged item, hedging instrument, and hedged risk. Amended hedging relationships should meet
all qualifying criteria to apply hedge accounting, including effectiveness requirements. The amendments are effective
for annual reporting periods beginning on or after January 1, 2021 and are to be applied retrospectively. On March
25, 2022, the Company amended its unsecured revolving long-term bank credit facility and term loan to replace
LIBOR references with Term Secured Overnight Financing Rate (‘‘Term SOFR’’). On June 30, 2022, the Company
amended its notes purchase agreement to include LIBOR fallback provisions to replace LIBOR with adjusted term
SOFR, adjusted daily simple SOFR or any relevant alternate rate selected by the note holders and the Company
upon a benchmark transition event or early opt-in election. In addition, the Company and its counterparties under
interest rate swap agreements are expected to negotiate the substitution of reference rates in such agreements. The
Company applied the IFRS 9 interest rate benchmark reform practical expedient for amendments required by the
interest rate reform to the revolving-long term bank credit facility, term loan and related interest rate swap
agreements.
GILDAN 2022 REPORT TO SHAREHOLDERS 67
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
3. SIGNIFICANT ACCOUNTING POLICIES:
The accounting policies set out below have been applied consistently to all periods presented in these consolidated
financial statements, unless otherwise indicated.
(a) Basis of consolidation:
(i) Business combinations:
Business combinations are accounted for using the acquisition method. Accordingly, the consideration
transferred for the acquisition of a business is the fair value of the assets transferred and any debt and equity
interests issued by the Company on the date control of the acquired company is obtained. The consideration
transferred includes the fair value of any asset or liability resulting from a contingent consideration arrangement.
Contingent consideration classified as an asset or a liability that is a financial instrument is subsequently
remeasured at fair value, with any resulting gain or loss recognized and included in restructuring and acquisition-
related costs in the consolidated statement of earnings and comprehensive income. Acquisition-related costs,
other than those associated with the issue of debt or equity securities, are expensed as incurred and are
included in restructuring and acquisition-related costs in the consolidated statement of earnings and
comprehensive income. Identifiable assets acquired and liabilities and contingent liabilities assumed in a
business combination are generally measured initially at their fair values at the acquisition date. The Company
recognizes any non-controlling interest in an acquired company either at fair value or at the non-controlling
interest’s proportionate share of the acquired company’s net identifiable assets. The excess of the consideration
transferred over the fair value of the identifiable net assets acquired is recorded as goodwill. If the total of
consideration transferred and non-controlling interest recognized is less than the fair value of the net assets of
the business acquired, a purchase gain is recognized immediately in the consolidated statement of earnings and
comprehensive income and applied as a reduction of restructuring and acquisition-related costs.
(ii) Subsidiaries:
Subsidiaries are entities controlled by the Company. The financial statements of subsidiaries are included in the
consolidated financial statements from the date that control commences until the date that control ceases. The
accounting policies of subsidiaries are aligned with the policies adopted by the Company. Intragroup
transactions, balances, and unrealized gains or losses on transactions between group companies are eliminated.
The Company’s principal subsidiaries, their jurisdiction of incorporation, and the Company’s percentage
ownership share of each are as follows:
Subsidiary
Gildan Activewear SRL
Gildan Yarns, LLC
Gildan USA LLC
Gildan Honduras Properties, S. de R.L.
Frontier Yarns, Inc.
Gildan Activewear (UK) Limited
Gildan Activewear EU SRL
Gildan Textiles de Sula, S. de R.L.
G.A.B. Limited
SDS International Limited
Gildan Activewear Honduras Textile Company, S. de R.L.
Gildan Activewear (Eden) Inc.
Gildan Hosiery Rio Nance, S. de R.L.
Gildan Mayan Textiles, S. de R.L.
Gildan Charleston Inc.
Gildan Activewear Dominican Republic Textile Company Inc.
Gildan Choloma Textiles, S. de R. L.
Jurisdiction of
incorporation
Ownership
percentage
Barbados
Delaware
Delaware
Honduras
North Carolina
United Kingdom
Belgium
Honduras
Bangladesh
Bangladesh
Honduras
North Carolina
Honduras
Honduras
Delaware
Barbados
Honduras
100 %
100 %
100 %
100 %
100 %
100 %
100 %
100 %
100 %
100 %
100 %
100 %
100 %
100 %
100 %
100 %
100 %
GILDAN 2022 REPORT TO SHAREHOLDERS 68
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
3. SIGNIFICANT ACCOUNTING POLICIES (continued):
(a) Basis of consolidation (continued):
(ii) Subsidiaries (continued):
The Company has no other subsidiaries representing individually more than 10% of the total consolidated assets
and 10% of the consolidated net sales of the Company, or in the aggregate more than 20% of the total
consolidated assets and the consolidated net sales of the Company as at and for the fiscal year ended
January 1, 2023.
(b) Foreign currency translation:
Monetary assets and liabilities of the Company’s Canadian and foreign operations denominated in currencies other
than the U.S. dollar are translated using exchange rates in effect at the reporting date. Non-monetary assets and
liabilities denominated in currencies other than U.S. dollars are translated at the rates prevailing at the respective
transaction dates. Income and expenses denominated in currencies other than U.S. dollars are translated at average
rates prevailing during the year. Gains or losses on foreign exchange are recorded in net earnings and presented in
the statement of earnings and comprehensive income within financial expenses.
(c) Cash and cash equivalents:
The Company considers all liquid investments with maturities of three months or less from the date of purchase to be
cash equivalents.
(d) Trade accounts receivable:
Trade accounts receivable consist of amounts due from our normal business activities. An allowance for expected
credit losses is maintained to reflect an impairment risk for trade accounts receivable based on an expected credit
loss model which factors in changes in credit quality since the initial recognition of trade accounts receivable based
on customer risk categories. Expected credit losses are also provided for based on collection history and specific
risks identified on a customer-by-customer basis. Trade accounts receivable are presented net of allowances for
expected credit losses, sales discounts, and sales returns when the Company has a right to offset the amounts.
The Company may continuously sell trade accounts receivables of certain designated customers to a third-party
financial institution in exchange for a cash payment equal to the face value of the sold trade receivables less an
applicable discount. The Company retains servicing responsibilities, including collection, for these trade accounts
receivables but does not retain any credit risk with respect to any trade accounts receivables that have been sold. All
trade accounts receivables sold under the receivables purchase agreement are removed from the consolidated
statements of financial position, as the sale of the trade accounts receivables qualify for de-recognition. The net cash
proceeds received by the Company are included as cash flows from operating activities in the consolidated
statements of cash flows. The difference between the carrying amount of the trade accounts receivables sold under
the agreement and the cash received at the time of transfer is recorded in the statement of earnings and
comprehensive income within financial expenses.
GILDAN 2022 REPORT TO SHAREHOLDERS 69
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
3. SIGNIFICANT ACCOUNTING POLICIES (continued):
(e)
Inventories:
Inventories are stated at the lower of cost and net realizable value. The cost of inventories is based on the first-in,
first-out principle, and reflect the various stages of production that inventories have reached at period-end. Inventory
costs include the purchase price and other costs directly related to the acquisition of raw materials and spare parts
held for use in the manufacturing process, and the cost of purchased finished goods. Inventory costs also include the
costs directly related to the conversion of materials to finished goods, such as direct labour, and a systematic
allocation of fixed and variable production overhead, including manufacturing depreciation expense. The allocation of
fixed production overhead to the cost of inventories is based on the normal capacity of the production facilities.
Additional costs incurred as a result of operating below the normal capacity of the production facilities are excluded
from the carrying value of inventories and charged directly to cost of sales. Normal capacity is the average production
expected to be achieved during the fiscal year, under normal circumstances. The Company manages its day-to-day
production costs and inventories using a standard inventory costing system whereby the cost of a product is
determined using pre-established rates for materials, labour and production overhead expenses based on the
manufacturing specifications of the product. At period end, the Company assesses whether the variances between
the standard costs and the actual costs incurred relate to the conversion of materials to finished goods, or if they
represent abnormal costs that should be charged directly to cost of sales. The carrying value of inventories is then
adjusted to record the manufacturing variances related to inventories still on hand and manufacturing variances
related to inventories that have been sold are charged to cost of sales, through an allocation method which uses an
estimated variance deferral factor based on the number of days of inventory on hand based on the most recent past
production. The Company's inventory costing process involves a combination of automated and non-automated
systems and processes using data obtained from different geographical locations. Net realizable value is the
estimated selling price of finished goods in normal sales channels, or where applicable, liquidation channels, less the
estimated costs of completion and selling expenses. Raw materials, work in progress, and spare parts inventories are
not written down if the finished products in which they will be incorporated are expected to be sold at or above cost.
(f) Assets held for sale:
Non-current assets which are classified as assets held for sale are reported in current assets in the statement of
financial position, when their carrying amount is to be recovered principally through a sale transaction rather than
through continuing use, and a sale is considered highly probable. Assets held for sale are stated at the lower of their
carrying amount and fair value less costs to sell.
(g) Property, plant and equipment:
Property, plant and equipment are initially recorded at cost and are subsequently carried at cost less any
accumulated depreciation and any accumulated impairment losses. The cost of an item of property, plant and
equipment includes expenditures that are directly attributable to the acquisition or construction of an asset. The cost
of self-constructed assets includes the cost of materials and direct labour, site preparation costs, initial delivery and
handling costs, installation and assembly costs, and any other costs directly attributable to bringing the assets to the
location and condition necessary for the assets to be capable of operating in the manner intended by management.
The cost of property, plant and equipment also includes, when applicable, borrowing costs, as well as the initial
present value estimate of the costs of decommissioning or dismantling and removing the asset and restoring the site
on which it is located at the end of its useful life which is amortized over the remaining life of the underlying asset.
Purchased software that is integral to the functionality of the related equipment is capitalized as part of other
equipment. Subsequent costs are included in an asset’s carrying amount or recognized as a separate asset, as
appropriate, only when it is probable that future economic benefits are present and the cost of the item can be
measured reliably. When property, plant and equipment are replaced they are fully written down. Gains and losses on
the disposal of an item of property, plant and equipment are determined by comparing the proceeds from disposal
with the carrying amount of property, plant and equipment and are recognized in the statement of earnings and
comprehensive income.
GILDAN 2022 REPORT TO SHAREHOLDERS 70
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
3. SIGNIFICANT ACCOUNTING POLICIES (continued):
(g) Property, plant and equipment (continued):
Land is not depreciated. The cost of property, plant and equipment less its residual value, if any, is depreciated on a
straight-line basis over the following estimated useful lives:
Asset
Buildings and improvements
Manufacturing equipment
Other equipment
Useful life
5 to 40 years
2 to 20 years
3 to 10 years
(1) The majority of the Company's manufacturing equipment is depreciated over a 15 to 20 year period.
Significant components of plant and equipment which are identified as having different useful lives are depreciated
separately over their respective useful lives. Depreciation methods, useful lives and residual values, if applicable, are
reviewed and adjusted, if appropriate, on a prospective basis at the end of each fiscal year.
Assets not yet utilized in operations include expenditures incurred to date for plant constructions or expansions which
are still in process and equipment not yet placed into service as at the reporting date. Depreciation on these assets
commences when the assets are available for use.
Borrowing costs
Borrowing costs that are directly attributable to the acquisition or construction of a qualifying asset are capitalized as
part of the cost of the asset. A qualifying asset is one that necessarily takes a substantial period of time to get ready
for its intended use. Capitalization of borrowing costs ceases when the asset is completed and available for use. All
other borrowing costs are recognized as financial expenses in the consolidated statement of earnings and
comprehensive income as incurred.
(h)
Intangible assets:
Definite life intangible assets are measured at cost less accumulated amortization and any accumulated impairment
losses. Intangible assets include identifiable intangible assets acquired and consist of customer contracts and
customer relationships, license agreements, trademarks, and non-compete agreements. Intangible assets also
include computer software that is not an integral part of the related hardware. Indefinite life intangible assets
represent intangible assets which the Company controls which have no contractual or legal expiration date and
therefore are not amortized as there is no foreseeable time limit to their useful economic life. An assessment of
indefinite life intangible assets is performed annually to determine whether events and circumstances continue to
support an indefinite useful life and any change in the useful life assessment from indefinite to finite is accounted for
as a change in accounting estimate on a prospective basis. Intangible assets with finite lives are amortized on a
straight-line basis over the following estimated useful lives:
Asset
Customer contracts and customer relationships
License agreements
Computer software
Trademarks with a finite life
Non-compete agreements
Useful life
7 to 20 years
3 to 10 years
4 to 7 years
5 years
2 years
Most of the Company's trademarks are not amortized as they are considered to be indefinite life intangible assets.
GILDAN 2022 REPORT TO SHAREHOLDERS 71
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
3. SIGNIFICANT ACCOUNTING POLICIES (continued):
(h)
Intangible assets (continued):
The costs of information technology projects that are directly attributable to the design and testing of identifiable and
unique software products, including internally developed computer software, are recognized as intangible assets
when the following criteria are met:
it is technically feasible to complete the software product so that it will be available for use;
•
• management intends to complete the software product and use it;
•
•
•
there is an ability to use the software product;
it can be demonstrated how the software product will generate probable future economic benefits;
adequate technical, financial, and other resources to complete the development and to use the software product
are available; and
the expenditures attributable to the software product during its development can be reliably measured.
•
Other development expenditures that do not meet these criteria are recognized as an expense in the consolidated
statement of earnings and comprehensive income as incurred.
(i) Goodwill:
Goodwill is measured at cost less accumulated impairment losses, if any. Goodwill arises on business combinations
and is measured as the excess of the consideration transferred and the recognized amount of the non-controlling
interest in the acquired business, if any, over the fair value of identifiable assets acquired and liabilities assumed of an
acquired business.
(j)
Impairment of non-financial assets:
Non-financial assets that have an indefinite useful life such as goodwill and trademarks are not subject to
amortization and are therefore tested annually for impairment or more frequently if events or changes in
circumstances indicate that the asset might be impaired. Assets that are subject to amortization are assessed at the
end of each reporting period as to whether there is any indication of impairment or whenever events or changes in
circumstances indicate that the carrying amount may not be recoverable. An impairment loss is recognized for the
amount by which the carrying amount exceeds its recoverable amount. The recoverable amount is the higher of an
asset’s value in use and fair value less costs of disposal. The recoverable amount is determined for an individual
asset, unless the asset does not generate cash inflows that are largely independent of those from other assets or
groups of assets, in which case assets are grouped at the lowest levels for which there are separately identifiable
cash inflows (i.e. cash-generating units or "CGUs").
In assessing value in use, the estimated future cash flows expected to be derived from the asset or CGU by the
Company are discounted to their present value using a pre-tax discount rate that reflects current market assessments
of the time value of money and the risks specific to the asset and or the CGU. In assessing a CGU’s fair value less
costs of disposal, the Company uses the best information available to reflect the amount that the Company could
obtain, at the time of the impairment test, from the disposal of the asset or CGU in an arm’s length transaction
between knowledgeable, willing parties, after deducting the estimated costs of disposal.
For the purpose of testing goodwill for impairment, goodwill acquired in a business combination is allocated to a CGU
or a group of CGUs that is expected to benefit from the synergies of the combination, regardless of whether other
assets or liabilities of the acquired company are assigned to those CGUs. Impairment losses recognized are allocated
first to reduce the carrying amount of any goodwill allocated to the CGU and then to reduce the carrying amounts of
the other assets in the CGU on a pro rata basis. Impairment losses are recognized in the statement of earnings and
comprehensive income.
Reversal of impairment losses
A goodwill impairment loss is not reversed. Impairment losses on non-financial assets other than goodwill recognized
in prior periods are assessed at each reporting date for any indications that the loss has decreased or no longer
exists. An impairment loss is reversed if there has been a change in the estimates used to determine the recoverable
amount. An impairment loss is reversed only to the extent that the asset’s carrying amount does not exceed the
carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had
been recognized.
GILDAN 2022 REPORT TO SHAREHOLDERS 72
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
3. SIGNIFICANT ACCOUNTING POLICIES (continued):
(k) Financial instruments:
The Company initially recognizes financial assets on the trade date at which the Company becomes a party to the
contractual provisions of the instrument. Financial assets are initially measured at fair value. If the financial asset is
not subsequently accounted for at fair value through profit or loss, then the initial measurement includes transaction
costs that are directly attributable to the asset’s acquisition or origination. On initial recognition, the Company
classifies its financial assets as subsequently measured at either amortized cost or fair value, depending on its
business model for managing the financial assets and the contractual cash flow characteristics of the financial assets.
Financial assets
Financial assets are classified into the following categories and depend on the purpose for which the financial assets
were acquired.
Financial assets measured at amortized cost
A financial asset is subsequently measured at amortized cost, using the effective interest method and net of any
impairment loss, if:
•
•
The asset is held within a business model whose objective is to hold assets in order to collect contractual
cash flows; and
The contractual terms of the financial asset give rise, on specified dates, to cash flows that are solely
payments of principal and/or interest.
The Company currently classifies its cash and cash equivalents, trade accounts receivable, certain other current
assets (excluding derivative financial instruments designated as effective hedging instruments), and long-term
non-trade receivables as financial assets measured at amortized cost. The Company de-recognizes a financial
asset when the contractual rights to the cash flows from the asset expire, or it transfers the rights to receive the
contractual cash flows on the financial asset in a transaction in which substantially all the risks and rewards of
ownership of the financial asset are transferred.
Financial assets measured at fair value
These assets are measured at fair value and changes therein, including any interest or dividend income, are
recognized in profit or loss. However, for investments in equity instruments that are not held for trading, the
Company may elect at initial recognition to present gains and losses in other comprehensive income. For such
investments measured at fair value through other comprehensive income, gains and losses are never
reclassified to profit or loss, and no impairment is recognized in profit or loss. Dividends earned from such
investments are recognized in profit or loss, unless the dividend clearly represents a repayment of part of the
cost of the investment. The Company currently has no significant financial assets measured at fair value other
than derivative financial instruments.
Fair value through other comprehensive income ("FVOCI")
A debt investment is measured at FVOCI if it is not designated as at fair value through profit or loss, is held within
a business model whose objective is achieved by both collecting contractual cash flows and selling financial
assets, and its contractual terms give rise to cash flows on specified dates that are solely payments of principal
and interest on the principal amount outstanding. These assets are subsequently measured at fair value. Interest
income calculated using the effective interest method, foreign exchange gains and losses and impairment are
recognized in profit or loss. Other net gains and losses are recognized in other comprehensive income ("OCI").
On derecognition, gains and losses accumulated in OCI are reclassified to profit or loss. On initial recognition of
an equity investment that is not held for trading, the Company may irrevocably elect to present subsequent
changes in the investments fair value in OCI. This election is made on an investment by investment basis. These
assets are subsequently measured at fair value. Dividends are recognized as income in profit or loss unless the
dividend clearly represents a recovery of part of the cost of the investment. Other net gains and losses are
recognized in OCI and are never reclassified to profit or loss. The Company currently has no financial assets
measured at FVOCI.
GILDAN 2022 REPORT TO SHAREHOLDERS 73
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
3. SIGNIFICANT ACCOUNTING POLICIES (continued):
(k) Financial instruments (continued):
Financial liabilities
Financial liabilities are classified into the following categories.
Financial liabilities measured at amortized cost
A financial liability is subsequently measured at amortized cost, using the effective interest method. The
Company currently classifies accounts payable and accrued liabilities (excluding derivative financial instruments
designated as effective hedging instruments), and long-term debt bearing interest at variable and fixed rates as
financial liabilities measured at amortized cost.
Financial liabilities measured at fair value
Financial liabilities at fair value are initially recognized at fair value and are remeasured at each reporting date
with any changes therein recognized in net earnings. The Company currently has no significant financial liabilities
measured at fair value.
The Company derecognizes a financial liability when its contractual obligations are discharged or cancelled or
expired.
Financial assets and liabilities are offset and the net amount presented in the statement of financial position when,
and only when, the Company has a legal right to offset the amounts and intends either to settle on a net basis or to
realize the asset and settle the liability simultaneously.
Fair value of financial instruments
Financial instruments measured at fair value use the following fair value hierarchy to prioritize the inputs used in
measuring fair value:
•
•
Level 1: quoted prices (unadjusted) in active markets for identical assets or liabilities;
Level 2: inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either
directly (i.e. as prices) or indirectly (i.e. derived from prices); and
Level 3: inputs for the asset or liability that are not based on observable market data.
•
Impairment of financial assets
The Company recognizes loss allowances for expected credit losses on financial assets measured at amortized cost.
The Company recognizes a loss allowance at an amount equal to the lifetime expected credit losses if the credit risk
on that financial instrument has increased significantly since initial recognition. Otherwise, the loss allowance for that
financial instrument corresponds to an amount equal to twelve-month expected credit losses. The Company uses the
simplified method to measure the loss allowance for trade receivables at lifetime expected losses. The Company
uses historical trends of default, the timing of recoveries and the amount of loss incurred, adjusted for management’s
judgement as to whether current economic and credit conditions are such that the actual losses are likely to be
greater or less than suggested by historical trends. Losses are recognized in the consolidated statement of income
and reflected in an allowance account against trade and other receivables.
(l) Derivative financial instruments and hedging relationships:
The Company enters into derivative financial instruments to hedge its market risk exposures. On initial designation of
the hedge, the Company formally documents the relationship between the hedging instruments and hedged items,
including the risk management objectives and strategy in undertaking the hedge transaction, together with the
methods that will be used to assess the effectiveness of the hedging relationship. The Company makes an
assessment, both at the inception of the hedge relationship as well as on an ongoing basis, whether the hedging
instruments are expected to be effective in offsetting the changes in the fair value or cash flows of the respective
hedged items during the period for which the hedge is designated. For a cash flow hedge of a forecasted transaction,
the transaction should be highly probable to occur and should present an exposure to variations in cash flows that
could ultimately affect reported net earnings.
Derivatives are recognized initially at fair value, and attributable transaction costs are recognized in net earnings as
incurred. Subsequent to initial recognition, derivatives are measured at fair value, and changes therein are accounted
for as described below.
GILDAN 2022 REPORT TO SHAREHOLDERS 74
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
3. SIGNIFICANT ACCOUNTING POLICIES (continued):
(l) Derivative financial instruments and hedging relationships (continued):
Cash flow hedges
When a derivative is designated as the hedging instrument in a hedge of the variability in cash flows attributable to a
particular risk associated with a recognized asset or liability or a highly probable forecasted transaction that could
affect net earnings, the effective portion of changes in the fair value of the derivative is recognized in other
comprehensive income and presented in accumulated other comprehensive income as part of equity. The amount
recognized in other comprehensive income is removed and included in net earnings under the same line item in the
consolidated statement of earnings and comprehensive income as the hedged item, in the same period that the
hedged cash flows affect net earnings. When a hedged forecasted transaction subsequently results in the recognition
of a non-financial asset or liability, the cash flow hedge reserve is removed from accumulated other comprehensive
income and included in the initial cost or carrying amount of the asset or liability. Any ineffective portion of changes in
the fair value of the derivative is recognized immediately in net earnings. If the hedging instrument no longer meets
the criteria for hedge accounting, expires or is sold, terminated, exercised, or the designation is revoked, then hedge
accounting is discontinued prospectively. If the forecasted transaction is no longer expected to occur, then the
balance in accumulated other comprehensive income is recognized immediately in net earnings.
Fair value hedges
Changes in the fair value of derivatives that are designated and qualify as fair value hedges are recognized in net
earnings, together with any changes in the fair value of the hedged asset, liability or firm commitment that are
attributable to the hedged risk. The change in fair value of the hedging instrument and the change in the hedged item
attributable to the hedged risk are recognized in the statement of earnings and comprehensive income or in the
statement of financial position caption relating to the hedged item. If the hedging instrument no longer meets the
criteria for hedge accounting, expires or is sold, terminated, exercised, or the designation is revoked, then hedge
accounting is discontinued prospectively.
Embedded derivatives
Embedded derivatives within a financial liability are separated from the host contract and accounted for separately if
the economic characteristics and risks of the host contract and the embedded derivative are not closely related, a
separate instrument with the same terms as the embedded derivative would meet the definition of a derivative, and
the combined instrument is not measured at fair value through profit or loss.
Other derivatives
When a derivative financial instrument is not designated in a qualifying hedge relationship, all changes in its fair value
are recognized immediately in net earnings.
(m) Accounts payable and accrued liabilities:
Accounts payable and accrued liabilities are recognized initially at fair value and subsequently measured at amortized
cost using the effective interest method. Accounts payable and accrued liabilities are classified as current liabilities if
payment is due within one year, otherwise, they are presented as non-current liabilities.
(n) Long-term debt:
Long-term debt is recognized initially at fair value and is subsequently carried at amortized cost. Initial facility fees are
deferred and treated as an adjustment to the instrument's effective interest rate and recognized as an expense over
the instrument's estimated life if it is probable that the facility will be drawn down. However, if it is not probable that a
facility will be drawn down for its entire term, then the fees are considered service fees and are deferred and
recognized as an expense on a straight-line basis over the commitment period.
GILDAN 2022 REPORT TO SHAREHOLDERS 75
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
3. SIGNIFICANT ACCOUNTING POLICIES (continued):
(o) Employee benefits:
Short-term employee benefits
Short-term employee benefits include wages, salaries, commissions, compensated absences and bonuses. Short-
term employee benefit obligations are measured on an undiscounted basis and are expensed as the related service
is provided. A liability is recognized for the amount expected to be paid under short-term cash bonus or profit sharing
plans if the Company has a present legal or constructive obligation to pay this amount as a result of past service
provided by the employee, and the obligation can be estimated reliably. Short-term employee benefit obligations are
included in accounts payable and accrued liabilities.
Defined contribution plans
The Company offers group defined contribution plans to eligible employees whereby the Company matches
employees' contributions up to a fixed percentage of the employee's salary. Contributions by the Company to trustee-
managed investment portfolios or employee associations are expensed as incurred. Benefits are also provided to
employees through defined contribution plans administered by the governments in the countries in which the
Company operates. The Company’s contributions to these plans are recognized in the period when services are
rendered.
Defined benefit plans
The Company maintains a liability for statutory severance obligations for active employees primarily located in the
Caribbean and Central America which is payable to the employees in a lump sum payment upon termination of
employment. The liability is based on management’s best estimates of the ultimate costs to be incurred to settle the
liability and is based on a number of assumptions and factors, including historical trends, actuarial assumptions and
economic conditions. Liabilities related to defined benefit plans are included in other non-current liabilities in the
consolidated statement of financial position. Service costs, interest costs, and costs related to the impact of program
changes are recognized in cost of sales in the consolidated statement of earnings. Actuarial gains and losses arising
from experience adjustments and changes in actuarial assumptions are recognized directly to other comprehensive
income in the period in which they arise, and are immediately transferred to retained earnings without reclassification
to net earnings in a subsequent period.
(p) Provisions:
Provisions are recognized when the Company has a present legal or constructive obligation as a result of past
events, it is probable that an outflow of resources will be required to settle the obligation, and the amount can be
reliably estimated. Provisions are not recognized for future operating losses. Provisions are measured at the present
value of the expenditures expected to be required to settle the obligation using a pre-tax rate that reflects current
market assessments of the time value of money and the risks specific to the obligation. The increase in the provision
due to passage of time is recognized as financial expense. Provisions are included in other non-current liabilities in
the consolidated statement of financial position.
Decommissioning and site restoration costs
The Company recognizes decommissioning and site restoration obligations for future removal and site restoration
costs associated with the restoration of certain property and plant should it decide to discontinue some of its activities.
Onerous contracts
Provisions for onerous contracts are recognized if the unavoidable costs of meeting the obligations specified in a
contractual arrangement exceed the economic benefits expected to be received from the contract. Provisions for
onerous contracts are measured at the lower of the cost of fulfilling the contract and the expected cost of terminating
the contract.
GILDAN 2022 REPORT TO SHAREHOLDERS 76
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
3. SIGNIFICANT ACCOUNTING POLICIES (continued):
(q) Share capital:
Common shares are classified as equity. Incremental costs directly attributable to the issuance of common shares
and stock options are recognized as a deduction from equity, net of any tax effects.
When the Company repurchases its own shares, the consideration paid, including any directly attributable
incremental costs (net of income taxes) is deducted from equity attributable to the Company’s equity holders until the
shares are cancelled or reissued. When the shares are cancelled, the excess of the consideration paid over the
average stated value of the shares purchased for cancellation is charged to retained earnings.
(r) Dividends declared:
Dividends declared to the Company’s shareholders are recognized as a liability in the consolidated statement of
financial position and charged to retained earnings in the period in which the dividends are approved by the
Company’s Board of Directors.
(s) Revenue recognition:
The Company derives revenue from the sale of finished goods, which include activewear, hosiery, and underwear.
The Company recognizes revenue at a point in time when it transfers control of the finished goods to a customer,
which generally occurs upon shipment of the finished goods from the Company’s facilities. In certain arrangements,
control is transferred and revenue is recognized upon delivery of the finished goods to the customer’s premises.
Some arrangements for the sale of finished goods provide for customer price discounts, rights of return and/or
volume rebates based on aggregate sales over a specified period, which gives rise to variable consideration. At the
time of sale, estimates are made for items giving rise to variable consideration based on the terms of the sales
program or arrangement. The variable consideration is estimated at contract inception using the most likely amount
method and revenue is only recognized to the extent that a significant reversal of revenue is not expected to occur.
The estimate is based on historical experience, current trends, and other known factors. New sales incentive
programs which relate to sales made in a prior period are recognized at the time the new program is introduced.
Sales are recorded net of customer discounts, rebates, and estimated sales returns, and exclude sales taxes. A
provision is recognized for expected returns in relation to sales made before the end of the reporting period.
Consideration payable to a customer that is not considered a distinct good or service from the customer, such as one-
time fees paid to customers for product placement or product introduction, is accounted for as a reduction of the
transaction price, and the Company recognizes the reduction of revenue at the later of when Company recognizes
revenue for the transfer of the related goods to the customer or when the Company pays or promises to pay the
consideration.
(t) Cost of sales and gross profit:
Cost of sales includes all raw material costs, manufacturing conversion costs, including manufacturing depreciation
expense, sourcing costs, inbound freight and inter-facility transportation costs, and outbound freight to customers.
Cost of sales also includes the cost of purchased finished goods, costs relating to purchasing, receiving and
inspection activities, manufacturing administration, third-party manufacturing services, sales-based royalty costs,
insurance, inventory write-downs, and customs and duties, as well as net insurance gains as described in note 17 (c).
Gross profit is the result of net sales less cost of sales. The Company’s gross profit may not be comparable to gross
profit as reported by other companies, since some entities include warehousing and handling costs, and/or exclude
depreciation expense, outbound freight to customers and royalty costs from cost of sales.
(u) Selling, general and administrative expenses:
Selling, general and administrative (“SG&A”) expenses include warehousing and handling costs, selling and
administrative personnel costs, advertising and marketing expenses, costs of leased non-manufacturing facilities and
equipment, professional fees, non-manufacturing depreciation expense, and other general and administrative
expenses. SG&A expenses also include amortization of intangible assets.
GILDAN 2022 REPORT TO SHAREHOLDERS 77
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
3. SIGNIFICANT ACCOUNTING POLICIES (continued):
(v) Restructuring and acquisition-related costs:
Restructuring and acquisition-related costs are expensed when incurred, or when a legal or constructive obligation
exists. Restructuring and acquisition-related costs are comprised of costs directly related to significant exit activities,
including the closure of business locations or the relocation of business activities, significant changes in management
structure, as well as transaction and integration costs incurred pursuant to business acquisitions. The nature of
expenses included in restructuring and acquisition-related costs may include: severance and termination benefits,
including the termination of employee benefit plans; gains or losses from the remeasurement and disposal of assets
held for sale; write-downs of property, plant and equipment, right-of-use assets, and software related to exit activities;
facility exit and closure costs, including the costs of physically transferring inventory and fixed assets to other
facilities; costs of integrating the IT systems of an acquired business to Gildan’s existing IT systems; legal, accounting
and other professional fees (excluding costs of issuing debt or equity) directly incurred in connection with a business
acquisition; purchase gains on business acquisitions; losses on business acquisitions achieved in stages; contingent
amounts payable to selling shareholders under their employment agreements pursuant to a business acquisition; and
the remeasurement of liabilities related to contingent consideration incurred in connection with a business acquisition.
(w) Cotton and cotton-based yarn procurements:
The Company contracts to buy cotton and cotton-based yarn with future delivery dates at fixed prices in order to
reduce the effects of fluctuations in the prices of cotton used in the manufacture of its products. These contracts are
not used for trading purposes and are not considered to be financial instruments as they are entered into for purchase
and receipt in accordance with the Company’s expected usage requirements, and therefore are not measured at fair
value. The Company commits to fixed prices on a percentage of its cotton and cotton-based yarn requirements up to
eighteen months in the future. If the cost of committed prices for cotton and cotton-based yarn plus estimated costs to
complete production exceed current selling prices, a loss is recognized for the excess as a charge to cost of sales.
(x) Government assistance:
Government assistance is recognized only when there is reasonable assurance the Company will comply with all
related conditions for receipt of the assistance. Government assistance, including grants and tax credits, related to
operating expenses is accounted for as a reduction to the related expenses. Government assistance, including
monetary and non-monetary grants and tax credits related to the acquisition of property, plant and equipment, is
accounted for as a reduction of the cost of the related property, plant and equipment, and is recognized in net
earnings using the same methods, periods and rates as for the related property, plant and equipment.
(y) Financial expenses (income):
Financial expenses (income) include: interest expense on borrowings, including realized gains and/or losses on
interest rate swaps designated for hedge accounting; bank and other financial charges; amortization of debt facility
fees, discount on the sales of trade accounts receivable; interest income on funds invested; interest on lease
obligations; accretion of interest on discounted provisions; net foreign currency losses and/or gains; and losses and/
or gains on financial derivatives that do not meet the criteria for effective hedge accounting.
(z)
Income taxes:
Income tax expense is comprised of current and deferred income taxes, and is included in net earnings except to the
extent that it relates to a business acquisition, or items recognized directly in equity or in other comprehensive
income. Current tax is the expected tax payable or receivable on the taxable income or loss for the year, using tax
rates enacted or substantively enacted at the reporting date, and any adjustment to tax payable in respect of previous
years.
Deferred income tax assets and liabilities are measured at the tax rates that are expected to be applied to temporary
differences when they reverse, based on the laws that have been enacted or substantively enacted by the reporting
date, for all temporary differences caused when the tax bases of assets and liabilities differ from those reported in the
financial statements. The Company recognizes deferred income tax assets for unused tax losses and deductible
temporary differences only to the extent that, in management’s opinion, it is probable that future taxable profit will be
available against which the temporary differences can be utilized. Deferred tax assets are reviewed at each reporting
date and are derecognized to the extent that it is no longer probable that the related tax benefit will be realized.
GILDAN 2022 REPORT TO SHAREHOLDERS 78
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
3. SIGNIFICANT ACCOUNTING POLICIES (continued):
(z)
Income taxes (continued):
Deferred income tax is not recognized for the following temporary differences: the initial recognition of assets or
liabilities in a transaction that is not a business combination and that affects neither accounting nor taxable profit or
loss at the time of the transaction; and, where the timing of the reversal of a temporary difference is controlled by the
Company and it is probable that the temporary difference will not reverse in the foreseeable future. In addition,
deferred tax is not recognized for taxable temporary differences arising on the initial recognition of goodwill.
In determining the amount of current and deferred income taxes, the Company takes into account the impact of
uncertain tax positions and whether additional taxes and interest may be due. Provisions for uncertain tax positions
are measured at the best estimate of the amounts expected to be paid upon ultimate resolution. The Company
periodically reviews and adjusts its estimates and assumptions of income tax assets and liabilities as circumstances
warrant, such as changes to tax laws, administrative guidance, change in management’s assessment of the technical
merits of its positions due to new information, and the resolution of uncertainties through either the conclusion of tax
audits or expiration of prescribed time limits within relevant statutes.
(aa) Earnings per share:
Basic earnings per share are computed by dividing net earnings by the weighted average number of common shares
outstanding for the year. Diluted earnings per share are computed using the weighted average number of common
shares outstanding for the period adjusted to include the dilutive impact of stock options and restricted share units.
The number of additional shares is calculated by assuming that all common shares held in trust for the purpose of
settling non-Treasury restricted share units have been delivered, all dilutive outstanding options are exercised and all
dilutive outstanding Treasury restricted share units have vested, and that the proceeds from such exercises, as well
as the amount of unrecognized share-based compensation which is considered to be assumed proceeds, are used to
repurchase common shares at the average share price for the period. For Treasury restricted share units, only the
unrecognized share-based compensation is considered assumed proceeds since there is no exercise price paid by
the holder.
(bb) Share-based payments:
Stock options, Stock appreciation rights, Treasury and non-Treasury restricted share units
Stock options, Stock appreciation rights ("SARs"), Treasury restricted share units, and non-Treasury restricted share
units are equity settled share-based payments, which are measured at fair value at the grant date. For stock options
and SARs, the compensation cost is measured using the Black-Scholes option pricing model and is expensed over
the award's vesting period. For Treasury and non-Treasury restricted share units, compensation cost is measured at
the fair value of the underlying common share at the grant date and is expensed over the award's vesting period.
Compensation expense is recognized in net earnings with a corresponding increase in contributed surplus. Any
consideration paid by plan participants on the exercise of stock options is credited to share capital. Upon the exercise
of stock options, the vesting of Treasury restricted share units, and upon delivery of the common shares for
settlement of vesting non-Treasury restricted share units or SARs, the corresponding amounts previously credited to
contributed surplus are transferred to share capital. The number of non-Treasury restricted share units remitted to the
participants upon settlement is equal to the number of non-Treasury restricted share units awarded less units withheld
to satisfy the participants' statutory withholding tax requirements. Stock options and Treasury restricted share units
that are dilutive and meet non-market performance conditions as at the reporting date are considered in the
calculation of diluted earnings per share, as per note 3(aa) to these consolidated financial statements.
Estimates for forfeitures and performance conditions
The measurement of compensation expense for stock options, SARs, Treasury restricted share units and non-
Treasury restricted share units is net of estimated forfeitures. For the portion of Treasury restricted share units and
non-Treasury restricted share units that are issuable based on non-market performance conditions, the amount
recognized as an expense is adjusted to reflect the number of awards for which the related service and performance
conditions are expected to be met, such that the amount ultimately recognized as an expense is based on the
number of awards that do meet the related service and non-market performance conditions at the vesting date.
GILDAN 2022 REPORT TO SHAREHOLDERS 79
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
3. SIGNIFICANT ACCOUNTING POLICIES (continued):
(bb) Share-based payments (continued):
Deferred share unit plan
The Company has a deferred share unit plan for independent members of the Company’s Board of Directors, who
receive a portion of their compensation in the form of deferred share units (“DSUs”). These DSUs are cash settled
awards and are initially recognized in net earnings based on fair value at the grant date. The DSU obligation is
included in accounts payable and accrued liabilities and is remeasured at fair value, based on the market price of the
Company’s common shares, at each reporting date.
Employee share purchase plans
For employee share purchase plans, the Company's contribution, on the employee's behalf, is recognized as
compensation expense with an offset to share capital, and consideration paid by employees on purchase of common
shares is also recorded as an increase to share capital.
(cc) Leases:
At inception of a contract, the Company assesses whether a contract is, or contains, a lease based on whether the
contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration.
The Company recognizes a right-of-use ("ROU") asset and a lease liability at the lease commencement date. The
ROU asset is initially measured at cost, which comprises the initial amount of the lease liability adjusted for any lease
payments made at or before the commencement date, plus any initial direct costs incurred and an estimate of costs
to dismantle and remove the underlying asset or to restore the underlying asset or the site on which it is located, less
any lease incentives received. The ROU asset is subsequently depreciated using the straight-line method from the
commencement date to the earlier of the end of the useful life of the ROU asset or the lease term. The lease term
includes consideration of an option to renew or to terminate if the Company is reasonably certain to exercise that
option. Lease terms range from 1 to 17 years for manufacturing, sales, distribution, and administrative facilities. In
addition, the ROU asset is periodically reduced by impairment losses, if any, and adjusted for certain
remeasurements of the lease liability.
The lease liability is initially measured at the present value of the lease payments that are not paid at the
commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily
determined, the Company’s incremental borrowing rate. Generally, the Company uses its incremental borrowing rate
as the discount rate. Lease payments mainly include fixed, or in substance fixed, payments and variable lease
payments that depend on an index or a rate. Variable lease payments that do not depend on an index or rate are not
included in the measurement of the lease liability. The lease liability is measured at amortized cost using the effective
interest method. It is remeasured when there is a change in future lease payments arising from a change in an index
or rate, or if the Company changes its assessment of whether it will exercise a purchase, extension, or termination
option. When the lease liability is remeasured in this way, a corresponding adjustment is made to the carrying amount
of the ROU asset, or is recorded in profit or loss if the carrying amount of the ROU asset has been reduced to zero.
The Company has elected to apply the practical expedient not to recognize ROU assets and lease liabilities for short-
term leases that have a lease term of 12 months or less and leases of low-value assets. The lease payments
associated with these leases are recognized as an expense on a straight-line basis over the lease term.
GILDAN 2022 REPORT TO SHAREHOLDERS 80
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
3. SIGNIFICANT ACCOUNTING POLICIES (continued):
(dd) Use of estimates and judgments:
The preparation of financial statements in conformity with IFRS requires management to make estimates and
assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income
and expenses. Actual results may differ from these estimates.
Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are
recognized in the period in which the estimates are revised and in any future periods affected.
Critical judgments in applying accounting policies:
The following are critical judgments that management has made in the process of applying accounting policies and
that have the most significant effect on the amounts recognized in the consolidated financial statements:
Determination of cash generating units
The identification of CGUs and grouping of assets into the respective CGUs is based on currently available
information about actual utilization experience and expected future business plans. Management has taken into
consideration various factors in identifying its CGUs. The Company has identified its CGUs for purposes of testing the
recoverability and impairment of non-financial assets to be Textile & Sewing and Hosiery as they represent the lowest
level at which the goodwill and indefinite life intangible assets are monitored for internal management purposes.
Income taxes
The Company’s income tax provisions and income tax assets and liabilities are based on interpretations of applicable
tax laws, including income tax treaties between various countries in which the Company operates, as well as
underlying rules and regulations with respect to transfer pricing. These interpretations involve judgments and
estimates and may be challenged through government taxation audits that the Company is regularly subject to. New
information may become available that causes the Company to change its judgment regarding the adequacy of
existing income tax assets and liabilities; such changes will impact net earnings in the period that such a
determination is made.
Key sources of estimation uncertainty:
Key sources of estimation uncertainty that have a significant risk of resulting in a material adjustment to the carrying
amount of assets and liabilities within the next financial year are as follows:
Inventory valuation
The cost of inventories may no longer be recoverable if inventories are discontinued, damaged, in excess quantities,
or if their selling prices or estimated forecast of product demand decline. Discontinued, damaged, and excess
inventories are carried at the net realizable value, as those inventories are sold below cost in liquidation channels. In
determining the net realizable value of finished goods, the Company considers recent recovery rates and current
market conditions in these channels. The Company regularly reviews inventory quantities on hand, current production
plans, and forecasted future sales, and inventories are written down to net realizable value when it is determined that
they are no longer fully recoverable. There is estimation uncertainty in relation to the identification of excess
inventories and in the expected selling prices used in establishing the net realizable value. As at January 1, 2023, a
10% decrease or increase in the expected selling prices used to establish the net realizable value of discontinued,
damaged, and excess inventories would result in either a decrease or an increase in inventories of approximately
$1.6 million, with a corresponding adjustment to cost of sales. If actual market conditions are less favorable than
previously projected or if liquidation of the inventory which is no longer deemed fully recoverable is more difficult than
anticipated, additional write-downs may be required.
GILDAN 2022 REPORT TO SHAREHOLDERS 81
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
3. SIGNIFICANT ACCOUNTING POLICIES (continued):
(dd) Use of estimates and judgments (continued):
Recoverability and impairment of non-financial assets
The calculation of fair value less costs of disposal or value in use for purposes of measuring the recoverable amount
of non-financial assets involves the use of significant assumptions and estimates with respect to a variety of factors,
including estimated sales volumes, selling prices, input costs, SG&A expenses, cash flows, capital expenditures, and
the selection of an appropriate earnings multiple or discount rate, all of which are subject to inherent uncertainties and
subjectivity. The assumptions are based on annual business plans and other forecasted results, earnings multiples
obtained by using market comparables as references, and discount rates which are used to reflect market-based
estimates of the risks associated with the projected cash flows, based on the best information available as of the date
of the impairment test. Changes in circumstances, such as technological advances, adverse changes in third-party
licensing arrangements, changes to the Company’s business strategy, and changes in economic and market
conditions can result in actual useful lives and future cash flows that differ significantly from estimates and could
result in increased charges for amortization or impairment. Revisions to the estimated useful lives of finite-life non-
financial assets or future cash flows constitute a change in accounting estimate and are applied prospectively. There
can be no assurance that the estimates and assumptions used in the impairment tests will prove to be accurate
predictions of the future. If the future adversely differs from management’s best estimate of key economic
assumptions and the associated cash flows materially decrease, the Company may be required to record material
impairment charges or accelerated depreciation and amortization charges related to its non-financial assets. Please
refer to note 11 for additional details on the recoverability of the Company’s cash-generating units.
GILDAN 2022 REPORT TO SHAREHOLDERS 82
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
4. NEW ACCOUNTING STANDARDS AND INTERPRETATIONS NOT YET APPLIED:
Amendments to IAS 1, Presentation of Financial Statements
On January 23, 2020, the IASB issued narrow-scope amendments to IAS 1, Presentation of Financial Statements, to
clarify how to classify debt and other liabilities as current or non-current. The amendments (which affect only the
presentation of liabilities in the statement of financial position) clarify that the classification of liabilities as current or non-
current should be based on rights that are in existence at the end of the reporting period to defer settlement by at least
twelve months and make explicit that only rights in place at the end of the reporting period should affect the classification
of a liability; clarify that classification is unaffected by expectations about whether an entity will exercise its right to defer
settlement of a liability; and make clear that settlement refers to the transfer to the counterparty of cash, equity
instruments, other assets, or services. On October 31, 2022, the IASB issued Non-current Liabilities with Covenants
(Amendments to IAS 1). These further amendments clarify how to address the effects on classification and disclosure of
covenants which an entity is required to comply with on or before the reporting date and covenants which an entity must
comply with only after the reporting date.
These amendments will be effective for annual periods beginning on or after January 1, 2024, with earlier application
permitted and are to be applied retrospectively. The Company is currently evaluating the impact of these amendments on
its consolidated financial statements.
Amendments to IAS 1 and IFRS Practice Statement 2, Disclosure of Accounting Policy Information
In February 2021, the IASB issued amendments to IAS 1 Presentation of Financial Statements and IFRS Practice
Statement 2 Making Materiality Judgements. The amendments help entities provide accounting policy disclosures that are
more useful to primary users of financial statements by:
– Replacing the requirement to disclose “significant” accounting policies under IAS 1 with a requirement to disclose
“material” accounting policies. Under this, an accounting policy would be material if, when considered together
with other information included in an entity’s financial statements, it can reasonably be expected to influence
decisions that primary users of general purpose financial statements make on the basis of those financial
statements.
Providing guidance in IFRS Practice Statement 2 to explain and demonstrate the application of the four-step
materiality process to accounting policy disclosures.
–
The amendments shall be applied prospectively. The amendments to IAS 1 are effective for annual periods beginning on
or after January 1, 2023. Earlier application is permitted. Once an entity applies the amendments to IAS 1, it is also
permitted to apply the amendments to IFRS Practice Statement 2. The Company is currently evaluating the impact of the
amendment on its consolidated financial statements.
Amendments to IAS 8, Definition of Accounting Estimates
In February 2021, the IASB amended IAS 8 Accounting Policies, Changes in Accounting Estimates and Errors to
introduce a new definition of “accounting estimates” to replace the definition of “change in accounting estimates” and also
include clarifications intended to help entities distinguish changes in accounting policies from changes in accounting
estimates. This distinction is important because changes in accounting policies must be applied retrospectively while
changes in accounting estimates are accounted for prospectively. The amendments are effective for annual periods
beginning on or after January 1, 2023. Earlier application is permitted. The Company is currently evaluating the impact of
the amendment on its consolidated financial statements.
Amendments to IAS 12, Deferred Tax related to Assets and Liabilities arising from a Single Transaction
On May 7, 2021, the IASB amended IAS 12 Income Taxes, to narrow the scope of the initial recognition exemption so that
it does not apply to transactions that give rise to equal and offsetting temporary differences. The amendments are
effective for annual periods beginning on or after January 1, 2023. The Company is currently evaluating the impact of the
amendment on its consolidated financial statements.
GILDAN 2022 REPORT TO SHAREHOLDERS 83
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
5. BUSINESS ACQUISITIONS/DISPOSITIONS:
Frontier Yarns - Plant 3
On August 1, 2022 the Company sold a yarn spinning facility located in the U.S., which was the smallest of the four
facilities that the Company acquired on December 10, 2021 as part of the Frontier Yarns acquisition. The sale included the
disposition of inventory, equipment, goodwill and the transfer of a leasehold interest and related lease liability. The
proceeds of disposition of $29.4 million, of which $1.5 million is being held in escrow subject to certain post-closing
matters, exceeded the carrying value of net assets sold of $23.4 million (including $13.9 million of allocated goodwill),
resulting in a pre-tax gain on disposal of $6.0 million ($1.0 million after tax). The pre-tax gain of $6.0 million is included as
a recovery in restructuring and acquisition-related costs.
Other
During the fourth quarter of fiscal 2022, the Company sold its sheer inventory and trademarks for total proceeds of
$6.4 million, of which $0.7 million is being held in escrow subject to certain post-closing matters. The gain on disposal of
these assets was insignificant.
Frontier Yarns
On December 10, 2021, the Company acquired 100% of the equity interest of Phoenix Sanford, LLC, the parent company
of Frontier Yarns, for cash consideration (net of cash acquired and net of the settlement of pre-existing relationships) of
$164.0 million. Frontier Yarns operations included four facilities located in North Carolina. During 2021, approximately
40% of Frontier Yarns' production was dedicated to yarn sold to Gildan for textile manufacturing in Central America and
the Caribbean. The acquisition will allow the Company to build on its global vertically integrated supply chain through
further internalizing yarn production and is expected to support incremental yarn needs for Gildan’s textile capacity
expansion plans in Central America and the Caribbean.
The Company accounted for the acquisition using the acquisition method in accordance with IFRS 3, Business
Combinations. The Company determined the fair value of the assets acquired and liabilities assumed based on
management's best estimate of their fair values and taking into account all relevant information available at that time.
Goodwill is attributable primarily to the assembled workforce and business processes of Frontier Yarns which were not
recorded separately since they did not meet the recognition criteria for identifiable intangible assets. The final purchase
price allocation is summarized as follows:
Assets acquired:
Inventories
Prepaid expenses, deposits and other current assets(1)
Property, plant and equipment
Right-of-use assets
Other non-current assets
Liabilities assumed:
Accounts payable and accrued liabilities
Current portion of lease obligations
Lease obligations
Deferred income taxes(2)
Goodwill(2)
Net assets acquired at fair value
Cash consideration paid at closing, net of cash acquired
Settlement of pre-existing relationships
$
$
$
23,799
29,845
64,306
43,539
9
161,498
(30,191)
(1,940)
(41,599)
(2,733)
(76,463)
78,933
163,968
167,040
(3,072)
163,968
(1) Includes $26.2 million of trade receivables of Frontier Yarns, that was classified in Prepaid expenses, deposits and other current
assets in the consolidated statement of financial position of the Company.
(2) During the fourth quarter of fiscal 2022, the Company recorded a purchase price allocation adjustment due to a change in the
preliminary valuation of assets acquired and liabilities assumed as of the acquisition date. As a result, the Company increased "Goodwill"
and increased "Deferred income taxes" both by $1.8 million.
GILDAN 2022 REPORT TO SHAREHOLDERS 84
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
5. BUSINESS ACQUISITIONS/DISPOSITIONS (continued):
The consolidated results of the Company for fiscal 2021 included net earnings of $0.3 million relating to the Frontier Yarns
results of operations since the date of acquisition. Had the acquired business been consolidated from January 4, 2021,
the consolidated income statement would have shown unchanged net sales and net earnings for the fiscal year ended
January 2, 2022 of $612.4 million. The pro forma amount has been adjusted to reflect the elimination of intercompany
sales as if the acquisition occurred on January 4, 2021.
6. CASH AND CASH EQUIVALENTS:
Cash and cash equivalents consisted entirely of bank balances as at January 1, 2023 and January 2, 2022.
7. TRADE ACCOUNTS RECEIVABLE:
Trade accounts receivable
Allowance for expected credit losses
January 1,
2023
January 2,
2022
$ 264,179 $ 343,671
(13,704)
$ 248,785 $ 329,967
(15,394)
As at January 1, 2023, trade accounts receivables being serviced under a receivables purchase agreement amounted to
$228.9 million (January 2, 2022 - $144.9 million). The difference between the carrying amount of the receivables sold
under the agreement and the cash received at the time of transfer was $5.1 million for fiscal 2022 (2021 - $1.6 million) and
was recorded in bank and other financial charges. Refer to note 26 for additional information related to the receivables
purchase agreement.
The movement in the allowance for expected credit losses in respect of trade receivables was as follows:
Balance, beginning of fiscal year
(Impairment) Reversal of impairment of trade accounts receivable
Write-off of trade accounts receivable
Balance, end of fiscal year
2022
2021
$
$
(13,704) $
(2,150)
460
(15,394) $
(18,994)
2,617
2,673
(13,704)
The impairment of trade accounts receivable for fiscal 2022, is mainly related to specific provisions on higher risk
customers, partially offset by lower provisions on lower risk customers due to the decrease in trade accounts receivable.
The reversal of impairment of trade accounts receivable for fiscal 2021 was mainly related to a decrease in expected
credit loss rates to reflect the improved economic environment.
8. INVENTORIES:
Raw materials and spare parts inventories
Work in progress
Finished goods
January 1,
2023
January 2,
2022
$ 251,700 $ 183,065
53,482
537,811
$ 1,225,940 $ 774,358
77,726
896,514
The amount of inventories recognized as an expense and included in cost of sales was $2,164.0 million for
fiscal 2022 (2021 - $1,910.6 million). For fiscal 2022, cost of sales included an expense of $19.7 million related the write-
down of inventory to net realizable value. For fiscal 2021, cost of sales included a net recovery of $1.3 million related to
discontinued and closeout inventories carried at net realizable value.
GILDAN 2022 REPORT TO SHAREHOLDERS 85
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
9. PROPERTY, PLANT AND EQUIPMENT:
2022
Cost
Land
Buildings and
improvements
Manufacturing
equipment
Other
equipment
Assets not
yet utilized in
operations
Total
Balance, January 2, 2022
$ 127,068
$
582,643
$ 1,109,128
$ 171,147
$
76,660
$ 2,066,646
Additions
Transfers
Disposals(1)
4,321
—
(449)
22,578
(8,128)
(5,791)
48,665
67,782
8,375
2,847
158,595
(62,501)
242,534
—
(19,974)
(7,003)
—
(33,217)
Balance, January 1, 2023
$ 130,940
$
591,302
$ 1,205,601
$ 175,366
$ 172,754
$ 2,275,963
Accumulated depreciation
Balance, January 2, 2022
Depreciation (note 21)
Disposals(1)
Balance, January 1, 2023
$
$
—
—
—
—
Carrying amount, January 1, 2023
$ 130,940
$
244,971
$
699,988
$ 136,614
$
23,872
(5,460)
67,185
(10,856)
11,257
(6,777)
756,317
$ 141,094
$
$
$
263,383
327,919
$
$
—
—
—
—
$ 1,081,573
102,314
(23,093)
$ 1,160,794
449,284
$
34,272
$ 172,754
$ 1,115,169
(1) Includes disposals of manufacturing equipment with a cost of $7.8 million and accumulated depreciation of $2.0 million related to the
sale of Frontier Yarns - Plant 3. See note 5 for additional information. Disposals also include the write-off of certain equipment relating to
the closure of the Company's Cedartown yarn facility in Georgia.
2021
Cost
Land
Buildings and
improvements
Manufacturing
equipment
Other
equipment
Assets not
yet utilized in
operations
Total
Balance, January 3, 2021
$ 123,549
$
571,464
$ 1,070,612
$ 174,760
$
16,156
$ 1,956,541
3,519
—
—
—
4,008
13,397
4,579
44,381
50,817
8,320
5,914
73,679
92
276
—
(13,175)
131,501
64,306
—
(10,805)
(65,002)
(9,895)
—
(85,702)
$ 127,068
$
582,643
$ 1,109,128
$ 171,147
$
76,660
$ 2,066,646
$
$
—
—
—
—
—
$
230,088
$
695,979
$ 133,674
$
22,696
(7,813)
—
58,435
(54,426)
—
11,045
(8,139)
34
$
$
244,971
337,672
$
$
699,988
$ 136,614
409,140
$
34,533
$
$
—
—
—
—
—
$ 1,059,741
92,176
(70,378)
34
$ 1,081,573
76,660
$
985,073
Carrying amount, January 2, 2022
$ 127,068
(1) Included in disposals for fiscal 2021 are manufacturing equipment with a cost of $31.5 million and accumulated depreciation of
$25.2 million that were determined to be unrepairable due to damages resulting from the two hurricanes which impacted the Company’s
operations in Central America in November 2020. See note 17 (c) for additional information.
Effective January 3, 2022, the Company revised the estimated useful lives of certain textile manufacturing equipment
based on a re-assessment of their expected use to the Company and recent experience of their economic lives. These
assets, which were previously being depreciated on a straight-line basis over 10 years, are now depreciated on a straight-
line basis over 15 years. For the year ended January 1, 2023, the change in estimate was made on a prospective basis
and resulted in a reduction of depreciation of approximately $5.0 million.
Assets not yet utilized in operations include expenditures incurred to date for plant expansions which are still in process
and equipment not yet placed into service as at the end of the reporting period.
As at January 1, 2023, there were contractual purchase obligations outstanding of approximately $168.5 million for the
purchase of property, plant and equipment compared to $159.4 million as of January 2, 2022.
GILDAN 2022 REPORT TO SHAREHOLDERS 86
Additions
Additions through business acquisitions
Transfers
Disposals(1)
Balance, January 2, 2022
Accumulated depreciation
Balance, January 3, 2021
Depreciation (note 21)
Disposals(1)
Write-downs and impairments
Balance, January 2, 2022
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
10. RIGHT-OF-USE ASSETS AND LEASE OBLIGATIONS:
(a) Right-of-use assets:
The following table presents the right-of-use assets for the Company:
Balance, beginning of fiscal year
Additions
Business (dispositions) acquisitions
Write-downs, impairments, and accelerated depreciation
Depreciation (note 21)
Balance, end of fiscal year
2022
2021
$
$
92,447 $
11,688
(8,426)
(2,974)
(14,777)
77,958 $
59,445
8,132
43,539
(4,696)
(13,973)
92,447
(b) Lease obligations:
The Company’s leases are primarily for manufacturing, sales, distribution, and administrative facilities.
The following table presents lease obligations recorded in the statement of financial position:
Current
Non-current
January 1,
2023
January 2,
2022
$
$
13,828 $
80,162
15,290
93,812
93,990 $
109,102
Leases of certain facilities contain extension or termination options exercisable by the Company before the end of the
non-cancellable contract period. The Company has applied judgment to determine the lease term for the contracts
with renewal and termination options and has included renewal and termination options in the measurement of lease
obligations when it is reasonably certain to exercise the options. The Company reassesses whether it is reasonably
certain to exercise the options if there is a significant event or a significant change in circumstances within its control
which impacts the original assessments made. As at January 1, 2023, potential undiscounted future lease payments
related to renewal options not included in the measurement of lease obligations are $58.8 million (January 2, 2022 -
$45.8 million).
The following table presents the undiscounted future minimum lease payments under non-cancellable leases
(including short term leases) as at January 1, 2023:
Less than one year
One to five years
More than five years
$
January 1,
2023
19,296
51,941
43,565
$
114,802
For the year ended January 1, 2023, expenses relating to short-term leases and leases of low-value assets were
$3.8 million (2021 - $3.3 million).
For the year ended January 1, 2023, the total cash outflow for recognized lease obligations (including interest) was
$19.7 million (2021 - $24.1 million), of which $16.6 million (2021 - $21.5 million) was included as part of cash outflows
from financing activities.
GILDAN 2022 REPORT TO SHAREHOLDERS 87
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
11. INTANGIBLE ASSETS AND GOODWILL:
Intangible assets:
2022
Cost
Customer
contracts and
customer
relationships
Trademarks
License
agreements
Computer
software
Non-compete
agreements
Total
Balance, January 2, 2022
$
224,489
$ 226,172
$
72,796
$
67,157
$
1,790
$
592,404
Additions
Disposals
—
—
—
—
—
(2,346)
5,205
(1,788)
—
—
5,205
(4,134)
Balance, January 1, 2023
$
224,489
$ 226,172
$
70,450
$
70,574
$
1,790
$
593,475
Accumulated amortization
Balance, January 2, 2022
Amortization (note 21)
Disposals
Write-downs and impairments
Balance, January 1, 2023
Carrying amount, January 1, 2023
2021
Cost
$
148,132
$
19,127
$
66,929
$
49,796
$
1,790
$
285,774
11,194
—
—
—
25,095
36,320
2,561
(1,967)
875
5,397
(1,725)
—
—
—
—
19,152
(3,692)
62,290
184,421
$
55,447
$
68,398
$
53,468
$
1,790
$
363,524
40,068
$ 170,725
$
2,052
$
17,106
$
—
$
229,951
$
$
Customer
contracts and
customer
relationships
Trademarks
License
agreements
Computer
software
Non-compete
agreements
Total
Balance, January 3, 2021
$
224,489
$ 226,172
$
72,796
$
64,295
$
1,790
$
589,542
Additions
Disposals
—
—
—
—
—
—
3,635
(773)
—
—
3,635
(773)
Balance, January 2, 2022
$
224,489
$ 226,172
$
72,796
$
67,157
$
1,790
$
592,404
Accumulated amortization
Balance, January 3, 2021
Amortization (note 21)
Disposals
$
142,131
$
46,351
$
64,347
$
45,022
$
1,790
$
299,641
(Impairment reversal, net of write-downs)
(3,943)
(27,516)
Balance, January 2, 2022
Carrying amount, January 2, 2022
$
$
148,132
$
19,127
76,357
$ 207,045
$
$
66,929
5,867
$
$
9,944
—
292
—
2,582
—
—
5,258
(484)
—
49,796
17,361
—
—
—
$
$
1,790
—
$
$
18,076
(484)
(31,459)
285,774
306,630
During fiscal 2022, the Company recorded an impairment charge of $62.3 million relating to intangible assets (both
definite and indefinite life) acquired in previous business acquisitions.
During fiscal 2021, the Company recorded an impairment reversal, net of write-downs, of $31.5 million. The impairment
reversal, net of write-downs includes a $55.6 million impairment reversal relating to intangible assets (both definite and
indefinite life) acquired in previous business acquisitions, partially offset by a $24.1 million write-off of certain intangible
assets relating to the Company's Hosiery CGU. The write-off of intangible assets included a write-down of $10.4 million in
trademarks and $13.7 million in customer relationships, that were assessed as having no future economic benefit. These
asset write-offs related to the Company’s plan to exit its sheer panty hose, tights, leggings, ladies shapewear, intimates,
and accessories products.
The carrying amount of internally-generated assets within computer software was $13.6 million as at January 1, 2023
(January 2, 2022 - $14.1 million). Included in computer software as at January 1, 2023 is $4.4 million (January 2, 2022 -
$3.6 million) of assets not yet utilized in operations.
GILDAN 2022 REPORT TO SHAREHOLDERS 88
11. INTANGIBLE ASSETS AND GOODWILL (continued):
Goodwill:
Balance, beginning of fiscal year
Goodwill (disposed) acquired
Purchase price allocation adjustment
Balance, end of fiscal year
Recoverability of cash-generating units:
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
2022
2021
$ 283,815
(13,892)
1,754
$ 271,677
$ 206,636
77,179
—
$ 283,815
Goodwill acquired through business acquisitions and intangibles have been allocated to the Company's CGUs as follows:
Textile & Sewing:
Goodwill
Definite life intangible assets (excluding computer software)
Indefinite life intangible assets
Hosiery:
Goodwill
Definite life intangible assets (excluding computer software)
Indefinite life intangible assets
January 1,
2023
January 2,
2022
$ 271,677
19,282
93,400
$ 384,359
$ 283,815
23,430
93,400
$ 400,645
$
—
22,838
77,325
$ 100,163
$
—
58,794
113,645
$ 172,439
In assessing whether goodwill and indefinite life intangible assets are impaired, the carrying amounts of the CGUs
(including goodwill and indefinite life intangible assets) are compared to their recoverable amounts. The recoverable
amounts of CGUs are based on the higher of the value in use and fair value less costs of disposal.
The Company performed its annual impairment review for goodwill and indefinite life intangible assets as at January 1,
2023 and January 2, 2022. The estimated recoverable amount for the Textile & Sewing CGU exceeded its carrying
amounts and as a result, there was no impairment identified. The carrying value for the Hosiery CGU was in excess of its
estimated recoverable amount and as a result the Company recorded an impairment charge of $62.3 million for the year
ended January 1, 2023 relating to intangible assets (both definite and indefinite life) acquired in previous business
acquisitions. For the year ended January 2, 2022, the estimated recoverable amount for the Hosiery CGU was in excess
of its carrying value resulting in an impairment reversal of $55.6 million, relating to intangible assets (both definite and
indefinite life) acquired in previous business acquisitions.
Recoverable amount for Textile & Sewing and Hosiery CGUs
The Company determined the recoverable amounts of the Textile & Sewing and Hosiery CGUs based on the fair value
less costs of disposal method. The fair values of the Textile & Sewing and Hosiery CGUs were based on a multiple applied
to adjusted EBITDA (as defined in note 25) for the next year, which takes into account financial forecasts approved by
senior management. The key assumptions for the fair value less costs of disposal method include estimated sales
volumes, selling prices, input costs, and SG&A expenses in determining forecasted adjusted EBITDA, as well as the
multiple applied to forecasted adjusted EBITDA. The adjusted EBITDA multiple was obtained by using market
comparables as a reference. The values assigned to the key assumptions represent management’s assessment of future
trends and have been based on historical data from external and internal sources.
GILDAN 2022 REPORT TO SHAREHOLDERS 89
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
11. INTANGIBLE ASSETS AND GOODWILL (continued):
Recoverability of cash-generating units (continued):
Textile & Sewing CGU
For the Textile & Sewing CGU, no reasonably possible change in the key assumptions used in determining the
recoverable amount would result in any impairment of goodwill or indefinite life intangible assets.
Hosiery CGU
Based on the results of the impairment test performed on January 1, 2023, the recoverable amount of the CGU of
$265.5 million (2021 - $544.0 million) is lower than the carrying value and as a result there was $62.3 million impairment
identified.
The fair value of the Hosiery CGU was based on a multiple applied to the risk-adjusted forecasted adjusted EBITDA (see
definition of adjusted EBITDA in note 25). The key assumptions used in the estimation of the recoverable amount for the
Hosiery CGU are the risk-adjusted forecasted adjusted EBITDA for the next year and the adjusted EBITDA multiple of 7.5
(January 1, 2023 test) and 10 (January 2, 2022 test). The adjusted EBITDA multiple was obtained by using market
comparables as a reference. The most significant assumptions that form part of the risk-adjusted forecasted adjusted
EBITDA for the Hosiery CGU relate to estimated sales volumes, selling prices, input costs, and SG&A expenses. A
decrease in the risk adjusted forecasted adjusted EBITDA of 10% in the Hosiery CGU combined with a decrease in the
adjusted EBITDA multiple by a factor of 1 would result in an additional impairment of approximately $50.0 million.
Conversely an increase in the risk adjusted forecasted adjusted EBITDA of 10% combined with an increase in the
adjusted EBITDA multiple by a factor of 1 would result in a reduction of impairment of approximately $55.0 million. The
values assigned to the key assumptions represent management’s assessment of future trends and have been based on
historical data from external and internal sources.
GILDAN 2022 REPORT TO SHAREHOLDERS 90
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
12. LONG-TERM DEBT:
Effective
interest
rate (1)
Principal amount
January 1,
2023
January 2,
2022
Maturity
date
Non-current portion of long-term debt
Revolving long-term bank credit facility, interest at variable U.S. interest
rate(2)(3)
3.4% $
330,000 $
—
March
2027
Term loan, interest at variable U.S. interest rate, payable monthly(2)(4)
3.0%
300,000
300,000
Notes payable, interest at fixed rate of 2.70%, payable semi-annually(5)
Notes payable, interest at Adjusted LIBOR plus a spread of 1.53%,
payable quarterly(5)(6)
n/a
n/a
—
100,000
—
50,000
Notes payable, interest at fixed rate of 2.91%, payable semi-annually(5)
2.9%
100,000
100,000
Notes payable, interest at Adjusted LIBOR plus a spread of 1.57%,
payable quarterly(5)(6)
2.9%
50,000
50,000
$
780,000 $
600,000
Current portion of long-term debt
June
2026
August
2023
August
2023
August
2026
August
2026
Notes payable, interest at fixed rate of 2.70%, payable semi-annually(5)
2.7%
100,000
Notes payable, interest at Adjusted LIBOR plus a spread of 1.53%,
payable quarterly(5)(6)
2.7%
50,000
Long-term debt
$
$
150,000 $
930,000 $
600,000
August
2023
August
2023
—
—
—
(1) Represents the annualized effective interest rate for the year ended January 1, 2023, including the cash impact of interest rate swaps,
where applicable.
(2) SOFR advances at adjusted Term SOFR (includes a 0% to 0.25% reference rate adjustment) plus a spread ranging from 1% to 3%.
(3) The Company’s committed unsecured revolving long-term bank credit facility of $1 billion provides for an annual extension which is
subject to the approval of the lenders. The spread added to the adjusted Term SOFR is a function of the total net debt to EBITDA ratio (as
defined in the credit facility agreement and its amendments). In addition, an amount of $43.9 million (January 2, 2022 - $51.1 million) has
been committed against this facility to cover various letters of credit.
(4) The unsecured term loan is non-revolving and can be prepaid in whole or in part at any time with no penalties. The spread added to
the adjusted Term SOFR is a function of the total net debt to EBITDA ratio (as defined in the term loan agreements and its amendments).
(5) The unsecured notes issued for a total aggregate principal amount of $300 million to accredited investors in the U.S. private
placement market can be prepaid in whole or in part at any time, subject to the payment of a prepayment penalty as provided for in the
Note Purchase Agreement.
(6) Adjusted LIBOR rate is determined on the basis of floating rate notes that bear interest at a floating rate plus a spread of 1.53%.
On April 20, 2021, the Company fully repaid its $400 million unsecured two-year term loan which was due on
April 6, 2022. In June 2021, the Company amended its unsecured term loan of $300 million to extend the maturity date
from April 2025 to June 2026.
On March 25, 2022, the Company amended and extended its unsecured revolving long-term bank credit facility of
$1 billion to March 2027. As part of the amendment, LIBOR references were replaced with Term Secured Overnight
Financing Rate (‘‘Term SOFR’’) and the revolving facility includes a sustainability-linked loan ("SLL") structure, whereby its
applicable margins are adjusted upon achievement of certain sustainability targets, commencing in 2023.
On March 25, 2022, the Company amended its $300 million term loan to replace LIBOR references by Term SOFR
references.
GILDAN 2022 REPORT TO SHAREHOLDERS 91
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
12. LONG-TERM DEBT (continued):
On June 30, 2022, the Company amended its notes purchase agreement to include LIBOR fallback provisions to replace
LIBOR with adjusted term SOFR, adjusted daily simple SOFR or any relevant alternate rate selected by the note holders
and the Company upon a benchmark transition event or early opt-in election.
The Company applied the IFRS 9 interest rate benchmark reform practical expedient for amendments required by the
interest rate reform to the revolving-long term bank credit facility, term loan and related interest rate swap agreements.
The Company and its counterparties under interest rate swap agreements are in the process of negotiating the
substitution of reference rates in such agreements.
Under the terms of the revolving facility, term loan facility, and notes, the Company is required to comply with certain
covenants, including maintenance of financial ratios. The Company was in compliance with all financial covenants at
January 1, 2023.
13. OTHER NON-CURRENT LIABILITIES:
Employee benefit obligation - Statutory severance and pre-notice (a)
Employee benefit obligation - Defined contribution plan (b)
Provisions (c)
(a) Statutory severance and pre-notice obligations:
Obligation, beginning of fiscal year
Service cost
Interest cost
Actuarial (gain) loss(1)
Foreign exchange gain
Benefits paid
Obligation, end of fiscal year
January 1,
2023
January 2,
2022
$
42,127 $
3,383
10,707
56,217 $
$
42,931
3,742
13,189
59,862
2022
2021
$
$
42,931 $
18,166
8,543
(8,094)
(626)
(18,793)
42,127 $
19,889
13,942
6,562
21,678
(179)
(18,961)
42,931
(1) The actuarial gain in fiscal 2022 is mainly due to changes in the actuarial assumptions used to determine the statutory severance
obligations. The actuarial loss in fiscal 2021 is due to changes in the actuarial assumptions used to determine the statutory
severance obligations.
Significant assumptions for the calculation of the statutory severance obligations included the use of a discount rate
ranging between 8.5% and 11.0% (2021 - between 8.5% and 9.2%) and rates of compensation increases between
8.0% and 10.5% (2021 - 7.75% and 10.5%). A 1% increase in the discount rates would result in a corresponding
decrease in the statutory severance obligations of $8.0 million, and a 1% decrease in the discount rates would result
in a corresponding increase in the statutory severance obligations of $9.3 million. A 1% increase in the rates of
compensation increases used would result in a corresponding increase in the statutory severance obligations of
$9.6 million, and a 1% decrease in the rates of compensation increases used would result in a corresponding
decrease in the statutory severance obligations of $8.3 million.
The cumulative amount of actuarial losses recognized in other comprehensive income as at January 1, 2023 was
$26.5 million (January 2, 2022 - $34.6 million) which have been reclassified to retained earnings in the period in
which they were recognized.
(b) Defined contribution plan:
During fiscal 2022, defined contribution expenses were $4.7 million (2021 - $5.3 million).
GILDAN 2022 REPORT TO SHAREHOLDERS 92
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
13. OTHER NON-CURRENT LIABILITIES (continued):
(c) Provisions:
The following table presents the provisions for decommissioning and site restoration costs of the Company:
Balance, beginning of fiscal year
Changes in estimates made during the fiscal year
Accretion of interest
Balance, end of fiscal year
2022
13,189 $
(2,689)
207
10,707 $
2021
12,240
796
153
13,189
$
$
Provisions as at January 1, 2023 include estimated future costs of decommissioning and site restoration for certain
assets located at the Company’s textile and sock facilities for which the timing of settlement is uncertain, but has
been estimated to be in excess of twenty years.
14. EQUITY:
(a) Shareholder rights plan:
The Company has a shareholder rights plan which provides the Board of Directors and the shareholders with
additional time to assess any unsolicited take-over bid for the Company and, where appropriate, pursue other
alternatives for maximizing shareholder value.
(b) Accumulated other comprehensive income ("AOCI"):
Accumulated other comprehensive income includes the changes in the fair value of the effective portion of qualifying
cash flow hedging instruments, for which the hedged transaction has not yet occurred at the end of the fiscal year.
(c) Share capital:
Authorized:
Common shares, authorized without limit as to number and without par value. First preferred shares, without limit as
to number and without par value, issuable in series and non-voting. Second preferred shares, without limit as to
number and without par value, issuable in series and non-voting. As at January 1, 2023 and January 2, 2022, none of
the first and second preferred shares were issued.
Issued:
As at January 1, 2023, there were 179,709,339 common shares (January 2, 2022 - 192,267,273) issued and
outstanding, which are net of 8,129 common shares (January 2, 2022 - 8,759) that have been purchased and are
held in trust as described in note 14(e).
GILDAN 2022 REPORT TO SHAREHOLDERS 93
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
14. EQUITY (continued):
(d) Normal course issuer bid ("NCIB"):
On August 4, 2021, the Company received approval from the Toronto Stock Exchange (TSX) to renew its NCIB
commencing on August 9, 2021 to purchase for cancellation up to 9,926,177 common shares, representing
approximately 5% of the Company’s issued and outstanding common shares. During the year ended January 2,
2022, the Company repurchased for cancellation a total of 6,475,375 common shares under its NCIB programs for a
total cost of $250.4 million. Of the total cost of $250.4 million, $6.2 million was charged to share capital and $244.3
million was charged to retained earnings.
On February 22, 2022, the Company received approval from the TSX to amend its current NCIB, which commenced
on August 9, 2021, in order to increase the maximum number of common shares that may be repurchased from
9,926,177, or 5% of the Company’s issued and outstanding common shares as at July 31, 2021 (the reference date
for the NCIB), to 19,477,744 common shares, representing 10% of the public float as at July 31, 2021. No other terms
of the NCIB have been amended.
In August 2022, the Company received approval from the TSX to renew its normal course issuer bid (NCIB) program
commencing on August 9, 2022, to purchase for cancellation a maximum of 9,132,337 common shares, representing
5% of the Company's issued and outstanding common shares, as at July 31, 2022 (the reference date for the NCIB).
Under the NCIB, the Company is authorized to make purchases under the normal course issuer bid during the period
from August 9, 2022 to August 8, 2023 in accordance with the requirements of the TSX. Purchases can be made by
means of open market transactions on both the TSX and the New York Stock Exchange (NYSE), or alternative
Canadian trading systems, if eligible, or by such other means as may be permitted by securities regulatory
authorities, including pre-arranged crosses, exempt offers, private agreements under an issuer bid exemption order
issued by securities regulatory authorities and block purchases of common shares.
During the third quarter of fiscal 2022, the Company completed share repurchases under its NCIB ending
August 8, 2022 and following the renewal of the Company's NCIB, effective August 9, 2022, the Company continued
to repurchase shares. During the year ended January 1, 2023, the Company repurchased for cancellation a total of
13,096,866 common shares purchased for cancellation, for a total cost of $443.9 million, of which $13.3 million was
charged to share capital and $430.5 million was charged to retained earnings.
(e) Common shares purchased as settlement for non-Treasury RSUs:
The Company has established a trust for the purpose of settling the vesting of non-Treasury RSUs. For non-Treasury
RSUs that are to be settled in common shares in lieu of cash, the Company directs the trustee to purchase common
shares of the Company on the open market to be held in trust for and on behalf of the holders of non-Treasury RSUs
until they are delivered for settlement, when the non-Treasury RSUs vest. For accounting purposes, the common
shares are considered as held in treasury, and recorded as a temporary reduction of outstanding common shares and
share capital. Upon delivery of the common shares for settlement of the non-Treasury RSUs, the number of common
shares outstanding is increased, and the amount in contributed surplus is transferred to share capital. As at
January 1, 2023, a total of 8,129 common shares purchased as settlement for non-Treasury RSUs were considered
as held in treasury and recorded as a temporary reduction of outstanding common shares and share capital
(January 2, 2022 - 8,759 common shares).
(f) Contributed surplus:
The contributed surplus account is used to record the accumulated compensation expense related to equity-settled
share-based compensation transactions. Upon the exercise of stock options, the vesting of Treasury RSUs, and the
delivery of common shares for settlement of vesting non-Treasury RSUs or SARs, the corresponding amounts
previously credited to contributed surplus are transferred to share capital, except for the portion of the share-based
payment that the Company settles on a net basis when the Company has an obligation under tax laws to withhold an
amount for an employee’s tax obligation, in which case the corresponding amounts previously credited to contributed
surplus are transferred to accounts payable and accrued liabilities.
GILDAN 2022 REPORT TO SHAREHOLDERS 94
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
15. FINANCIAL INSTRUMENTS:
(a) Financial instruments - carrying amounts and fair values:
The carrying amounts and fair values of financial assets and liabilities included in the consolidated statements of
financial position are as follows:
Financial assets
Amortized cost:
Cash and cash equivalents
Trade accounts receivable
January 1,
2023
January 2,
2022
$ 150,417 $ 179,246
329,967
248,785
Financial assets included in prepaid expenses, deposits and other current assets
48,274
69,995
Long-term non-trade receivables included in other non-current assets
118
390
Derivative financial assets included in prepaid expenses, deposits and other current
assets
23,765
62,758
Financial liabilities
Amortized cost:
Accounts payable and accrued liabilities (1)
Long-term debt - bearing interest at variable rates
Long-term debt - bearing interest at fixed rates (2)
Derivative financial liabilities included in accounts payable and accrued liabilities
$ 462,496 $ 436,073
400,000
200,000
4,328
730,000
200,000
8,712
1) Accounts payable and accrued liabilities include $26.9 million (January 2, 2022 - $18.1 million) under supply-chain financing
arrangements (reverse factoring) with a financial institution, whereby receivables due from the Company to certain suppliers can be
collected by the suppliers from a financial institution before their original due date. These balances are classified as accounts
payable and accrued liabilities and the related payments as cash flows from operating activities, given the principal business
purpose of the arrangement is to provide funding to the supplier and not the Company, the arrangement does not significantly
extend the payment terms beyond the normal terms agreed with other suppliers, and no additional deferral or special guarantees to
secure the payments are included in the arrangement. Accounts payable and accrued liabilities also include balances payable of
$35.7 million (January 2, 2022 - $48.8 million) resulting mainly from a one-week timing difference between the collection of sold
receivables and the weekly remittance to our bank counterparty under our receivables purchase agreement that is disclosed in note
7 to these consolidated financial statements.
2) The fair value of the long-term debt bearing interest at fixed rates was $197.1 million as at January 1, 2023 (January 2, 2022 -
$212.2 million).
GILDAN 2022 REPORT TO SHAREHOLDERS 95
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
15. FINANCIAL INSTRUMENTS (continued):
(a) Financial instruments - carrying amounts and fair values (continued):
Short-term financial assets and liabilities
The Company has determined that the fair value of its short-term financial assets and liabilities approximates their
respective carrying amounts as at the reporting dates due to the short-term maturities of these instruments, as they
bear variable interest-rates or because the terms and conditions are comparable to current market terms and
conditions for similar items.
Non-current assets and long-term debt bearing interest at variable rates
The fair values of the long-term non-trade receivables included in other non-current assets and the Company’s long-
term debt bearing interest at variable rates also approximate their respective carrying amounts because the interest
rates applied to measure their carrying amounts approximate current market interest rates.
Long-term debt bearing interest at fixed rates
The fair value of the long-term debt bearing interest at fixed rates is determined using the discounted future cash
flows method and at discount rates based on yield to maturities for similar issuances. The fair value of the long-term
debt bearing interest at fixed rates was measured using Level 2 inputs in the fair value hierarchy. In determining the
fair value of the long-term debt bearing interest at fixed rates, the Company takes into account its own credit risk and
the credit risk of the counterparties.
Derivatives
Derivative financial instruments are designated as effective hedging instruments and consist of foreign exchange and
commodity forward, option, and swap contracts, as well as floating-to-fixed interest rate swaps to fix the variable
interest rates on a designated portion of borrowings under the term loan and unsecured notes. The fair value of the
forward contracts is measured using a generally accepted valuation technique which is the discounted value of the
difference between the contract’s value at maturity based on the rate set out in the contract and the contract’s value
at maturity based on the rate that the counterparty would use if it were to renegotiate the same contract terms at the
measurement date under current conditions. The fair value of the option contracts is measured using option pricing
models that utilize a variety of inputs that are a combination of quoted prices and market-corroborated inputs,
including volatility estimates and option adjusted credit spreads. The fair value of the interest rate swaps is
determined based on market data, by measuring the difference between the fixed contracted rate and the forward
curve for the applicable floating interest rates.
The Company also has a total return swap (“TRS”) outstanding that is intended to reduce the variability of net
earnings associated with deferred share units, which are settled in cash. The TRS is not designated as a hedging
instrument and, therefore, the fair value adjustment at the end of each reporting period is recognized in selling,
general and administrative expenses. The fair value of the TRS is measured by reference to the market price of the
Company’s common shares, at each reporting date. The TRS has a one-year term, may be extended annually, and
the contract allows for early termination at the option of the Company. As at January 1, 2023, the notional amount of
TRS outstanding was 362,608 shares (January 2, 2022 - 319,639 shares) and the carrying amount and fair value
included in accounts payable and accrued liabilities was $4.7 million (January 2, 2022 - $0.03 million included in
prepaid expenses, deposits and other current assets).
Derivative financial instruments were measured using Level 2 inputs in the fair value hierarchy. In determining the fair
value of derivative financial instruments the Company takes into account its own credit risk and the credit risk of the
counterparties.
GILDAN 2022 REPORT TO SHAREHOLDERS 96
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
15. FINANCIAL INSTRUMENTS (continued):
(b) Derivative financial instruments - hedge accounting:
During fiscal 2022 and 2021, the Company entered into foreign exchange and commodity forward, option, and swap
contracts in order to minimize the exposure of forecasted cash inflows and outflows in currencies other than the U.S.
dollar and to manage its exposure to movements in commodity prices, as well as floating-to-fixed interest rate swaps
to fix the variable interest rates on a designated portion of borrowings under the term loan and unsecured notes.
The forward foreign exchange contracts were designated as cash flow hedges and qualified for hedge accounting.
The forward foreign exchange contracts outstanding as at January 1, 2023 and January 2, 2022 consisted primarily of
contracts to reduce the exposure to fluctuations in Canadian dollars, Euros, Australian dollars, Pounds sterling, and
Mexican pesos against the U.S. dollar.
The commodity forward, option, and swap contracts were designated as cash flow hedges and qualified for hedge
accounting. The commodity contracts outstanding as at January 1, 2023 and January 2, 2022 consisted primarily of
forward, collar, and swap contracts to reduce the exposure to movements in commodity prices.
The floating-to-fixed interest rate swaps were designated as cash flow hedges and qualified for hedge accounting.
The floating-to-fixed interest rate swaps contracts outstanding as at January 1, 2023 and January 2, 2022 served to
fix the variable interest rates on the designated interest payments of a portion of the Company's long-term debt.
The following table summarizes the Company’s commitments to buy and sell foreign currencies (cash flow hedges)
as at January 1, 2023:
Notional foreign
currency amount
equivalent
Average
exchange
rate
Notional Prepaid expenses,
U.S. $ deposits and other
current assets
equivalent
Accounts
payable and
accrued liabilities
0 to 12
months
Carrying and fair value
Maturity
Forward foreign exchange contracts:
Sell GBP/Buy USD
Sell EUR/Buy USD
Sell CAD/Buy USD
Buy CAD/Sell USD
Sell AUD/Buy USD
Sell MXN/Buy USD
Buy EUR/Sell USD
39,600
1.2000
$ 47,520
$
42,544
1.0513
47,531
0.7534
30,497
0.7662
12,258
63,776
3,137
0.6836
0.0469
1.0592
44,726
35,812
23,367
8,379
2,989
3,323
686
328
707
17
153
—
56
$
(1,023)
$
(337)
(1,355)
(1,027)
(56)
(815)
(122)
(242)
(14)
651
(798)
31
(242)
42
$ 166,116
$
1,947
$
(3,627)
$
(1,680)
The following table summarizes the Company’s commitments to buy and sell foreign currencies (cash flow hedges)
as at January 2, 2022:
Notional foreign
currency amount
equivalent
Average
exchange
rate
Notional Prepaid expenses,
deposits and other
current assets
U.S. $
equivalent
Accounts
payable and
accrued liabilities
0 to 12
months
Carrying and fair value
Maturity
Forward foreign exchange contracts:
Sell GBP/Buy USD
Sell EUR/Buy USD
Sell CAD/Buy USD
Buy CAD/Sell USD
Sell AUD/Buy USD
29,390
1.1916
39,274
0.8015
31,016
0.7840
8,885
0.7427
Sell MXN/Buy USD
151,791
0.0480
26,752
1.3769
$ 36,834
$
808
$
(54)
$
35,020
31,478
24,316
6,599
7,279
1,592
665
92
161
39
—
—
(88)
(13)
(11)
754
1,592
665
4
148
28
$ 141,526
$
3,357
$
(166)
$
3,191
GILDAN 2022 REPORT TO SHAREHOLDERS 97
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
15. FINANCIAL INSTRUMENTS (continued):
(b) Derivative financial instruments - hedge accounting (continued):
The following table summarizes the Company's commodity contracts outstanding (cash flow hedges) as at
January 1, 2023:
Type of
commodity
Notional amount (1)
Forward contracts
Cotton
118.9 million pounds
Swap & option contracts
Energy
1.7 million gallons
(1) Notional amounts are not in thousands.
Carrying and fair value
Maturity
Prepaid expenses,
deposits and other
current assets
Accounts
payable and
accrued liabilities
0 to 12
months
$
$
5,105
253
5,358
$
$
—
$
5,105
(358)
(105)
(358)
$
5,000
The following table summarizes the Company's commodity contracts outstanding (cash flow hedges) as at
January 2, 2022:
Type of
commodity
Notional amount (1)
Forward contracts
Cotton
251.0 million pounds
Swap & option contracts
Energy
5.7 million gallons
(1) Notional amounts are not in thousands.
Carrying and fair value
Maturity
Prepaid expenses,
deposits and other
current assets
Accounts
payable and
accrued liabilities
0 to 12
months
$
$
56,419
1,660
58,079
$
$
—
$ 56,419
(102)
1,558
(102)
$ 57,977
GILDAN 2022 REPORT TO SHAREHOLDERS 98
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
15. FINANCIAL INSTRUMENTS (continued):
(b) Derivative financial instruments - hedge accounting (continued):
The following table summarizes the Company’s floating-to-fixed interest rate swap contracts outstanding (cash flow
hedges) as at January 1, 2023:
Notional
amount of
borrowings
Maturity
date
Pay / Receive
Fixed
rate
Floating
rate(2)
Carrying and fair value
Prepaid expenses,
deposits and other
current assets
Accounts
payable and
accrued liabilities
Term Loan(1)
$
75,000
April 30,
2023
Pay fixed rate /
receive floating rate
2.85 % US LIBOR
$
435
$
50,000
25,000
50,000
25,000
25,000
April 30,
2024
Pay fixed rate /
receive floating rate
1.51 % US LIBOR
April 30,
2025
Pay fixed rate /
receive floating rate
1.06 % US LIBOR
April 30,
2025
Pay fixed rate /
receive floating rate
June 30,
2026
Pay fixed rate /
receive floating rate
June 30,
2026
Pay fixed rate /
receive floating rate
0.78 % US LIBOR
1.59 % US LIBOR
1.23 % US LIBOR
Unsecured Notes
50,000
August 25,
2023
Pay fixed rate /
receive floating rate
1.18 % US LIBOR
50,000
August 25,
2026
Pay fixed rate /
receive floating rate
1.34 % US LIBOR
2,124
1,839
3,346
443
1,999
1,394
4,880
$
16,460
$
—
—
—
—
—
—
—
—
—
(1) The notional amounts for the interest rate swap contracts maturing in 2025 and 2026 are extensions to the $100 million interest
rate swap contracts originally entered into related to the $300 million term loan.
(2) The Company and its counterparties under interest rate swap agreements have begun discussions to negotiate the substitution
of reference rates in such agreements.
GILDAN 2022 REPORT TO SHAREHOLDERS 99
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
15. FINANCIAL INSTRUMENTS (continued):
(b) Derivative financial instruments - hedge accounting (continued):
The following table summarizes the Company’s floating-to-fixed interest rate swap contracts outstanding (cash flow
hedges) as at January 2, 2022:
Notional
amount of
borrowings
Maturity
date
Pay / Receive
Fixed
rate
Floating
rate
Carrying and fair value
Prepaid expenses,
deposits and other
current assets
Accounts
payable and
accrued liabilities
Term Loan(1)
$
75,000
April 30,
2023
Pay fixed rate /
receive floating rate
2.85 % US LIBOR
$
50,000
25,000
50,000
25,000
25,000
April 30,
2024
April 30,
2025
Pay fixed rate /
receive floating rate
Pay fixed rate /
receive floating rate
1.51 % US LIBOR
1.06 % US LIBOR
April 30,
2025
Pay fixed rate /
receive floating rate
0.78 % US LIBOR
June 30,
2026
June 30,
2026
Pay fixed rate /
receive floating rate
Pay fixed rate /
receive floating rate
1.59 % US LIBOR
1.23 % US LIBOR
Unsecured Notes
50,000
50,000
August 25,
2023
August 25,
2026
Pay fixed rate /
receive floating rate
Pay fixed rate /
receive floating rate
1.18 % US LIBOR
1.34 % US LIBOR
—
32
167
624
—
171
—
328
$
(2,272)
(744)
(154)
—
(22)
—
(380)
(454)
(1) The notional amounts for the interest rate swap contracts maturing in 2025 and 2026 were extensions to the $100 million interest
rate swap contracts originally entered into related to the $300 million term loan.
$
1,322
$
(4,026)
The following table summarizes the Company’s hedged items as at January 1, 2023:
Cash flow hedges:
Foreign currency risk:
Forecast sales
Forecast expenses
Commodity risk:
Forecast purchases
Interest rate risk:
Forecast interest payments
Carrying amount of
the hedged item
Liabilities
Assets
Change in
value used for
calculating hedge
ineffectiveness
Cash flow
hedge reserve
(AOCI)
$
— $
—
—
—
$
— $
—
—
—
—
—
$
(1,359) $
(750)
1,359
750
(4,112)
4,112
16,066
(16,066)
$
9,845
$
(9,845)
No ineffectiveness was recognized in net earnings as the change in value of the hedging instrument used for
calculating ineffectiveness was the same or smaller as the change in value of the hedged items used for calculating
the ineffectiveness.
GILDAN 2022 REPORT TO SHAREHOLDERS 100
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
15. FINANCIAL INSTRUMENTS (continued):
(b) Derivative financial instruments - hedge accounting (continued):
The following table summarizes the Company’s hedged items as at January 2, 2022:
Cash flow hedges:
Foreign currency risk:
Forecast sales
Forecast expenses
Commodity risk:
Forecast purchases
Interest rate risk:
Forecast interest payments
Change in
Carrying amount of
value used for
Cash flow
the hedged item
calculating hedge
hedge reserve
Assets
Liabilities
ineffectiveness
(AOCI)
$
— $
—
—
—
$
— $
—
—
—
—
—
$
2,554
$
(2,554)
4
(4)
64,813
(64,813)
(2,562)
2,562
$
64,809
$
(64,809)
No ineffectiveness was recognized in net earnings as the change in value of the hedging instrument used for
calculating ineffectiveness was the same or smaller as the change in value of the hedged items used for calculating
the ineffectiveness.
(c) Financial expenses, net:
Interest expense on financial liabilities recorded at amortized cost (1)
Bank and other financial charges
Interest accretion on discounted lease obligations
Interest accretion on discounted provisions
Foreign exchange (gain) loss
(1) Net of capitalized borrowing costs of $2.3 million (2021 - $1.6 million).
2022
25,619 $
10,524
3,097
47
(2,330)
36,957 $
2021
14,923
8,823
2,650
153
782
27,331
$
$
GILDAN 2022 REPORT TO SHAREHOLDERS 101
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
15. FINANCIAL INSTRUMENTS (continued):
(d) Hedging components of other comprehensive income (“OCI”):
Net gain (loss) on derivatives designated as cash flow hedges:
Foreign currency risk
Commodity price risk
Interest rate risk
Income taxes
2022
2021
$
10,965 $
46,056
18,628
3,599
83,130
8,203
(110)
(36)
Amounts reclassified from OCI to inventory, related to commodity
price risk
(114,989)
(22,515)
Amounts reclassified from OCI to net earnings, related to foreign currency risk,
commodity risk, and interest rate risk, and included in:
Net sales
Cost of sales
Selling, general and administrative expenses
Financial expenses, net
Income taxes
Other comprehensive (loss) income
$
(11,904)
22
316
(4,100)
152
(54,964) $
3,326
—
(1,992)
146
(14)
73,847
The change in the time value element of option and swap contracts designated as cash flow hedges to reduce the
exposure in movements of commodity prices was not significant for the years ended January 1, 2023 and January 2,
2022. The change in the forward element of derivatives designated as cash flow hedges to reduce foreign currency
risk was not significant for the years ended January 1, 2023 and January 2, 2022.
Approximately $1.4 million of net gains presented in accumulated other comprehensive income as at January 1, 2023
are expected to be reclassified to inventory or net earnings within the next twelve months.
GILDAN 2022 REPORT TO SHAREHOLDERS 102
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
16. SHARE-BASED COMPENSATION:
The Company’s Long-Term Incentive Plan (the "LTIP") includes stock options, stock appreciation rights ('SARs'), and
restricted share units. The LTIP allows the Board of Directors to grant stock options, SARs, dilutive restricted share units
("Treasury RSUs"), and non-dilutive restricted share units ("non-Treasury RSUs") to officers and other key employees of
the Company and its subsidiaries. The number of common shares that are issuable pursuant to the exercise of stock
options and the vesting of Treasury RSUs for the LTIP is fixed at 12,000,632. As at January 1, 2023, 83,545 common
shares remained authorized for future issuance under this plan.
The exercise price payable for each common share covered by a stock option or SARs is determined by the Board of
Directors at the date of the grant, but may not be less than the closing price of the common shares of the Company on the
trading day immediately preceding the effective date of the grant. Most stock options vest equally beginning on the
second, third, fourth, and fifth anniversary of the grant date. Stock options granted in fiscal 2020 all vest on the third
anniversary of the grant date, subject to performance vesting conditions in some cases. SARs granted in fiscal 2020 vest
on the third anniversary of the grant date, and all are subject to performance vesting conditions.
Holders of Treasury RSUs and non-Treasury RSUs are entitled to dividends declared by the Company which are
recognized in the form of additional equity awards equivalent in value to the dividends paid on common shares. The
vesting conditions of the additional equity awards are subject to the same performance objectives and other terms and
conditions as the underlying equity awards. The additional awards related to outstanding Treasury RSUs and non-
Treasury RSUs expected to be settled in common shares are credited to contributed surplus when the dividends are
declared.
(a) Stock options:
Outstanding stock options were as follows:
Stock options issued in Canadian dollars and to be exercised on the TSX:
Stock options outstanding, January 3, 2021
Changes in outstanding stock options:
Exercised
Stock options outstanding, January 2, 2022
Changes in outstanding stock options:
Exercised
Stock options outstanding, January 1, 2023
Stock options issued in U.S. dollars and to be exercised on the NYSE:
Stock options outstanding, January 3, 2021
Changes in outstanding stock options:
Forfeited
Stock options outstanding, January 2, 2022
Changes in outstanding stock options:
Granted
Forfeited
Stock options outstanding, January 1, 2023
Number
Weighted exercise
price (CA$)
1,463
$
36.33
(227)
1,236
(490)
746
$
33.48
36.85
37.35
36.52
Number
Weighted exercise
price (US$)
2,056
$
27.27
(68)
1,988
—
—
1,988
$
29.01
27.21
—
—
27.21
GILDAN 2022 REPORT TO SHAREHOLDERS 103
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
16. SHARE-BASED COMPENSATION (continued):
(a) Stock options (continued):
As at January 1, 2023, 745,902 outstanding options issued in Canadian dollars to be exercised on the TSX were
exercisable at the weighted average exercise price of CA$36.52 (January 2, 2022 - 1,235,845 options at CA$36.85),
and 601,186 outstanding options issued in U.S. dollars and to be exercised on the NYSE, were exercisable at the
weighted average exercise price of US$29.01 (January 2, 2022 - 433,962 options at US$29.01).
For stock options exercised during fiscal 2022, the weighted average share price at the date of exercise on the TSX
was CA$39.02 (2021 - CA$48.12), and there were no stock options exercised on NYSE during fiscal 2022 (2021 -
CA$40.58).
The following table summarizes information about stock options issued and outstanding and exercisable at January 1,
2023:
Exercise prices
CA$33.01
CA$42.27
US$20.77
US$29.01
US$30.00
Options issued and outstanding
Remaining
contractual life (yrs)
Number
463
283
746
537
601
850
2,734
1
3
5
2
5
Options exercisable
Number
463
283
746
—
601
—
1,347
The compensation expense related to stock options included in operating income for fiscal 2022 was $2.5 million
(2021 - $2.8 million), and the counterpart has been recorded as contributed surplus. When the underlying shares are
issued to the employees, the amounts previously credited to contributed surplus are transferred to share capital.
GILDAN 2022 REPORT TO SHAREHOLDERS 104
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
16. SHARE-BASED COMPENSATION (continued):
(b) Stock appreciation rights ("SARs"):
As at January 1, 2023, 824,406 SARs, at the weighted average exercise price of US$30, remained outstanding with a
remaining contractual life of 1 year. Based on the Black-Scholes option pricing model, the grant date weighted
average fair value of options granted during 2020 was $5.60. None of the outstanding SARs were exercisable as at
January 1, 2023. The compensation expense related to SARs included in operating income for fiscal 2022 was
$1.5 million (2021 - $1.5 million), and the counterpart has been recorded as contributed surplus.
(c) Restricted share units:
A Treasury RSU represents the right of an individual to receive one common share on the vesting date without any
monetary consideration being paid to the Company. All Treasury RSUs awarded to date vest within a five-year vesting
period. The vesting of at least 50% of each Treasury RSU grant is contingent on the achievement of performance
conditions that are based on the Company’s average return on assets performance for the period as compared to the
S&P/TSX Capped Consumer Discretionary Index, excluding income trusts.
Outstanding Treasury RSUs were as follows:
Treasury RSUs outstanding, January 3, 2021
Changes in outstanding Treasury RSUs:
Granted
Granted for dividends declared
Settled through the issuance of common shares
Forfeited
Treasury RSUs outstanding, January 2, 2022
Changes in outstanding Treasury RSUs:
Granted
Granted for dividends declared
Treasury RSUs outstanding, January 1, 2023
Number
Weighted average
fair value per unit
43
$
30.47
5
1
(5)
(21)
23
48
2
73
$
36.45
37.93
29.68
29.95
32.55
34.67
30.48
33.91
As at January 1, 2023 and January 2, 2022, none of the outstanding Treasury RSUs vested.
The compensation expense related to Treasury RSUs included in operating income for fiscal 2022 was an expense of
$0.4 million (2021 - $0.2 million recovery), and the counterpart has been recorded as contributed surplus. When the
underlying shares are issued to the employees, the amounts previously credited to contributed surplus are transferred
to share capital.
GILDAN 2022 REPORT TO SHAREHOLDERS 105
16. SHARE-BASED COMPENSATION (continued):
(c) Restricted share units (continued):
Outstanding non-Treasury RSUs were as follows:
Non-Treasury RSUs outstanding, January 3, 2021
Changes in outstanding non-Treasury RSUs:
Granted
Granted for dividends declared
Settled - common shares
Settled - payment of withholding taxes
Forfeited
Non-Treasury RSUs outstanding, January 2, 2022
Changes in outstanding non-Treasury RSUs:
Granted
Granted for dividends declared
Settled - common shares
Settled - payment of withholding taxes
Forfeited
Non-Treasury RSUs outstanding, January 1, 2023
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Number
Weighted average
fair value per unit
1,877
$
29.38
733
25
(127)
(70)
(492)
1,946
672
47
(229)
(146)
(201)
2,089
$
30.38
37.69
25.14
25.48
32.46
29.50
38.28
30.79
30.69
31.30
34.40
31.63
Non-Treasury RSUs have the same features as Treasury RSUs, except that their vesting period is a maximum of
three years and they can be settled in cash based on the Company’s share price on the vesting date, or through the
delivery of common shares purchased on the open market, at the Company's option. Non-Treasury RSUs are settled
in common shares purchased on the open market, and to the extent that the Company has an obligation under tax
laws to withhold an amount for an employee’s tax obligation associated with the share-based payment the Company
settles non-Treasury RSUs on a net basis.
The outstanding non-Treasury RSUs awarded to executive officers prior to fiscal 2022 have vesting conditions that
are dependent upon the attainment of strategic performance objectives which are set based on the Company’s long-
term strategic plan. The outstanding non-Treasury RSUs awarded to executive officers in fiscal 2022 have vesting
conditions that are dependent upon the financial performance and share price of the Company relative to a
benchmark group of North American publicly listed companies. In addition, up to two times the actual number of non-
Treasury RSUs awarded can vest if exceptional financial performance is achieved. As at January 1, 2023 and
January 2, 2022, none of the outstanding non-Treasury RSUs were vested.
The compensation cost related to non-Treasury RSUs included in operating income for fiscal 2022 was an expense of
$27.8 million (2021 - $33.3 million), and the counterpart has been recorded as contributed surplus. When the
underlying common shares are delivered to employees for settlement upon vesting, the amounts previously credited
to contributed surplus are transferred to share capital.
GILDAN 2022 REPORT TO SHAREHOLDERS 106
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
16. SHARE-BASED COMPENSATION (continued):
(d) Deferred share unit plan:
The Company has a deferred share unit plan for independent members of the Company’s Board of Directors who
must receive at least 50% of their annual board retainers in the form of deferred share units ("DSUs"). The value of
these DSUs is based on the Company’s share price at the time of payment of the retainers or fees. Holders of
deferred share units are entitled to dividends declared by the Company which are recognized in the form of additional
awards equivalent in value to the dividends paid on common shares. DSUs granted under the plan will be
redeemable and the value thereof payable in cash only after the director ceases to act as a director of the Company.
As at January 1, 2023, there were 385,403 (January 2, 2022 - 313,271) DSUs outstanding at a value of $10.6 million
(January 2, 2022 - $13.3 million). This amount is included in accounts payable and accrued liabilities based on a fair
value per deferred share unit of $27.40 (January 2, 2022 - $42.39). The DSU obligation is adjusted each quarter
based on the market value of the Company’s common shares. The Company includes the cost of the DSU plan in
selling, general and administrative expenses, which for fiscal 2022 was $2.5 million (2021 - $2.5 million).
Changes in outstanding DSUs were as follows:
DSUs outstanding, beginning of fiscal year
Granted
Granted for dividends declared
Redeemed
DSUs outstanding, end of fiscal year
(e) Employee share purchase plans:
2022
313
82
7
(17)
385
2021
301
58
4
(50)
313
The Company has employee share purchase plans which allow eligible employees to authorize payroll deductions of
up to 10% of their salary to purchase common shares of the Company at a price of 90% of the then current share
price as defined in the plans from Treasury. Employees purchasing shares under the plans subsequent to
January 1, 2008 must hold the shares for a minimum of two years. The Company has reserved 5,000,000 common
shares for issuance under the plans. As at January 1, 2023, 4,431,093 common shares remained authorized for
future issuance under the plans. Included as compensation costs in selling, general and administrative expenses is
$0.1 million (2021 - $0.1 million) relating to the employee share purchase plans.
17. SUPPLEMENTARY INFORMATION RELATING TO THE NATURE OF EXPENSES:
(a) Selling, general and administrative expenses:
Selling expenses
Administrative expenses
Distribution expenses
(b) Employee benefit expenses:
Salaries, wages and other short-term employee benefits
Share-based payments
Post-employment benefits
2022
78,520 $
144,925
100,663
324,108 $
$
$
2022
$
631,619 $
32,401
33,608
$
697,628 $
2021
68,591
147,260
98,320
314,171
2021
501,036
37,660
28,085
566,781
GILDAN 2022 REPORT TO SHAREHOLDERS 107
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
17. SUPPLEMENTARY INFORMATION RELATING TO THE NATURE OF EXPENSES (continued):
(c) Cost of sales:
Included in cost of sales for the year ended January 1, 2023 are the following items:
•
•
An expense of $19.7 million related to the write-down of inventory to net realizable value was included in cost of
sales.
Net insurance gains of $25.9 million, related to the two hurricanes which occurred in Central America in
November 2020. The net insurance gains reflected costs of $7.0 million (mainly attributable to equipment repairs
and other costs and charges) which were more than offset by related accrued insurance recoveries of
$32.9 million. The insurance gains primarily relate to accrued insurance recoveries at replacement cost value for
damaged equipment in excess of the write-off of the net book value of property plant and equipment.
Since November 2020, the Company has recognized $245.7 million of accrued insurance recoveries, of which
$235.3 million has been received as an advance ($50.0 million in December 2020, $50.0 million in March 2021,
$50.0 million in June 2021, $50.0 million in September 2021 and $35.3 million in December 2022), of which
receipts of $12.2 million are included in cash flow from operating activities and $23.1 million included in cash
flows from investing activities for the year ended January 1, 2023. As at January 1, 2023, $10.2 million of
insurance recoveries receivable are recorded in prepaid expenses, deposits and other current assets in the
consolidated statement of financial position.
The Company recognizes insurance recoveries for items that it has an unconditional contractual right to receive.
The Company expects to recognize additional insurance recoveries as the insurance claim process progresses.
Included in cost of sales for the year ended January 2, 2022 are the following items:
•
•
•
•
A reduction of cost of sales related to pandemic government assistance for users of U.S. cotton of
$18.3 million.
Net insurance gains of $46.0 million, related to the two hurricanes which occurred in Central America in
November 2020. The net insurance gain reflected costs of $54.7 million, (mainly attributable to equipment
repairs, salary and benefits continuation for idle employees, and other costs and charges), which were more
than offset by related accrued insurance recoveries of $100.7 million. The insurance gains primarily relate to
accrued insurance recoveries at replacement cost value for damaged equipment in excess of the write-off of
the net book value of property plant and equipment.
Charges of $4.2 million related to the Company's strategic initiatives to significantly reduce its product line
SKU count.
A write-down of production equipment and other assets relating to discontinued SKUs of $4.6 million.
(d) Government assistance:
During the year ended January 1, 2023 an amount of $18.1 million (2021 - $34.1 million) was recognized in cost of
sales in the consolidated statement of earnings and comprehensive income relating to government assistance for
production costs. The $34.1 million for the year ended January 2, 2022 included a COVID relief stimulus payment of
$18.3 million for users of U.S. cotton.
GILDAN 2022 REPORT TO SHAREHOLDERS 108
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
18. RESTRUCTURING AND ACQUISITION-RELATED COSTS:
Restructuring and acquisition-related costs are presented in the following table, and are comprised of costs directly related
to significant exit activities, including the closure of business locations or the relocation of business activities, significant
changes in management structure, as well as transaction, exit, and integration costs incurred pursuant to business
acquisitions.
2022
2021
Employee termination and benefit costs
Exit, relocation and other costs
Net (gain) loss on disposal, write-downs and accelerated depreciation of property, plant and
equipment, right-of-use assets and computer software related to exit activities
Acquisition-related transaction costs
971 $
$
2,179
251
3,312
(3,259) 3,136
1,526
588
479 $ 8,225
$
Restructuring and acquisition-related costs in fiscal 2022 related to the following: $4.8 million for the closure of a yarn-
spinning plant in the U.S, $2.6 million in accelerated depreciation of right-of-use assets relating to facilities no longer in
use, $0.6 million in employee termination and benefit costs related to the closure of a distribution center in the U.S., as
well $1.9 million related to the completion of previously initiated restructuring activities, partly offset by a gain of $6.0
million on business dispositions (refer to note 5 of the consolidated financial statements), and a gain of $3.4 million on the
sale of a former manufacturing facility in Mexico.
Restructuring and acquisition-related costs in fiscal 2021 related to the following: $4.1 million for post-closure costs
relating to the Company's former textile manufacturing and sewing operations in Mexico; $2.0 million for yarn-spinning
plant in the U.S., that was closed in 2020, including a lease exit charge; $1.5 million in transaction costs incurred in
connection with the acquisition of Frontier Yarns; and $0.6 million in other costs, to complete restructuring activities that
were initiated in prior years.
GILDAN 2022 REPORT TO SHAREHOLDERS 109
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
19. INCOME TAXES:
The income tax provision differs from the amount computed by applying the combined Canadian federal and provincial tax
rates to earnings before income taxes. The reasons for the difference and the related tax effects are as follows:
Earnings before income taxes
Applicable statutory tax rate
Income taxes at applicable statutory rate
Increase (decrease) in income taxes resulting from:
Effect of different tax rates and additional income taxes in other jurisdictions
Income tax and other adjustments related to prior taxation years
Recognition of previously de-recognized tax benefits related to tax losses and
temporary differences
Non-recognition of tax benefits related to tax losses and temporary differences
Effect of non-deductible expenses and other
Total income tax expense
Average effective tax rate
2022
2021
$
566,428
$
624,558
26.5 %
26.5 %
150,103
165,508
(132,436)
321
(157,321)
73
(9,938)
13,151
3,687
24,888
$
(8,593)
11,035
6,673
17,375
4.4 %
2.8 %
$
The Company’s applicable statutory tax rate is the Canadian combined rate applicable in the jurisdictions in which the
Company operates.
The details of income tax expense are as follows:
Current income taxes, includes a recovery of $1,283 (2021 - $1,061) relating to prior
taxation years
Deferred income taxes:
Origination and reversal of temporary differences
Recognition of previously de-recognized tax benefits related to tax losses and
temporary differences
Non-recognition of tax benefits related to tax losses and temporary differences
Adjustments relating to prior taxation years
2022
2021
$
25,039 $
18,340
(4,968)
(4,541)
(9,938)
13,151
1,604
(151)
(8,593)
11,035
1,134
(965)
17,375
Total income tax expense
$
24,888 $
In fiscal 2022, the Company re-recognized $9.9 million (2021 - $8.6 million) of previously de-recognized (in fiscal 2017
pursuant to the organizational realignment plan) deferred income tax assets in the U.S. relating to deferred income tax
assets that are now more likely than not to be recovered.
GILDAN 2022 REPORT TO SHAREHOLDERS 110
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
19. INCOME TAXES (continued):
Significant components of the Company’s deferred income tax assets and liabilities relate to the following temporary
differences and unused tax losses:
January 1,
2023
January 2,
2022
Deferred income tax assets:
Non-capital losses
Non-deductible reserves and accruals
Property, plant and equipment and Right-of-use assets
Intangible assets
Other items
Unrecognized deferred income tax assets
Deferred income tax assets
Deferred income tax liabilities:
Property, plant and equipment
Deferred income tax liabilities
Deferred income taxes
The details of changes to deferred income tax assets and liabilities were as follows:
Balance, beginning of fiscal year, net
Recognized in the statements of earnings:
Non-capital losses
Non-deductible reserves and accruals
Property, plant and equipment
Intangible assets
Other
Unrecognized deferred income tax assets
Business acquisitions
Other
Balance, end of fiscal year, net
$ 111,792 $ 102,138
26,304
16,434
2,537
7,730
155,143
(102,749)
52,394
14,837
19,761
3,427
10,189
160,006
(105,658)
54,348 $
$
$
$
$
(38,348) $
(38,348) $
(34,668)
(34,668)
16,000 $
17,726
2022
2021
$
17,726 $
17,689
10,133
(11,218)
797
888
2,459
(2,908)
151
3,462
(1,944)
(4,909)
6,425
274
(2,343)
965
(1,754)
(123)
16,000 $
(979)
51
17,726
$
As at January 1, 2023, the Company has tax credits, capital and non-capital loss carryforwards, and other deductible
temporary differences available to reduce future taxable income for tax purposes representing a tax benefit of
approximately $105.7 million, for which no deferred tax asset has been recognized (January 2, 2022 - $102.7 million),
because the criteria for recognition of the tax asset was not met. The tax credits and capital and non-capital loss
carryforwards expire between 2027 and 2042. The recognized deferred tax asset related to loss carryforwards is
supported by projections of future profitability of the Company.
The Company has not recognized a deferred income tax liability for the undistributed profits of subsidiaries operating in
foreign jurisdictions, as the Company currently has no intention to repatriate these profits. If expectations or intentions
change in the future, the Company may be subject to an additional tax liability upon distribution of these earnings in the
form of dividends or otherwise. As at January 1, 2023, a deferred income tax liability of approximately $67 million would
result from the recognition of the taxable temporary differences of approximately $627 million.
GILDAN 2022 REPORT TO SHAREHOLDERS 111
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
20. EARNINGS PER SHARE:
Reconciliation between basic and diluted earnings per share is as follows:
Net earnings - basic and diluted
Basic earnings per share:
Basic weighted average number of common shares outstanding
Basic earnings per share
Diluted earnings per share:
2022
2021
$
541,540 $
607,183
184,128
$
2.94 $
197,014
3.08
Basic weighted average number of common shares outstanding
184,128
197,014
Plus dilutive impact of stock options, Treasury RSUs, and common
shares held in trust
Diluted weighted average number of common shares outstanding
Diluted earnings per share
404
184,532
$
2.93 $
581
197,595
3.07
Excluded from the above calculation for the year ended January 1, 2023 are 282,737 stock options (2021 - nil) and 25,614
Treasury RSUs (2021 - nil) which were deemed to be anti-dilutive.
21. DEPRECIATION AND AMORTIZATION:
Depreciation of property, plant and equipment (note 9)
Depreciation of right-of-use assets (note 10)
Adjustment for the variation of depreciation included in inventories at the beginning
and end of the year
Amortization of intangible assets, excluding software (note 11)
Amortization of software (note 11)
Depreciation and amortization included in net earnings
2022
$
102,314 $
14,777
(11,317)
13,755
5,397
124,926 $
$
2021
92,176
13,973
11,177
12,818
5,258
135,402
GILDAN 2022 REPORT TO SHAREHOLDERS 112
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
22. SUPPLEMENTAL CASH FLOW DISCLOSURE:
(a) Adjustments to reconcile net earnings to cash flows from operating activities - other items:
Deferred income taxes (note 19)
Unrealized net (gain) loss on foreign exchange and financial derivatives
Other non-current assets
Other non-current liabilities
(b) Variations in non-cash transactions:
2022
(151) $
(352)
1,654
6,989
8,140 $
2021
(965)
(5,958)
2,246
2,653
(2,024)
$
$
2022
2021
Net additions to property, plant and equipment and intangible assets included in
accounts payable and accrued liabilities
$
1,522 $
4,641
Proceeds on disposal of property, plant and equipment and computer software
included in other current assets
Additions to right-of-use assets included in lease obligations
Shares repurchases for cancellation included in accounts payable and accrued
liabilities
Non-cash ascribed value credited to share capital from shares issued or distributed
pursuant to vesting of restricted share units and exercise of stock options
Deferred compensation credited to contributed surplus
Non-cash ascribed value credited to contributed surplus for dividends attributed to
restricted share units
157
2,960
—
3,504
(5,299)
—
8,996
(2,110)
4,515
(2,075)
1,497
943
(c) Changes in non-cash working capital balances:
Trade accounts receivable
Income taxes
Inventories
Prepaid expenses, deposits and other current assets
Accounts payable and accrued liabilities
2022
2021
$
77,940 $
(135,103)
(1,571)
(448,838)
29,915
35,460
12,577
(33,744)
(18,964)
78,495
$
(307,094) $
(96,739)
GILDAN 2022 REPORT TO SHAREHOLDERS 113
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
23. RELATED PARTY TRANSACTIONS:
Key management personnel compensation:
Key management personnel includes those individuals that have authority and responsibility for planning, directing and
controlling the activities of the Company, directly or indirectly, and is comprised of the members of the executive
management team and the Board of Directors. The amount for compensation expense recognized in net earnings for key
management personnel, including amounts for an executive who retired during fiscal 2021, was as follows:
Short-term employee benefits
Post-employment benefits
Share-based payments
2022
7,894 $
181
24,826
32,901 $
2021
12,296
907
30,460
43,663
$
$
The amounts included in accounts payable and accrued liabilities for share-based compensation awards to key
management personnel were as follows:
DSUs
Other:
January 1,
2023
January 2,
2022
$ 10,560 $ 13,280
During fiscal 2022, the Company incurred expenses for aircraft and other services of $1.9 million (2021 - $1.5 million),
with companies controlled by the President and Chief Executive Officer of the Company. The payments made are in
accordance with the terms of the agreement established and agreed to by the related parties. As at January 1, 2023, the
amount in accounts payable and accrued liabilities related to the airplane usage and other services was $0.1 million
(January 2, 2022 - $0.3 million).
On June 23, 2021, the aircraft agreement was amended with an effective date of January 1, 2021 to incorporate a
minimum usage fee per year, which is calculated as the average usage in the two preceding fiscal years, excluding the
years 2020 and 2021, multiplied by the hourly fee. As at January 1, 2023, the Company has a commitment of $1.4 million
under this amended agreement, which relates to minimum usage fees for fiscal 2023.
24. COMMITMENTS, GUARANTEES AND CONTINGENT LIABILITIES:
(a) Claims and litigation:
The Company is a party to claims and litigation arising in the normal course of operations. The Company does not
expect the resolution of these matters to have a material adverse effect on the financial position or results of
operations of the Company.
(b) Guarantees:
The Company, and some of its subsidiaries, have granted financial guarantees, irrevocable standby letters of credit,
and surety bonds to third parties to indemnify them in the event the Company and some of its subsidiaries do not
perform their contractual obligations. As at January 1, 2023, the maximum potential liability under these guarantees
was $153.0 million (January 2, 2022 - $121.3 million), of which $17.3 million was for surety bonds and $135.7 million
was for financial guarantees and standby letters of credit (January 2, 2022 - $10.5 million and $110.8 million,
respectively).
As at January 1, 2023, the Company has recorded no liability with respect to these guarantees, as the Company does
not expect to make any payments for the aforementioned items.
GILDAN 2022 REPORT TO SHAREHOLDERS 114
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
25. CAPITAL DISCLOSURES:
The Company’s objective in managing capital is to ensure sufficient liquidity to pursue its organic growth strategy and
undertake selective acquisitions, while maintaining a strong credit profile and a capital structure that reflects a target ratio
of financial leverage as noted below.
The Company’s capital is composed of net debt and shareholders’ equity. Net debt consists of interest-bearing debt less
cash and cash equivalents. The Company’s use of capital is to finance working capital requirements, capital expenditures,
business acquisition, payment of dividends, as well as share repurchases. The Company currently funds these
requirements out of its internally-generated cash flows and with funds drawn from its long-term debt facilities.
The primary measure used by the Company to monitor its financial leverage is its net debt leverage ratio. The Company’s
net debt leverage ratio is defined as the ratio of net debt to adjusted EBITDA for the trailing twelve months, on a pro-forma
basis to reflect business acquisitions made during the trailing twelve month period, as if they had occurred at the
beginning of the trailing twelve month period. Adjusted EBITDA is calculated as earnings before financial expenses,
income taxes, and depreciation and amortization, and excludes the impact of restructuring and acquisition-related costs.
Adjusted EBITDA also excludes impairment of goodwill and intangible assets and reversal of impairments on intangible
assets, net insurance gains related to the two hurricanes which impacted the Company’s operations in Central America,
the discontinuance of PPE SKUs, the impact of the Company's strategic initiative to significantly reduce its retail product
line SKU count which the Company began implementing in the fourth quarter of fiscal 2020, and the impact of adjustments
related to the Company’s decision in the fourth quarter of fiscal 2019 to implement a strategic initiative to significantly
reduce its imprintables product line SKU count, by exiting all ship to-the-piece activities and discontinuing overlapping and
less productive styles and SKUs between brands. The Company has set a fiscal year-end net debt leverage target ratio of
one to two times adjusted EBITDA. As at January 1, 2023, the Company’s net debt leverage ratio was 1.1 times
(January 2, 2022 - 0.7 times).
In order to maintain or adjust its capital structure, the Company, upon approval from its Board of Directors, may issue or
repay long-term debt, issue shares, repurchase shares, pay dividends or undertake other activities as deemed appropriate
under the specific circumstances. The Board of Directors will consider several factors when deciding to declare quarterly
cash dividends or approve share repurchase programs, including the Company’s present and future earnings, cash flows,
capital requirements and present and/or future regulatory and legal restrictions. There can be no assurance as to the
declaration of future quarterly cash dividends. On February 22, 2022, the Board of Directors approved a 10% increase in
the amount of the current quarterly dividend and declared a cash dividend of $0.169 per share. The Company paid
dividends of $123.8 million during the year ended January 1, 2023, representing dividends declared per common share of
$0.676. On February 21, 2023, the Board of Directors approved a 10% increase in the amount of the current quarterly
dividend and declared a cash dividend of $0.186 per share, on all of the issued and outstanding common shares of the
Company, rateably and proportionately, to the holders of record on March 14, 2023. The Company repurchased for
cancellation a total of 13,096,866 common shares under its NCIB programs for a total cost of $443.9 million during the
year ended January 1, 2023.
The Company is not subject to any capital requirements imposed by a regulator.
GILDAN 2022 REPORT TO SHAREHOLDERS 115
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
26. FINANCIAL RISK MANAGEMENT:
Due to the nature of the activities that the Company carries out and as a result of holding financial instruments, the
Company is exposed to risks arising from financial instruments, including credit risk, liquidity risk, foreign currency risk,
interest rate risk, commodity price risk, as well as risks arising from changes in the price of its common shares under the
Company's share-based compensation plans.
The Company may periodically use derivative financial instruments to manage risks related to fluctuations in foreign
exchange rates, commodity prices, interest rates, and the market price of its own common shares. The use of derivative
financial instruments is governed by the Company’s Financial Risk Management Policy approved by the Board of
Directors and is administered by the Financial Risk Management Committee. The Financial Risk Management Policy of
the Company stipulates that derivative financial instruments should only be used to hedge or mitigate an existing financial
exposure that constitutes a commercial risk to the Company, and if the derivatives are determined to be the most efficient
and cost effective means of mitigating the Company’s exposure to liquidity risk, foreign currency risk, and interest rate risk,
as well as risks arising from commodity prices. Hedging limits, as well as counterparty credit rating and exposure
limitations are defined in the Company’s Financial Risk Management Policy, depending on the type of risk that is being
mitigated. Derivative financial instruments are not used for speculative purposes.
At the inception of each designated hedging derivative contract, the Company formally designates and document the
hedging relationship and its risk management objective and strategy for undertaking the hedge. Documentation includes
identification of the hedging instrument, the hedged item, the nature of the risk being hedged, and how the Company will
assess whether the hedging relationship meets the hedge effectiveness requirements, including its analysis of the sources
of hedge ineffectiveness and how they determine the hedge ratio.
Credit risk
Credit risk is the risk of an unexpected loss if a customer or counterparty to a financial instrument fails to meet its
contractual obligations and arises primarily from the Company’s trade accounts receivable. The Company may also have
credit risk relating to cash and cash equivalents and derivative financial instruments, which it manages by dealing only
with highly rated North American and European financial institutions. The Company's credit risk may also be exacerbated
during periods of weak general economic and financial conditions. The Company's trade accounts receivable and credit
exposure fluctuate throughout the year based on the seasonality of its sales and other factors. The Company’s average
trade accounts receivable and credit exposure during an interim reporting period may be significantly higher than the
balance at the end of that reporting period. In addition, due to the historical seasonality of the Company’s net sales, the
Company’s trade accounts receivable balance as at the end of a calendar year will typically be lower than at the end of an
interim reporting period.
Under the terms of a receivables purchase agreement, the Company may continuously sell trade accounts receivables of
certain designated customers to a third-party financial institution in exchange for a cash payment equal to the face value
of the sold trade accounts receivables, less an applicable discount. The Company retains servicing responsibilities,
including collection, for these trade accounts receivables but does not retain any credit risk with respect to any trade
accounts receivables that have been sold. All trade accounts receivables sold under the receivables purchase agreement
are removed from the consolidated statements of financial position, as the sale of the trade accounts receivables qualify
for de-recognition. The receivables purchase agreement, which allows for the sale of a maximum of $300 million of
accounts receivables at any one time, expires on June 19, 2023, subject to annual extensions.
The Company’s credit risk for trade accounts receivables is concentrated as the majority of its sales are to a relatively
small group of wholesale distributors and mass-market and other retailers. As at January 1, 2023, the Company’s ten
largest trade debtors accounted for 72% of trade accounts receivable (2021 - 78%); the largest of which accounted for
23% (2021 - 24%). The Company’s main trade debtors are located in the U.S. The remaining trade accounts receivable
balances are dispersed among a larger number of debtors across many geographic areas including the U.S., Canada,
Europe, Asia-Pacific, and Latin America.
The Company makes an assessment of whether accounts receivable are collectable, based on an expected credit loss
model which factors in changes in credit quality since the initial recognition of trade accounts receivable based on
customer risk categories. Credit quality is assessed by taking into account the financial condition and payment history of
the Company's customers, and other factors.
GILDAN 2022 REPORT TO SHAREHOLDERS 116
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
26. FINANCIAL RISK MANAGEMENT (continued):
Credit risk (continued)
In determining its allowance for expected credit losses, the Company applies the simplified approach per IFRS 9,
Financial Instruments, and calculates expected credit losses based on lifetime expected credit losses. The Company uses
a provision matrix, which segregates its customers by their economic characteristics and allocates expected credit loss
rates based on days past due of its trade receivables. Expected credit loss rates are based on the Company’s historical
credit loss experience, adjusted for forward-looking factors of the economic environment.
Most of the Company’s customers have been transacting with the Company or its subsidiaries for several years. Certain
wholesale distributors are highly leveraged with significant reliance on trade credit terms provided by a few major vendors,
including the Company, and third-party debt financing, including bank debt secured with trade accounts receivable and
inventory pledged as collateral. The financial leverage of these customers may limit or prevent their ability to refinance
existing indebtedness or to obtain additional financing and could affect their ability to comply with restrictive debt
covenants and meet other obligations. The profile and credit quality of the Company’s mass-market and other retailer
customers vary significantly.
The Company’s extension of credit to customers involves considerable judgment and is based on an evaluation of each
customer’s financial condition and payment history. The Company has established various internal controls designed to
mitigate credit risk, including a dedicated credit function which recommends customer credit limits and payment terms that
are reviewed and approved on a quarterly basis by senior management at the Company’s primary sales offices in
Christ Church, Barbados. Where available, the Company’s credit departments periodically review external ratings and
customer financial statements and, in some cases, obtain bank and other references. New customers are subject to a
specific validation and pre-approval process. From time to time, where circumstances warrant, the Company will
temporarily transact with customers on a prepayment basis. While the Company’s credit controls and processes have
been effective in mitigating credit risk, these controls cannot eliminate credit risk in its entirety and there can be no
assurance that these controls will continue to be effective or that the Company’s historical credit loss experience will
continue.
The Company’s exposure to credit risk for trade accounts receivable by geographic area was as follows as at:
Trade accounts receivable by geographic area:
United States
Canada
Europe and other
Total trade accounts receivable
The aging of trade accounts receivable balances was as follows as at:
Not past due
Past due 0-30 days
Past due 31-60 days
Past due 61-120 days
Past due over 121 days
Trade accounts receivable
Less allowance for expected credit losses
Total trade accounts receivable
January 1,
2023
January 2,
2022
198,949 $
13,279
36,557
248,785 $
296,100
16,954
16,913
329,967
January 1,
2023
January 2,
2022
239,218 $
10,842
3,907
6,837
3,375
264,179
(15,394)
248,785 $
318,528
9,352
3,667
2,903
9,221
343,671
(13,704)
329,967
$
$
$
$
GILDAN 2022 REPORT TO SHAREHOLDERS 117
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
26. FINANCIAL RISK MANAGEMENT (continued):
Liquidity risk
Liquidity risk is defined as the potential risk that the Company will not be able to meet its financial obligations as they fall
due.
The Company manages its liquidity risk through the management of its capital structure and financial leverage, as outlined
in note 25 to these consolidated financial statements. In addition, the Company manages this risk by continuously
monitoring actual and projected cash flows, taking into account the seasonality of its sales and cash receipts and the
expected timing of capital expenditures.
In managing its liquidity risk, the Company relies on cash resources, debt, and cash flows generated from operations to
satisfy its financing requirements. The Company may also require access to capital markets to support its operations as
well as to achieve its strategic plans. Any impediments to the Company's ability to continue to meet the covenants and
conditions contained in its long-term debt agreements as well as the Company's ability to access capital markets, the
failure of a financial institution participating in its revolving long-term bank credit facilities, or an adverse perception in
capital markets of the Company's financial condition or prospects could have a material impact on its future financing
capability. In addition, the Company's access to capital markets and to financing at reasonable terms and interest rates
could be influenced by the economic and credit market environment, including a potential prolonged economic downturn
and recessions resulting from the unprecedented nature of the COVID-19 pandemic.
The following tables present a maturity analysis based on contractual maturity date of the Company's financial liabilities.
All commitments have been reflected in the consolidated statements of financial position except for purchase
obligations, as well as minimum royalty payments, which are included in the table of contractual obligations below. The
amounts are the contractual undiscounted cash flows.
(in $ millions)
amount
cash flows
1 year and 3 years and 5 years
5 years
Carrying Contractual
Less than Between 1 Between 4 More than
Accounts payable and accrued liabilities
Long-term debt
Purchase and other obligations
Lease obligations
Total contractual obligations
471.2
930.0
—
94.0
1,495.2
471.2
930.0
598.5
114.9
2,114.6
471.2
150.0
335.8
19.3
976.3
—
—
132.5
29.2
161.7
—
780.0
87.7
22.8
890.5
—
—
42.5
43.6
86.1
As disclosed in note 24, the Company has granted financial guarantees, irrevocable standby letters of credit, and surety
bonds to third parties to indemnify them in the event the Company and some of its subsidiaries do not perform their
contractual obligations. As at January 1, 2023, the maximum potential liability under these guarantees was $153.0 million,
of which $17.3 million was for surety bonds and $135.7 million was for financial guarantees and standby letters of credit.
Foreign currency risk
The majority of the Company’s cash flows and financial assets and liabilities are denominated in U.S. dollars, which is the
Company’s functional and reporting currency. Foreign currency risk is mainly limited to the portion of the Company’s
business transactions denominated in currencies other than U.S. dollars, primarily for sales and distribution expenses for
customers outside the U.S., certain equipment purchases, and head office expenses in Canada. The Company’s
exposure relates primarily to changes in the U.S. dollar versus the Canadian dollar, the Pound sterling, the Euro, the
Australian dollar, the Mexican peso, and the Chinese yuan. For the Company’s foreign currency transactions, fluctuations
in the respective exchange rates relative to the U.S. dollar will create volatility in the Company’s cash flows, in the
reported amounts for sales and SG&A expenses in its consolidated statement of earnings and comprehensive income,
and for property, plant and equipment in its consolidated statement of financial position, both on a period-to-period basis
and compared with operating budgets and forecasts. Additional earnings variability arises from the translation of monetary
assets and liabilities denominated in currencies other than the U.S. dollar at the rates of exchange at each reporting
dates, the impact of which is reported as a foreign exchange gain or loss and included in financial expenses (net) in the
statement of earnings and comprehensive income.
GILDAN 2022 REPORT TO SHAREHOLDERS 118
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
26. FINANCIAL RISK MANAGEMENT (continued):
Foreign currency risk (continued)
The Company also incurs a portion of its manufacturing costs in foreign currencies, primarily payroll costs paid in
Honduran Lempiras, Dominican Pesos, Mexican Pesos, Nicaraguan Cordobas, as well as in Bangladeshi Taka.
Significant changes in these currencies relative to the U.S. dollar exchange rate in the future, could have a significant
impact on the Company's operating results.
The Company’s objective in managing its foreign currency risk is to minimize its net exposures to foreign currency cash
flows, by transacting with third parties in U.S. dollars to the maximum extent possible and practical and holding cash and
cash equivalents and incurring borrowings in U.S. dollars. The Company monitors and forecasts the values of net foreign
currency cash flows and, from time to time will authorize the use of derivative financial instruments, such as forward
foreign exchange contracts with maturities of up to three years, to economically hedge a portion of foreign currency cash
flows. The Company had forward foreign exchange contracts outstanding as at January 1, 2023, consisting primarily of
contracts to sell and buy Canadian dollars, sell and buy Euros, sell Pounds sterling, sell Australian dollars, and sell
Mexican pesos in exchange for U.S. dollars. The outstanding contracts and other foreign exchange contracts that were
settled during fiscal 2022 were designated as cash flow hedges and qualified for hedge accounting. The underlying risk of
the foreign exchange contracts is identical to the hedged risk and, accordingly, the Company has established a ratio of 1:1
for all foreign exchange hedges.
The following tables provide an indication of the Company’s significant foreign currency exposures included in the
consolidated statement of financial position as at January 1, 2023 arising from financial instruments:
(in U.S. $ millions)
Cash and cash equivalents
Trade accounts receivable
Prepaid expenses, deposits and other current
assets
Accounts payable and accrued liabilities
January 1, 2023
CAD GBP EUR AUD MXN CNY BDT COP
4.7 0.7 3.2 1.1 6.7 2.0 14.8 0.2
13.0 4.6 17.8 4.0 4.1 0.7 — —
1.4 0.3 7.7 — 0.8 0.6 3.1 0.3
(9.2) —
(17.2)
(0.7) (11.8)
(1.8)
(2.4)
(0.8)
Based on the Company’s foreign currency exposures arising from financial instruments noted above, and the impact of
outstanding derivative financial instruments designated as effective hedging instruments, varying the foreign exchange
rates to reflect a 5 percent strengthening of the U.S. dollar would have (decreased) increased earnings and other
comprehensive income as follows, assuming that all other variables remained constant:
(in U.S. $ millions)
Impact on earnings before income taxes
Impact on other comprehensive (loss) income before
income taxes
For the year ended January 1, 2023
CAD GBP EUR AUD MXN CNY BDT COP
(0.1)
(0.2)
(0.8)
(0.2)
(0.5)
(0.1)
(0.4) —
0.6 2.1 1.9 0.4 0.1 — — —
An assumed 5 percent weakening of the U.S. dollar during the year ended January 1, 2023 would have had an equal but
opposite effect on the above currencies to the amounts shown above, assuming that all other variables remain constant.
GILDAN 2022 REPORT TO SHAREHOLDERS 119
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
26. FINANCIAL RISK MANAGEMENT (continued):
Commodity risk
The Company is subject to the commodity risk of cotton prices and cotton price movements, as the majority of its products
are made of 100% cotton or blends of cotton and synthetic fibers. The Company is also subject to the risk of fluctuations
in the prices of crude oil and petrochemicals as they influence the cost of polyester fibers which are used in many of its
products. The Company purchases cotton from third-party merchants, cotton-based yarn from third-party yarn
manufacturers, and polyester fibers from third-party polyester manufacturers. The Company assumes the risk of price
fluctuations for these purchases. The Company enters into contracts, up to eighteen months in advance of future delivery
dates, to establish fixed prices for its cotton and cotton-based yarn purchases and polyester fibers purchases, in order to
reduce the effects of fluctuations in the cost of cotton, crude oil, and petrochemicals used in the manufacture of its
products. These contracts are not used for trading purposes and are not considered to be financial instruments that would
need to be accounted for at fair value in the Company’s consolidated financial statements. Without taking into account the
impact of fixed price contracts, a change of $0.01 per pound in the price of cotton would affect the Company’s annual raw
material costs by approximately $4.8 million, based on current production levels.
In addition, fluctuations in crude oil or petroleum prices also affect the Company's energy consumption costs and can
influence transportation costs and the cost of related items used in its business, including other raw materials the
Company uses to manufacture its products such as chemicals, dyestuffs, and trims. The Company generally purchases
these raw materials at market prices.
The Company also has the ability to enter into derivative financial instruments, including futures and option contracts, to
manage its exposure to movements in commodity prices. Such contracts are accounted for at fair value in these
consolidated financial statements in accordance with the accounting standards applicable to financial instruments. During
fiscal 2022, the Company entered into commodity derivative contracts as described in note 15. The underlying risk of the
commodity derivative contracts is identical to the hedged risk and accordingly, the Company has established a ratio of 1:1
for all commodity derivative hedges. Due to a strong correlation between commodity future contract prices and its
purchased costs, the Company did not experience any significant ineffectiveness on its hedges, other than as disclosed in
note 15(d).
Interest rate risk
The Company is subject to interest rate risk arising from its $300 million term loan, $100 million of its unsecured notes
payable, and amounts drawn on its revolving long-term bank credit facilities, all of which bear interest at a variable U.S.
interest rate, plus a spread. The spread added to the adjusted Term SOFR is a function of the total net debt to EBITDA
ratio.
The Company generally fixes the rates for both adjusted Term SOFR and LIBOR-based borrowings for periods of one to
three months. The interest rates on amounts drawn on debt agreements and on any future borrowings will vary and are
unpredictable. Increases in interest rates on new debt issuances may result in a material increase in financial charges.
The Company has the ability to enter into derivative financial instruments that would effectively fix its cost of current and
future borrowings for an extended period of time. The Company has floating-to-fixed interest rate swaps outstanding to
hedge up to $250 million of its floating interest rate exposure on a designated portion of certain long-term debt
agreements. The interest rate swap contracts are designated as cash flow hedges and qualify for hedge accounting. Refer
to note 15(b) for additional information.
As discussed in note 12 of these consolidated financial statements, the Company amended its revolving facility and term
loan facility to replace LIBOR references with Term Secured Overnight Financing Rate (‘‘Term SOFR’’). The notes
purchase agreement was also amended to include LIBOR fallback provisions to replace LIBOR with adjusted term SOFR,
adjusted daily simple SOFR or any relevant alternate rate selected by the note holders and the Company upon a
benchmark transition event or early opt-in election. In addition, the Company and its counterparties under interest rate
swap agreements are in the process of negotiating the substitution of reference rates in such agreements.
GILDAN 2022 REPORT TO SHAREHOLDERS 120
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
26. FINANCIAL RISK MANAGEMENT (continued):
Interest rate risk (continued):
In July 2017, the United Kingdom’s Financial Conduct Authority (FCA), which regulates LIBOR, announced that it intends
to stop persuading or compelling banks to submit rates for the calculation of LIBOR to the administrator of LIBOR after
2021. In March 2021, the FCA announced that it will cease the issuance of the EUR, CHF, JPY and GBP LIBOR for all
tenors, as well as the one week and two month USD LIBOR at the end of December 31, 2021. All other USD LIBOR
tenors will cease at the end of June 30, 2023.
The Company may be subject to disputes or litigation with lenders over the appropriateness or comparability to LIBOR of
the substitute reference rates.
Based on the value of interest-bearing financial instruments during the year ended January 1, 2023, an assumed 0.5
percentage point increase in interest rates during such period would have decreased earnings before income taxes by
$2.1 million. An assumed 0.5 percentage point decrease in interest rates would have had an equal but opposite effect on
earnings before income taxes, assuming that all other variables remain constant.
27. DISAGGREGATION OF REVENUE:
Net sales by major product group were as follows:
Activewear
Hosiery and underwear
Net sales were derived from customers located in the following geographic areas:
United States
Canada
International
2022
2021
2,762,533 $
477,949
3,240,482 $
2,364,740
557,830
2,922,570
2022
2021
2,846,810 $
122,518
271,154
3,240,482 $
2,526,552
114,800
281,218
2,922,570
$
$
$
$
GILDAN 2022 REPORT TO SHAREHOLDERS 121
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
28. ENTITY-WIDE DISCLOSURES:
Property, plant and equipment, right-of-use-assets, intangible assets, and goodwill, are allocated to geographic areas as
follows:
United States
Canada
Honduras
Caribbean
Asia-Pacific
Other
January 1,
2023
January 2,
2022
$
560,854 $
59,604
380,825
440,511
223,307
29,654
1,694,755 $
$
602,120
69,939
346,256
486,876
129,926
32,848
1,667,965
Customers accounting for at least 10% of total net sales for the fiscal years ended January 1, 2023 and January 2, 2022
were as follows:
Customer A
Customer B
Customer C
2022
18.6 %
18.1 %
10.7 %
2021
15.9 %
13.9 %
5.9 %
GILDAN 2022 REPORT TO SHAREHOLDERS 122